<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://jsfk.ffarmasi.unand.ac.id/lib/pkp/xml/oai2.xsl" ?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/
		http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
	<responseDate>2026-04-03T22:32:33Z</responseDate>
	<request from="2018-04-19" metadataPrefix="oai_dc" verb="ListRecords">https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/oai</request>
	<ListRecords>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/10</identifier>
				<datestamp>2019-06-30T21:21:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulation and Evaluation of Edible Film from Basil Leaves Extract (Ocimum  americanum L.) as Mouth Freshener</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Dispersi Padat Irbesartan-Poloxamer 188 Terhadap Tekanan Darah dan Kadar Nitric Oxide (NO) Pada Tikus Putih Jantan Hipertensi</dc:title>
	<dc:creator>Harmely, Fifi</dc:creator>
	<dc:creator>Nasrul, Ellyza</dc:creator>
	<dc:creator>Umar, Salman</dc:creator>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:creator>Aldi, Yufri</dc:creator>
	<dc:subject xml:lang="id-ID">Hipertensi</dc:subject>
	<dc:subject xml:lang="id-ID">nitrit  oxida</dc:subject>
	<dc:subject xml:lang="id-ID">irbesartan</dc:subject>
	<dc:subject xml:lang="id-ID">poloxamer 188</dc:subject>
	<dc:subject xml:lang="id-ID">dispersi padat.</dc:subject>
	<dc:subject xml:lang="en-US">edible film</dc:subject>
	<dc:subject xml:lang="en-US">mouth freshener</dc:subject>
	<dc:subject xml:lang="en-US">extract of basil leaves.</dc:subject>
	<dc:description xml:lang="en-US">A research on formulation of edible film from basil leaves extract as mouth freshener  has been done. The extract of basil leaves were used in various concentrations which are 2.5%, 5% and 7.5%. The products were evaluated for some parameters such as organoleptic,  friability, drying shrinkage, pH, thickness, flavonoid contents and respondents preference. The results of evaluation showed that edible filmsfrom basil leaves extract  meet requirements as required by Standard Nasional Indonesia (SNI) and have such quality as product in the market. Statistical analysis using Kruskal Wallis test showed that respondents preferred for the  F0 formulation in term of their appearance and taste while as mouth freshener, respondents preferred  the F3 formulation.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian tentang pengaruh dispersi padat irbesartan-poloxamer 188 terhadap kadarNitrit Oxide (NO) pada tikus putih jantan hipertensi telah dilakukan . Penginduksi hipertensi yang digunakan adalah prednison 1,5 mg/kgBB dengan NaCl 2,5 %. Pada penelitian ini hewan percobaan dikelompokkan menjadi 4 kelompok. Kelompok I (kontrol negatif) diberikan makanan tikus dan minum, kelompok II (kontrol positif) diberikan penginduksi prednison 1,5 mg/kgBB dan NaCl 2,5%, kelompok III diberikan irbesartan nondispersi, kelompok IV diberikan irbesartan-poloxamer 188 1:0,5. Sediaan uji dalam bentuk dispersi padat irbesartan-poloxamer 188 terbukti dapat menurunkan tekanan darah dibandingkan terhadap kontrol positif dan meningkatkan kadar Nitric Oxide (NO). Ada perbedaan kadar Nitric Oxide (NO) yang diberikan Â irbesartan non dispersi dan dispersi padat irbesartan-poloxamer 188 pada tikus putih jantan hipertensi. Pemberian sediaan irbesartan-poloxamer 188 1:0,5 menunjukkan hasil yang lebih baik dibandingkan dengan sediaan irbesartan nondispersi (P&amp;lt;0,05).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2018-10-11</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/10</dc:identifier>
	<dc:identifier>10.25077/jsfk.5.2.88-93.2018</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 5 No. 2 (2018): J Sains Farm Klin, Vol 5 No 2, August 2018; 88-93</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 5 No 2 (2018): J Sains Farm Klin 5(2), Agustus 2018; 88-93</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/10/6</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/11</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulation of  Mucoadhesive Ketoprofen Granule Using Chitosan Polymer</dc:title>
	<dc:title xml:lang="id-ID">Formulasi Granul Mukoadhesif Ketoprofen Menggunakan Polimer Kitosan</dc:title>
	<dc:creator>Umar, Salman</dc:creator>
	<dc:creator>Ningsih, Wida</dc:creator>
	<dc:creator>Meliana, Monalisa</dc:creator>
	<dc:subject xml:lang="id-ID">granul mukoadhesif</dc:subject>
	<dc:subject xml:lang="id-ID">ketoprofen</dc:subject>
	<dc:subject xml:lang="id-ID">kitosan</dc:subject>
	<dc:subject xml:lang="id-ID">in vitro uji disolusi</dc:subject>
	<dc:subject xml:lang="id-ID">in vitro mukoadhesif.</dc:subject>
	<dc:subject xml:lang="en-US">mucoadhesive granules</dc:subject>
	<dc:subject xml:lang="en-US">ketoprofen</dc:subject>
	<dc:subject xml:lang="en-US">chitosan</dc:subject>
	<dc:subject xml:lang="en-US">in vitro dissolution test</dc:subject>
	<dc:subject xml:lang="en-US">in vitro mucoadhesive.</dc:subject>
	<dc:description xml:lang="en-US">The aim of this research was to formulate of mucoadhesive ketoprofen granules using chitosan polymer. Ketoprofen granules were prepared by wet granulation method with several concentrations of chitosan polymer 0%, 10%, 20%, and 30% (w/v). Granules were evaluated physically and chemically. In vitro dissolution test was carried out for 6 hours using a basket method in buffer phosphate medium pH 7.4. General evaluation of granules showed the yield was relatively good. In vitro mucoadhesive test exhibited that mucoadhesive ketoprofen granules using chitosan polymer could provide mucoadhesive properties to stomach and intestinal of rabbits. The statistics tests for dissolution efficiency with one ways ANOVA (SPSS 17) showed a significant different among F0, F1, F2 and F3 (P0.05). All the formulas followed Langenbucher kinetic release model.</dc:description>
	<dc:description xml:lang="id-ID">Tujuan penelitian ini yaitu formulasi granul mukoadhesif ketoprofen menggunakan polimer kitosan. Granul ketoprofen dibuat dengan metode granulasi basah dengan konsentrasi polimer kitosan 0%, 10%, 20%, dan 30% (b/v). Granul dievaluasi secara fisika dan kimia. Uji disolusi in vitro dilakukan selama 6 jam menggunakan metode keranjang dalam larutan dapar fosfat pH 7.4 secara umum granul yang dihasilkan relatif baik. Uji mukoadhesif in vitro menunjukkan bahwa granul ketoprofen menggunakan kitosan polimer dapat memberikan sifat mukoadhesif yang baik pada lambung dan usus kelinci secara in vitro. Uji statistik untuk efisiensi disolusi dilakukan dengan uji ANOVA (SPSS 17), dimana terdapat perbedaan yang signifikan antara F0 dengan F1, F2 dan F3 (P  0,05). Semua formula mengikuti model kinetika pelepasan  Langenbucher.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/11</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.11</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 48-53</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 48-53</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/11/7</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/12</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Analgesic Activity of Papaya Leaf Extract (Carica papaya L.) on Male Mice induced by Acetic Acid 1%</dc:title>
	<dc:title xml:lang="id-ID">Uji Aktifitas Analgetik Ekstrak Etanol Daun Pepaya (Carica papaya L.) pada Mencit Putih Jantan yang di Induksi Asam Asetat 1%</dc:title>
	<dc:creator>Afrianti, Ria</dc:creator>
	<dc:creator>Yenti, Revi</dc:creator>
	<dc:creator>Meustika, Dewi</dc:creator>
	<dc:subject xml:lang="id-ID">aktivitas analgesik</dc:subject>
	<dc:subject xml:lang="id-ID">carica papaya</dc:subject>
	<dc:subject xml:lang="id-ID">daun pepaya</dc:subject>
	<dc:subject xml:lang="id-ID">gerakan menggeliat.</dc:subject>
	<dc:subject xml:lang="en-US">analgesic activity</dc:subject>
	<dc:subject xml:lang="en-US">carica papaya leaves</dc:subject>
	<dc:subject xml:lang="en-US">writhing movements.</dc:subject>
	<dc:description xml:lang="en-US">Analgesic activity of extract of papaya leaves (Carica papaya L.) to male mice has been evaluated. Twenty five of mice (20-30 g, 2-3 months old) were divided randomly into five groups. The first group was given sodium CMC as negative control, the second until fourth groups received ethanolic extract of Carica papaya leaves in the doses of 100, 300, and 600 mg/kgBW, respectively and the fifth group was given paracetamol 65 mg/kg BW. All interventions were administered as single dose by oral route on given day. Acetic acid 1% (w/v) was used as the pain inductor. Analgesic activity was measured by counting the percentage of writhing movements as a measure of the analgesic effect produced by each intervention. Data were analyzed with one way ANOVA to compare analgesic activity between treatment groups. The results showed that the analgesic effect of the extract on the doses of 100, 300, and 600 mg/kg BW was significantly different with control group (P</dc:description>
	<dc:description xml:lang="id-ID">Evaluasi aktivitas analgesia dari ekstrak etanol daun pepaya (Carica papaya L.) pada mencit putih jantan telah dilakukan. Dua puluh lima ekor mencit (20-30 g, 2-3 bulan) dibagi secara acak menjadi lima kelompok. Grup pertama diberi NaCMC sebagai kontrol negatif, sedangkan kelompok 2-4 menerima ekstrak etanol daun Carica papaya dengan dosis 100, 300, dan 600 mg/kgBB dan kelompok kelima diberi parasetamol 65 mg/kgBB sebagai pembanding. Semua intervensi diberikan sebagai dosis tunggal secara oral. Asam asetat 1% (b/v) digunakan sebagai penginduksi nyeri. Aktivitas analgesik diukur dengan menghitung persentase geliatan sebagai ukuran efek analgesik yang dihasilkan oleh setiap intervensi. Data dianalisis dengan ANOVA satu arah untuk membandingkan aktivitas analgesik antara kelompok perlakuan. Hasil penelitian menunjukkan ekstrak pada dosis 100, 300, dan 600 mg/kgBB memberikan efek yang berbeda nyata dibandingkan dengan kontrol (P </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/12</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.12</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 54-60</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 54-60</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/12/8</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/13</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulation of Ylang-Ylang Oil Transparent Soap and Antibacterial Test Against Acne-Causing Bacteria</dc:title>
	<dc:title xml:lang="id-ID">Formulasi Sabun Transparan Minyak Ylang-Ylang dan Uji  Efektivitas terhadap Bakteri Penyebab Jerawat</dc:title>
	<dc:creator>F., Febriyenti</dc:creator>
	<dc:creator>Sari, Lisa Indah</dc:creator>
	<dc:creator>Nofita, Rahmi</dc:creator>
	<dc:subject xml:lang="id-ID">minyak ylang-ylang</dc:subject>
	<dc:subject xml:lang="id-ID">sabun trasnparan</dc:subject>
	<dc:subject xml:lang="id-ID">VCO</dc:subject>
	<dc:subject xml:lang="id-ID">Staphylococcus epidermidis.</dc:subject>
	<dc:subject xml:lang="en-US">ylang-ylang oil</dc:subject>
	<dc:subject xml:lang="en-US">transparent soap</dc:subject>
	<dc:subject xml:lang="en-US">virgin coconut oil</dc:subject>
	<dc:subject xml:lang="en-US">Staphylococcus epidermidis</dc:subject>
	<dc:description xml:lang="en-US">Ylang-ylang oil transparent soaps in three concentration i.e. 3.1 %, 3.85 % and 4.58 % have been formulated using virgin coconut oil (VCO), olive oil and stearic acid as a base soap reacted with NaOH as alkalin base. Transparent soap were tested for its identification, pH, wetting test, the foam on distilled water, the foam on hard water, skin irritation consumen preference test and micobiology test using the agar diffusion technique against bacterium cause of acnes like Staphylococcus epidermidis. The results showed that all formulas were stable for six weeks during storage conditions. Ylang-ylang transparent soap had medium antimicrobial activity (12-16 mm) against S. epidermidis. Statistical evaluation of pH, wetting test and micobiology test from formulas against control by using one way ANOVA had significant difference (p&amp;lt;0,05).</dc:description>
	<dc:description xml:lang="id-ID">Sabun transparan minyak Ylang-ylang telah diformulasi dengan tiga konsentrasi yaitu 3,1%, 3,85% dan 4,58% dengan menggunakan VCO, minyak zaitun dan asam stearate sebagai bahan dasar pembentuk sabun yang direaksikan dengan NaOH sebagai basa alkali. Masing-masing formula dievaluasi berupa pemerian, pH, daya pembasah, uji busa dalam air suling dan air sadah, uji iritasi kulit, uji penerimaan oleh konsumen dan uji daya antibakteri dengan metode difusi agar terhadap bakteri Staphylococcus epidermidis penyebab jerawat. Hasil evaluasi fisik sabun transparan menunjukkan bahwa semua formula stabil selama enam minggu penyimpanan. Hasil uji mikrobiologi sabun transparan minyak ylang-ylang menunjukkan daya hambat sedang (12-16 mm) terhadap bakteri S. epidermidis. Hasil statistik dengan analisa variasi (ANOVA) satu arah pada evaluasi pH, uji daya pembasah dan uji daya hambat bakteri terhadap S. epidermidis menunjukkan hasil saling berbeda nyata (p&amp;lt;0,05) untuk ketiga formula terhadap sediaan pembanding.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/13</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.13</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 61-71</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 61-71</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/13/9</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/14</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Effect of Vanadyl Sulphate and Chromium (III) Chloride combination on  Kidney Function of Diabetic Mice</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Pemberian Vanadil Sulfat dan Kromium (III) Klorida  terhadap Fungsi Ginjal Mencit Putih Diabetes</dc:title>
	<dc:creator>Dillasamola, Dwisari</dc:creator>
	<dc:creator>Dharma, Surya</dc:creator>
	<dc:creator>Arifin, Helmi</dc:creator>
	<dc:subject xml:lang="id-ID">kromium (III) klorida</dc:subject>
	<dc:subject xml:lang="id-ID">vanadil sulfat</dc:subject>
	<dc:subject xml:lang="id-ID">kreatinin.</dc:subject>
	<dc:subject xml:lang="en-US">chromium (III) chloride</dc:subject>
	<dc:subject xml:lang="en-US">vanadyl sulphate</dc:subject>
	<dc:subject xml:lang="en-US">creatinine</dc:subject>
	<dc:description xml:lang="en-US">The objective of this study was to identify the effect of two heavy metals, vanadyl sulphate and chromium (III) chloride on creatinine level of hyperglycemic mice induced by dexamethasone 11mg/kg. The experimental animals were grouped into five groups comprised of 5 white mice. Group I was used as control group, only received standard feeding and food supplement. Group II-V were induced with dexamethasone 11mg/kg to increase the blood glucose level. Group III was also given chromium (III) chloride 5.2 ug/20g. Group IV was also given vanadyl sulphate at the dose of 0.78 mg/20g. Group V received combination of vanadyl sulphate 0.39 mg/20g and chromium (III) chloride 2.6 ug/20g. The level of blood creatininewas determined by enzymatic method conducted for 42 days and observations were taken at day 7, 21 and 42. This study concluded that administration of vanadyl sulphate and chromium (III) chloride combination significantly reduced blood creatinine level of white mice (p&amp;lt;0,05).</dc:description>
	<dc:description xml:lang="id-ID">Tujuan dari penelitian ini adalah untuk mengetahui pengaruh dari dua logam berat vanadil sulfat dan krom (III) klorida pada tingkat kreatinin darah tikus putih hiperglikemia yang disebabkan oleh deksametason 11mg/kgBB. Hewan-hewan percobaan dikelompokkan menjadi lima kelompok yang terdiri dari 5 tikus putih. Kelompok I digunakan sebagai kelompok kontrol, yang hanya menerima makanan standar dan suplemen makanan. Kelompok II - V diinduksi dengan dexametason 11mg/ kgBB untuk meningkatkan kadar glukosa mereka. Kelompok III juga diberikan kromium (III) klorida 5,2 ug/ 20g BW. Kelompok IV juga diberi vanadil sulfat pada dosis 0,78 mg/ 20 gBB. Kelompok V menerima kombinasi vanadil sulfat dengan dosis 0,39 mg/ 20 gBB dan kromium (III) klorida pada dosis 2,6 ug/ 20 gBB. Tingkat kreatinin darah ditentukan dengan metode enzimatik yang dilakukan selama 42 hari dan pengamatan dilakukan pada hari ke-7, hari ke-21 dan hari ke-42. Penelitian ini menyimpulkan bahwa pemberian kombinasi vanadil sulfat dan kromium (III) klorida secara signifikan mengurangi tingkat kreatinin darah tikus putih (P &amp;lt;0,05).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/14</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.14</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 72-78</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 72-78</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/14/10</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/15</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Release of Ibuprofen from Carbomer 940 Gel of Ibuprofen- Nicotinamide Cocrystal</dc:title>
	<dc:title xml:lang="id-ID">Pelepasan Ibuprofen dari Gel Karbomer 940 Kokristal  Ibuprofen-Nikotinamida</dc:title>
	<dc:creator>Agustin, Rini</dc:creator>
	<dc:creator>Sari, Novica</dc:creator>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:subject xml:lang="id-ID">kokristal</dc:subject>
	<dc:subject xml:lang="id-ID">ibuprofen-nicotinamida</dc:subject>
	<dc:subject xml:lang="id-ID">kelarutan</dc:subject>
	<dc:subject xml:lang="id-ID">gel karbomer</dc:subject>
	<dc:subject xml:lang="id-ID">uji pelepasan.</dc:subject>
	<dc:subject xml:lang="en-US">co-crystal</dc:subject>
	<dc:subject xml:lang="en-US">ibuprofen-nicotinamide</dc:subject>
	<dc:subject xml:lang="en-US">solubility</dc:subject>
	<dc:subject xml:lang="en-US">gel carbomer</dc:subject>
	<dc:subject xml:lang="en-US">release test.</dc:subject>
	<dc:description xml:lang="en-US">One of the methods to increase the solubility is co-crystalization. As Ibuprofen can be used in topical application for rheumatoid arthritis, a study about formulation and release of ibuprofen-nicotinamide co-crystal in carbomer gel had been conducted. Co-crystal was obtained from a dissolve method, which ibuprofen and nicotinamida were mixed with equimol composition (1:1). Gel consisted of two formulas with the same amount of ibuprofen (5%). The first formula was gel co-crystal ibuprofen-nicotinamide and the second formula was pure ibuprofen. The basis used was carbormer 940. The release test was done using the horizontal type of Franz diffusion cell and measured using HPLC (High Performance Liquid Chromatography) with mobile phase of methanol: aquabidest (80:20) pH 3.5 with orthophosphate acid. The results showed both formulas were not stable in homogeneity aspect for several storage days. Separation was occurred at low and high temperatures. The result of release profiles at the 120th minutes was 4.4793 % and 4.4293 % and the release efficiencies were 3.8891 and 3.8612. The statistic analysis showed that release efficiencies of both formulas were not significantly different (p&amp;gt;0.05) using One-Way ANOVA. In a conclusion, the process of making gel of co-crystal ibuprofen-nicotinamide did not influenced ibuprofen release in gel preparation.</dc:description>
	<dc:description xml:lang="id-ID">Salah satu metode untuk meningkatkan kelarutan adalah co-kristalisasi. Ibuprofen dapat digunakan dalam aplikasi topikal untuk rheumatoid arthrisi, sehingga telah dilakukan sebuah studi tentang formulasi dan pelepasan kokristal ibuprofen-nikotinamida dari gel karbomer 940. Kokristal diperoleh dari metode penguapan pelarut dengan komposisi equimol (1:1). Gel terdiri dari dua formula dengan jumlah ibuprofen yang sama (5%). Formula pertama adalah gel kokristal ibuprofen-nicotinamida dan Formula dua adalah gel ibuprofen murni. Basis digunakan adalah carbormer 940. Uji pelepasan dilakukan dengan menggunakan sel difusi Franz jenis horizontal dan diukur menggunakan HPLC (High Performance Liquid Chromatography) dengan fase gerak metanol:aquabidest (80:20) pH 3,5 dengan asam ortofosfat. Hasil penelitian menunjukkan kedua formula tidak stabil dalam aspek homogenitas selama beberapa hari penyimpanan. Pemisahan terjadi pada suhu rendah dan tinggi. Hasil profil pelepasan pada menit ke-120 adalah 4,4793% dan 4,4293% dan efisiensi pelepasan 3,8891 dan 3,8612. Analisis statistik menunjukkan bahwa efisiensi pelepasan kedua formula tidak berbeda nyata (p&amp;gt;0,05) dengan menggunakan One-Way ANOVA. Pembentukan kokristal ibuprofen-nicotinamida ternyata tidak mempengaruhi pelepasan ibuprofen dari sediaan gel walaupun dapat meningkatkan kelarutan ibuprofen.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/15</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.15</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 79-88</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 79-88</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/15/11</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/16</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Propolis Toothpaste as The Initial Therapy of Mild Gingivitis</dc:title>
	<dc:title xml:lang="id-ID">Efektifitas Propolis Toothpaste sebagai Initial Therapy pada Mild Gingivitis</dc:title>
	<dc:creator>Kasuma, Nila</dc:creator>
	<dc:subject xml:lang="id-ID">propolis</dc:subject>
	<dc:subject xml:lang="id-ID">gingivitis ringan</dc:subject>
	<dc:subject xml:lang="id-ID">indeks gingiva</dc:subject>
	<dc:subject xml:lang="id-ID">terapi awal.</dc:subject>
	<dc:subject xml:lang="en-US">propolis</dc:subject>
	<dc:subject xml:lang="en-US">mild gingivitis</dc:subject>
	<dc:subject xml:lang="en-US">gingival Index</dc:subject>
	<dc:subject xml:lang="en-US">initial therapy.</dc:subject>
	<dc:description xml:lang="en-US">Characteristics of mild gingivitis are change in the color of the gums, slight edema, and no bleeding and painless. If it does not receive the proper treatment, gingivitis can become periodontitis which cause alveolar jaw bone tissue damage, resulting in further tissue damage locally and systemically through the blood vessels. The selection of appropriate therapy is essential to reduce the prevalence of the disease. In addition to scaling and plaque control, the propolis toothpaste can be used as initial therapy. The toothpaste contains propolis known for anti-inflammatory effects that is useful as one of the initial teraphy to treat mild gingivitis. Gingival index of 15 patients were measured before and after use of propolis toothpaste. Data analysis was performed by means of univariate to describe each variabel using Kolmogorov Smirnof Test. Gingival Index difference between before and after brushing with toothpaste containing propolis by paired t-test. Toothpaste contains propolis which proved effective in the initial therapy of mild gingivitis with an average difference of reduction in Gingival Index scores before and after was 0.40 Â± 0.04 There are significant differences (p &amp;lt;0.05) difference between the average reduction in Gingival Index scores before and after the use of toothpaste containing propolis.</dc:description>
	<dc:description xml:lang="id-ID">Karakteristik gingivitis ringan adalah terjadinya perubahan warna gusi, edema ringan, tidak ada pendarahan dan tanpa ada rasa nyeri. Jika pasien tidak mendapatkan perawatan yang tepat, gingivitis dapat berubah menjadi periodontitis yang menyebabkan kerusakan jaringan tulang rahang alveolar, menyebabkan kerusakan jaringan lebih lanjut secara lokal dan sistemik melalui pembuluh darah. Pemilihan terapi yang tepat sangat penting untuk mengurangi prevalensi dari penyakit ini. Selain proses scaling dan kontrol plak, penggunaan pasta gigi propolis dapat digunakan sebagai terapi awal. Komposisi pasta gigi yang mengandung propolis memiliki efek anti-inflamasi yang bermanfaat sebagai salah satu terapi awal untuk mengobati gingivitis ringan. Penelitian ini menggunakan metode eksperimen. Indeks gingiva dari 15 pasien diukur sebelum dan sesudah penggunaan pasta gigi propolis. Analisis data dilakukan dengan cara univariat untuk menggambarkan masing-masing variabel dengan Kolmogorov-Smirnof Test. Perbedaan indeks gingiva antara sebelum dan sesudah menyikat gigi dengan pasta gigi yang mengandung propolis dianalisis dengan uji T berpasangan. Pasta gigi yang mengandung propolis ini terbukti efektif dalam terapi awal gingivitis ringan dengan rata-rata pengurangan skor indeks gingiva sebelum dan sesudah adalah 0,40 Â± 0,04. Terdepat perbedaan yang signifikan (p &amp;lt;0,05) antara rata-rata penurunan nilai gingiva indeks sebelum dan setelah penggunaan pasta gigi yang mengandung propolis.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/16</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.16</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 89-94</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 89-94</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/16/12</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/17</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Indication Accuracy of Alprazolam Use in Stroke Patients of Neurology Ward of National Stroke Hospital Bukittinggi - Indonesia</dc:title>
	<dc:title xml:lang="id-ID">Kajian Ketepatan Indikasi Penggunaan Alprazolam pada Pasien Stroke di Bangsal Rawat Inap Neurologi Rumah Sakit Stroke  Nasional Bukittinggi</dc:title>
	<dc:creator>Sepriani, Rika</dc:creator>
	<dc:creator>Wahyuni, Fatma Sri</dc:creator>
	<dc:creator>Almahdy, Almahdy</dc:creator>
	<dc:creator>Armal, Khairil</dc:creator>
	<dc:subject xml:lang="id-ID">alprazolam</dc:subject>
	<dc:subject xml:lang="id-ID">tepat indikasi</dc:subject>
	<dc:subject xml:lang="id-ID">drug related problem</dc:subject>
	<dc:subject xml:lang="id-ID">pasien stroke.</dc:subject>
	<dc:subject xml:lang="en-US">alprazolam</dc:subject>
	<dc:subject xml:lang="en-US">indication accuracy</dc:subject>
	<dc:subject xml:lang="en-US">drug related problem</dc:subject>
	<dc:subject xml:lang="en-US">stroke patients.</dc:subject>
	<dc:description xml:lang="en-US">Cerebrovascular disease such as stroke remains one of diseases that causes disability and death in the world. Having sufficient quality and quantity of good sleep is one important part of the healing process. Sleep disorders also increase the patientâ€™s risk of developing recurrent stroke. The objective of this study was to analyze the accuracy of the indications for alprazolam in patients with stroke in neurology ward of National Stroke Hospital Bukittinggi, Indonesia. The study was conducted on November 2011 to February 2012 with the prospective method through observations on the condition of the patients, medical records, drug instruction cards, and the nursing care records of stroke patients who use alprazolam. Data were analyzed descriptively based on the treatment standards related to inaccuracy: alprazolam use without medical indications and indications which were not treated. The study showed that of 35 patients taking alprazolam, 1 of them was without medical indication 1 (3.45%) and another 1 was categorized as untreated indication (3.45%) of 29 incidences of drug related problems (DRP).</dc:description>
	<dc:description xml:lang="id-ID">Penyakit serebrovaskuler atau stroke masih merupakan salah satu penyakit yang banyak menimbulkan kecacatan dan kematian di dunia. Mendapat kualitas dan kuantitas tidur yang baik merupakan salah satu bagian penting dalam proses penyembuhan (recovery) pascastroke. Gangguan tidur juga meningkatkan resiko pasien pascastroke untuk menderita stroke berulang. Tujuan penelitian ini adalah untuk menganalisis ketepatan indikasi penggunaan alprazolam pada pasien stroke di bangsal rawat inap neurologi Rumah Sakit Stroke Nasional Bukittinggi.Penelitian ini dilakukan di Rumah Sakit Stroke Nasional Bukittinggi dari bulan November 2011 hingga Februari 2012 dengan metode prospektif melalui penelusuran terhadap kondisi pasien, catatan rekam medik, Kartu Instruksi Obat (KIO) dan catatan asuhan keperawatan pasien stroke yang menggunakan alprazolam di bangsal rawat inap neurologi Rumah Sakit Stroke Nasional Bukittinggi. Data yang diperoleh selanjutnya dianalisis secara deskriptif berdasarkan literatur yang berkaitan dengan ketepatan indikasi dengan kategori pemberian alprazolam tanpa indikasi medis dan indikasi yang tidak diterapi. Berdasarkan hasil penelitian didapatkan bahwa dari 35 orang pasien yang menggunakan alprazolam didapatkan</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/17</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.17</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 95-100</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 95-100</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/17/13</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/18</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulation of Ranitidine HCl Microcapsules with Ethyl Cellulose  Using a Factorial Design</dc:title>
	<dc:title xml:lang="id-ID">Formulasi Mikrokapsul Ranitidin HCl Menggunakan Rancangan Faktorial dengan Penyalut Etil Selulosa</dc:title>
	<dc:creator>Fitriani, Lili</dc:creator>
	<dc:creator>Rahmi, Ulfi</dc:creator>
	<dc:creator>Ben, Elfi Sahlan</dc:creator>
	<dc:subject xml:lang="id-ID">mikrokapsul</dc:subject>
	<dc:subject xml:lang="id-ID">ranitidin HCl</dc:subject>
	<dc:subject xml:lang="id-ID">efisiensi penjerapan</dc:subject>
	<dc:subject xml:lang="id-ID">pelepasan mikrokapsul.</dc:subject>
	<dc:subject xml:lang="en-US">microcapsules</dc:subject>
	<dc:subject xml:lang="en-US">ranitidine HCl</dc:subject>
	<dc:subject xml:lang="en-US">entrapment efficiency</dc:subject>
	<dc:subject xml:lang="en-US">microcapsule release.</dc:subject>
	<dc:description xml:lang="en-US">Ranitidine HCl is a histamine H2-antagonist which is used in the treatment of benign gastric and duodenal ulceration. In order to improve its bioavailability and half life time, microcapsule is prepared to extend the dose regiment. The aim of this study was to formulate and optimize ranitidine HCl containing microcapsule to prepare a suitable sustained release delivery system using factorial design. Microspheres were prepared using ethylcellulose by solvent evaporation method. The effect of different formulation variables, including stabilizer concentration (1-2 %) and drug/polymer ratio (2:2-1:2) on appearance, and entrapment efficiency was investigated. Data analysis showed that microspheres with optimum entrapment efficiency could be prepared using 2 % span 80, and 1:2 drug/polymer ratio. The results showed spherical shaped microcapsules, and porous, with realeasing time up to 10,55 hours.</dc:description>
	<dc:description xml:lang="id-ID">Ranitidin HCl adalah H2-antagonis histamin yang digunakan dalam pengobatan ulkus lambung dan duodenum. Formulasi mikrokapsul ranitiditin HCl ditujukan untuk memperpanjang regimen dosis untuk meningkatkan bioavailabilitas dan waktu paruh. Tujuan dari penelitian untuk merumuskan dan mengoptimalkan mikrokapsul ranitidin HCl untuk menyiapkan sistem pelepasan yang sesuai dengan desain faktorial. Mikrokapsul disusun menggunakan etilselulosa dengan teknik penguapan pelarut. Variasi konsentrasi penstabil Span 80 (1-2%) dan rasio obat/polimer (2: 2-1: 2) dilakukan untuk mengamati efek efisiensi penjerapan. Analisis data menunjukkan bahwa mikrokapsul dengan efisiensi penjerapan optimal didapatkan pada formula yang mengandung 2% span 80, dan 1:2 rasio obat/polimer. Hasil penelitian menunjukkan mikrokapsul berbentuk sferis, dan berpori, dengan waktu pelepasan hingga 10,55 jam.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/18</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.18</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 101-110</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 101-110</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/18/14</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/19</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Analgesic activity of Ethanolic Extract of Voacanga foetida (Bl.) K. Schum) on Male Mice</dc:title>
	<dc:title xml:lang="id-ID">Efek Analgetik Ekstrak Etanol Daun Tampa Badak (Voacanga foetida (Bl.) K. Schum) Pada Mencit Putih Jantan</dc:title>
	<dc:creator>Susanty, Adriani</dc:creator>
	<dc:creator>Fernando, Armon</dc:creator>
	<dc:creator>Adelin, Ivona</dc:creator>
	<dc:subject xml:lang="id-ID">analgesia</dc:subject>
	<dc:subject xml:lang="id-ID">tampa badak</dc:subject>
	<dc:subject xml:lang="id-ID">Voacanga foetida</dc:subject>
	<dc:subject xml:lang="id-ID">writhing test.</dc:subject>
	<dc:subject xml:lang="en-US">analgesic</dc:subject>
	<dc:subject xml:lang="en-US">voacanga foetida</dc:subject>
	<dc:subject xml:lang="en-US">writhing test.</dc:subject>
	<dc:description xml:lang="en-US">A study on the analgesic activity ethanolic extract of Voacanga foetida leaves has been conducted on male mice by using Writhing test. The mice were induced with 0.1 mL of glacial acetic acid 1%. The extract was administered orally in the doses of 250, 500, and 1000 mg/kg, suspended with NaCMC 1%, while 65 mg/kg acetosal was used as positive control. The data was analyzed with two way ANOVA. The study revealed that the extract exhibited analgesic effect insignificantly different with acetosal at the doses of 250, 500, and 1000 mg/kg. This effect was different with negative control (p&amp;lt;0.05).</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian tentang uji efek analgetik ekstrak etanol daun tampa badak (Voacanga foetida (BI.) K. Schum) pada mencit putih (Mus musculus) jantan, menggunakan Metoda Writhing Test. Sebagai kontrol positif digunakan asetosal 65 mg/kgBB yang diinduksi dengan asam asetat glasial 1% sebanyak 0,1 mL. Rute pemberian ekstrak etanol daun tampa badak secara oral dengan dosis 250, 500 dan 1000 mg/kgBB, yang disuspensi dengan NaCMC 1%. Data yang diperoleh diolah dengan menggunakan Analysis Of Varian (ANOVA) dua arah. Hasil penelitian menunjukkan bahwa ekstrak etanol daun tampa badak mempunyai efek sebagai analgetik yang sama dengan asetosal (kontrol positif) pada dosis 250, 500 dan 1000 mg/kgBB dan berbeda secara nyata dengan kontrol negatif (p&amp;lt;0,05).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2014-11-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/19</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.19</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 1-9</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 1-9</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/19/15</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/20</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Protection Effect of Ethyl Acetate Fraction of Toona sureni (Blume) Merr. Against Atherosclerosis</dc:title>
	<dc:title xml:lang="id-ID">Efek Proteksi Fraksi Etil Asetat Daun Surian (Toona sureni (Blume) Merr. ) terhadap Aterosklerosis</dc:title>
	<dc:creator>Suhatri, Suhatri</dc:creator>
	<dc:creator>Marusin, Netty</dc:creator>
	<dc:creator>Yeni, Delva</dc:creator>
	<dc:creator>Yosmar, Rahmi</dc:creator>
	<dc:subject xml:lang="id-ID">fraksi etil asetat</dc:subject>
	<dc:subject xml:lang="id-ID">toona sureni</dc:subject>
	<dc:subject xml:lang="id-ID">aterosklerosis</dc:subject>
	<dc:subject xml:lang="id-ID">hiperkolesterol.</dc:subject>
	<dc:subject xml:lang="en-US">ethyl acetate fraction</dc:subject>
	<dc:subject xml:lang="en-US">toona sureni</dc:subject>
	<dc:subject xml:lang="en-US">atherosclerosis</dc:subject>
	<dc:subject xml:lang="en-US">hypercholesterolemia.</dc:subject>
	<dc:description xml:lang="en-US">A study of the protection effect of ethyl acetate fraction of toona leaves (Toona sureni (Blume) Merr.) to the atherosclerotic blood vessel on the hypercholesterolemic quails has been carried out. The observation was conducted for histopathology of the blood vessel. The hypercholesterolemic quails were obtained through high-fat diet and propylthiouracil (PTU) induction. Aortic wall thickness, changes on the aortic lumen are, and visual endothelial cell dysfunction were determined. The study showed that the ethyl acetate fraction of toona leaves on the dose of 50 mg/kg body weight exhibited the best protection effect, indicated by aortic wall thickness and lumen area, and the degree of endothelial cell dysfunction which were not significantly different with the negative control group (p&amp;gt;0.05), but significantly different with positive control group (p&amp;lt;0.05).</dc:description>
	<dc:description xml:lang="id-ID">Studi tentang efek proteksi fraksi etil asetat daun surian (Toona sureni (Blume) Merr.) terhadap aterosklerosis pada burung puyuh hiperkolesterol sudah dilakukan. Metoda yang digunakan adalah metoda hispatologi. Hiperkolesterol di induksi dengan pemberian makanan lemak tinggi (MLT) dan profil tio urasil (PTU). Parameter yang diamati adalah adanya perbaikan tebal dinding pembuluh darah aorta, perubahan luas lumen aorta dan keadaan sel endothelia. Hasil penelitian menunjukan pemberian fraksi etil asetat daun surian dosis 50 mg/ kgBB memberikan efek proteksi yang terbaik, ditandai dengan tebal dinding pembuluh darah aorta, luas lumen dan tingkat kerusakan sel endotelia aorta tidak berbeda nyata dengan kontrol negatif (p&amp;gt;0,05) dan berbeda nyata dengan hewan kelompok positif (p&amp;lt;0,05).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2014-11-24</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/20</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.20</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 10-19</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 10-19</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/20/16</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/21</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Immunomodulatory Activity of Meniran Extracts (Phyllanthus niruri Linn.) on Broiler Chickens</dc:title>
	<dc:title xml:lang="id-ID">Aktivitas Imunomodulator dari Ekstrak Etanol Meniran (Phyllanthus niruri Linn.) terhadap Ayam Broiler</dc:title>
	<dc:creator>Aldi, Yufri</dc:creator>
	<dc:creator>Rasyadi, Yahdian</dc:creator>
	<dc:creator>Handayani, Dian</dc:creator>
	<dc:subject xml:lang="id-ID">immunomodulator</dc:subject>
	<dc:subject xml:lang="id-ID">Phyllanthus niruri</dc:subject>
	<dc:subject xml:lang="id-ID">meniran</dc:subject>
	<dc:subject xml:lang="id-ID">ayam broiler</dc:subject>
	<dc:subject xml:lang="id-ID">bersihan karbon.</dc:subject>
	<dc:subject xml:lang="en-US">immunomodulatory</dc:subject>
	<dc:subject xml:lang="en-US">phyllanthus niruri</dc:subject>
	<dc:subject xml:lang="en-US">meniran</dc:subject>
	<dc:subject xml:lang="en-US">broiler chicken</dc:subject>
	<dc:subject xml:lang="en-US">carbon clearance.</dc:subject>
	<dc:description xml:lang="en-US">Broilers chickens are highly susceptible to many diseases caused by bacteria and viruses. Therefore to solve these problem we can use alternative medicine by administration of immunostimulatory compounds that can prevent disease in broiler chickens. One of the plants that can enhance the immune system is meniran. The study effect of immunomodulatory test from ethanol extract of meniran herbs (Phyllanthus niruri Linn.) has been conducted in broiler chickens with carbon clearance method. The study of extract administered orally with dose of 10; 30; 100; 300 mg/kg BW and a solution of 0.5% NaCMC as negative control also suspension StimunoÂ® forte 13.5 mg/kg BW as positive control for 6 days. The data of phagocytosis index was analyzed statisticaly with two way ANOVA followed with Duncanâ€™s test. The increasing of phagocytosis index with carbon clearance method showed the effect from each dose with negative control was significant (P&amp;lt;0,05). The highest phagocytic index obtained from a dose of 300 mg / kg BW. The dataâ€™s of increased relative spleen weight and an increased of blood limfosit cell was analyzed statisticaly with one way ANOVA followed with Duncanâ€™s test. Increased relative spleen weight and an increased of blood limfosit cell showed effect from each dose to negative control was significant (P&amp;lt;0,05). The results indicated that the ethanolic extract of meniran was active as immunostimulant for broiler chickens.Â </dc:description>
	<dc:description xml:lang="id-ID">Ayam Broiler sangat rentan terhadap penyakit-penyakit yang disebabkan oleh bakteri dan virus. Oleh karena itu untuk mengatasi masalah ini kita dapat menggunakan pengobatan alternatif dengan pemberian senyawa imunostimulan yang dapat mencegah penyakit pada ayam broiler. Salah satu tanaman yang dapat meningkatkan sistem kekebalan tubuh adalah meniran. Studi efek imunomodulator dari ekstrak etanol meniran (Phyllanthus niruri Linn.) telah dilakukan pada ayam broiler dengan metode bersihan karbon. Ekstrak diberikan secara oral dengan dosis 10; 30; 100; 300 mg/kg BB dan larutan 0,5% NaCMC sebagai kontrol serta suspensi StimunoÂ® forte 13,5 mg/kg BB sebagai pembanding selama 6 hari. Data indeks fagositosis dianalisis secara statistik dengan ANOVA dua arah dilanjutkan dengan uji Duncan. Peningkatan indeks fagositosis menunjukkan bahwa efek dari setiap dosis dengan kontrol negatif berbeda signifikan (P &amp;lt;0,05). Indeks fagositosis tertinggi diperoleh dari dosis 300 mg/kg BB. Data tentang peningkatan berat relatif limpa dan peningkatan sel limfosit darah dianalisis dengan ANOVA satu arah dilanjutkan dengan uji Duncan. Peningkatan berat limpa relatif dan peningkatan sel limfosit darah menunjukkan efek dari masing-masing dosis untuk kontrol negatif berbeda signifikan (P&amp;lt;0,05). Hasil penelitian menunjukkan bahwa ekstrak etanol meniran aktif sebagai imunostimulan untuk ayam broiler.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/21</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.21</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 20-26</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 20-26</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/21/17</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/22</identifier>
				<datestamp>2019-06-30T21:28:20Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Analysis on Protein Profile and Amino acid of Edible Birdâ€™s Nest (Collocalia fuchiphaga) from  Painan</dc:title>
	<dc:title xml:lang="id-ID">Analisis Profil Protein dan Asam Amino Sarang Burung Walet (Collocalia fuchiphaga) Asal Painan</dc:title>
	<dc:creator>Elfita, Lina</dc:creator>
	<dc:subject xml:lang="id-ID">sarang burung walet</dc:subject>
	<dc:subject xml:lang="id-ID">protein</dc:subject>
	<dc:subject xml:lang="id-ID">asam amino.</dc:subject>
	<dc:subject xml:lang="en-US">bird nest of wallet</dc:subject>
	<dc:subject xml:lang="en-US">protein and amino acid.</dc:subject>
	<dc:description xml:lang="en-US">This study was aimed to analyze protein profile and amino acid composition of bird nest from Painan, Pesisir Selatan Distric, West Sumatra. Protein analysis was performed by Sodium Dodecyl Sulphate Polyacrilamide Gel Electrophoresis (SDS-PAGE), meanwhile High Performance Liquid Chromatography (HPLC) was used for analysis of amino acid. Analysis on water extract of bird nest by SDS-PAGE showed six bands which correspond to molecular protein which had molecular weight of 147.2; 142.6; 133.4; 73.3; 66.2; and 37.7 kDa, respectively. HPLC analysis demonstrated that bird nest was composed of 16 amino acids. Seven of them were essential amino acids; histidine (2.31%), leucine (3.84%), threonine (3.82%), valine (3.93%), methionine (0.48%), isoleucine (1.80%), phenylalanine (4.49%), and nine of them were non-essential amino acids; serine (4.56%), aspartic acid (4.48%), arginine (3.93%), lysine (2.34%), proline (3.64%), glutamic acid (3.65%), glycine (1.87%), alanine (1.31%), and tyrosine (3.92%). Serine was the highest percentage of amino acid in the bird nest (4.56%), followed by phenylalanine (4.49%) and aspartic acid (4.48%). The study also showed that composition of amino acid in this bird nest was slightly different with composition of amino acid in bird nest from other area.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk menganalisa profil protein dan asam amino sarang burung walet yang berasal dari daerah Painan, Kabupaten Pesisir Selatan, Sumatera Barat. Analisis protein dilakukan dengan menggunakan metode Sodium Dodesil Sulfat Poliakrilamid Gel Elektroforesis (SDS-PAGE), sedangkan analisis asam amino dilakukan dengan menggunakan Kromatografi Cair Kinerja Tinggi (KCKT). Analisa ekstrak air sarang burung walet dengan SDS-PAGE menunjukan bahwa sarang burung walet terdiri dari 6 protein dengan bobot molekul masing-masing 147,2; 142,6; 133,4; 73,3; 66,2; dan 37,7 kDa. Hasil analisis asam amino dengan KCKT didapatkan 16 asam amino yang terkandung dalam sarang burung wallet, yang terdiri dari 7 jenis asam amino esensial yaitu Histidin (2,31%), Leusin (3,84%), Treonin (3,82%), Valin (3,93%), Metionin (0,48%), Isoleusin (1,80%), Fenilalanine (4,49%) dan 9 asam amino non esensial yaitu Asam Serin (4,56%), Aspartat (4,48%), Arginin (3,93%), Lisin (2,34 %), Prolin (3,64%), Asam glutamate (3,65%), Glisin (1,87%), Alanin (1,31%), dan Tirosin (3,92%). Serin merupakan asam amino dengan kadar tertinggi (4,56%), diikuti dengan Fenil alanine (4,49%) dan Asam aspartat (4,48%). Kandungan asam amino ini sedikit berbeda dengan kandungan asam amino sarang burung walet dari daerah dan negara lain.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-02-06</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/22</dc:identifier>
	<dc:identifier>10.29208/jsfk.2014.1.1.22</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 1 (2014); 27-37</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 1 (2014): J Sains Farm Klin 1(1), November 2014; 27-37</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/22/18</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/23</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Solubilization of Parasetamol With RyotoÂ® Sugar Ester and Propylenglikol</dc:title>
	<dc:title xml:lang="id-ID">Solubilsasi Parasetamol Dengan RyotoÂ® Sugar Ester dan Propilenglikol</dc:title>
	<dc:creator>Noviza, Deni</dc:creator>
	<dc:creator>Febrianti, Nine</dc:creator>
	<dc:creator>Umar, Salman</dc:creator>
	<dc:subject xml:lang="id-ID">parasetamol</dc:subject>
	<dc:subject xml:lang="id-ID">ryotoÂ® sugar ester</dc:subject>
	<dc:subject xml:lang="id-ID">propilenglikol</dc:subject>
	<dc:subject xml:lang="id-ID">solubilisasi</dc:subject>
	<dc:subject xml:lang="en-US">parasetamol</dc:subject>
	<dc:subject xml:lang="en-US">ryotoÂ® sugar ester</dc:subject>
	<dc:subject xml:lang="en-US">propylenglikol</dc:subject>
	<dc:subject xml:lang="en-US">solubilization</dc:subject>
	<dc:description xml:lang="en-US">Paracetamol was an active ingredient, which is poorly soluble in water. Absorption of poorly soluble or slightly soluble in water is influenced by the rate of dissolution. Solubilization is an alternative to improve drug solubility in water with the addition of surfactant. The addition of RyotoÂ® sugar ester surfactant and propylene glycol cosolvent conducted to determine the concentration of RyotoÂ® sugar ester and prophylene glycol that increase the solubility and stability of the dosage form. Solubilization of Paracetamol with the addition of RyotoÂ® sugar ester without propylene glycol and combinations RyotoÂ® sugar ester and propylene glycol at a concentration below the CMC point (Critical Micell Concentration), at the point of CMC, and above the CMC points in a row is 0.005 mg/ml, 0.006 mg/ml, and 0.007 mg/ml with 10% propylene glycol. The highest solubility of Paracetamol achieved in the formula 7 with a combination of the addition RyotoÂ® sugar ester (0.007 mg/ml) and propylene glycol (10%) by the recovery percentage of 99.6%, and the combination is also obtained the best preparation stability which is not occur the color change in the preparations during storage at room temperature and place protected from direct sunlight for a month. The addition of RyotoÂ® sugar ester surfactant and propylene glycol increase the solubility and stability of the solubilization of Paracetamol preparations.</dc:description>
	<dc:description xml:lang="id-ID">Parasetamol merupakan obat yang agak sukar larut dalam air. Absorbsi obat sukar larut atau agak sukar larut dalam air dipengaruhi oleh laju pelarutan. Solubilisasi merupakan alternatif untuk meningkatkan kelarutan obat dalam air dengan penambahan surfaktan. Penambahan surfaktan RyotoÂ® sugar ester dan kosolven propilen glikol dilakukan untuk menentukan konsentrasi RyotoÂ® sugar ester dan prolilen glikol yang dapat meningkatan kelarutan dan stabilitas sediaan. Solubilisasi parasetamol dengan penambahan RyotoÂ®Â  sugar ester tanpa propilen glikol dan kombinasi penambahan RyotoÂ® sugar ester dan propilen glikol pada konsentrasi dibawah titik CMC (Critical Micell Concentration), pada titik CMC, dan diatas titik CMC berturut-turut adalah 0,005 mg/ml, 0,006 mg/ml, dan 0,007 mg/ml dengan 10% propilen glikol. Kelarutan parasetamol tertinggi dicapai pada formula 7 dengan kombinasi penambahan RyotoÂ® sugar ester (0,007 mg/ml) dan propilen glikol (10%) yaitu dengan persentase perolehan kembali 99,6 %, serta pada kombinasi ini juga diperoleh stabilitas sediaan yang paling bagus yaitu tidak terjadinya perubahan warna pada sediaan selama penyimpanan pada suhu kamar dan ditempat yang terlindung dari cahaya matahari langsung selama satu bulan. Penambahan surfaktan RyotoÂ® sugar ester dan propilen glikol dapat meningkatkan kelarutan dan stabilitas sediaan solubilisasi parasetamol.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/23</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.23</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 132-139</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 132-139</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/23/19</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/27</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Clinical Outcomes of Antibiotic Use on Patients of Diabetic Foot Infection</dc:title>
	<dc:title xml:lang="id-ID">Clinical Outcomes Penggunaan Antibiotik pada Pasien Infeksi Kaki Diabetik</dc:title>
	<dc:creator>Anggriani, Yusi</dc:creator>
	<dc:creator>Restinia, Mita</dc:creator>
	<dc:creator>Mitakda, Venessya Cikita</dc:creator>
	<dc:creator>Rochsismandoko, Rochsismandoko</dc:creator>
	<dc:creator>Kusumaeni, Tri</dc:creator>
	<dc:subject xml:lang="id-ID">IKD</dc:subject>
	<dc:subject xml:lang="id-ID">Antibiotik</dc:subject>
	<dc:subject xml:lang="id-ID">Clinical Outcomes</dc:subject>
	<dc:subject xml:lang="en-US">DFI</dc:subject>
	<dc:subject xml:lang="en-US">Antibiotic</dc:subject>
	<dc:subject xml:lang="en-US">Clinical Outcomes</dc:subject>
	<dc:description xml:lang="en-US">An amputation and antibiotic resistant bacteria on diabetic foot infection (DFI) are still big issue. The research aimed to evaluate clinical outcomes of antibiotic use among patients of DFI in internal medicine ward at Hospital X. An observation of prospective longitudinal methode was conducted during 3 months. Patients were selected based on diagnosis of DFI that had length of stay â‰¥ 3 days. Total samples were 30 patients, 16(53.3%) women and 14(46.7%) men. Only 5(16.67%) patients who did culture and sensitivity. One of them with no pathogen bacteria. The most frequently antibiotic use was ampicillin-sulbactam. Based on clinical outcomes, 11(36,7%) improve, 15(50%) worse, and others were passed away. Based on statistic, there were no influence among clinical outcomes with gender, age, BMI and duration of diabetes. Therefore based on the research, antibiotics use were still not effective to achieve desired outcomes.</dc:description>
	<dc:description xml:lang="id-ID">Resiko amputasi dan resistensi bakteri terhadap antibiotik pada pasien infeksi kaki diabetik (IKD) masih merupakan masalah besar yang belum dapat diatasi. Penelitian bertujuan untuk mengevaluasi clinical outcomes penggunaan antibiotik pada pasien IKD di bangsal penyakit dalam rumah sakit X. Penelitian dilakukan selama 3 bulan dengan metode observasi prospektif longitudinal. Pasien dipilih berdasarkan diagnosa IKD dengan lama rawatan â‰¥ 3 hari. Total sampel yang diperoleh 30 pasien, perempuan 16 (53,3%) dan laki-laki 14 (46,7%). Tes kultur hanya dilakukan pada 5 (16,67%) pasien. Satu pasien menunjukkan tidak adanya bakteri patogen. Antibiotik yang paling sering digunakan adalah Ampisilin-sulbaktam. Berdasarkan clinical outcomes, 11 (36,7%) pasien membaik, 15 (50%) memburuk dan 4 (13,35%) meninggal. Berdasarkan statistik, jenis kelamin, umur, Indeks masa tubuh dan lama menderita DM tidak mempengaruhi clinical outcomes (P&amp;gt;0,05). Hasil penelitian yang diperoleh dapat disimpulkan bahwa antibiotik yang digunakan masih belum efektif dalam mencapai tujuan terapi.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/27</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.27</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 111-121</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 111-121</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/27/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/28</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">An Assay of Antioxidant Power of Methanolic Extract Various Type of Soybean</dc:title>
	<dc:creator>Yulia, Rika</dc:creator>
	<dc:creator>Azminah, Azminah</dc:creator>
	<dc:creator>Michella, Michella</dc:creator>
	<dc:creator>Tanzil, Andre</dc:creator>
	<dc:subject xml:lang="en-US">Soybean (Glycine max L.Merill)</dc:subject>
	<dc:subject xml:lang="en-US">Argomulyo variety</dc:subject>
	<dc:subject xml:lang="en-US">Burangrang variety</dc:subject>
	<dc:subject xml:lang="en-US">Ijen variety</dc:subject>
	<dc:subject xml:lang="en-US">Kaba variety</dc:subject>
	<dc:subject xml:lang="en-US">antioxidant power</dc:subject>
	<dc:subject xml:lang="en-US">DPPH (1</dc:subject>
	<dc:subject xml:lang="en-US">1-Diphenyl-2-picryhydrazyl)</dc:subject>
	<dc:description xml:lang="en-US">This study aimed to examine the antioxidant activity of methanolic extract of various type of soybean (Glycine max L.Merill) i.e Argomulyo, Burangrang, Ijen, and Kaba by using DPPH (1,1-Diphenyl-2-picryhydrazyl) method. The soybean was crushed, defatted using n-hexan, and extracted using methanol 90%. The processes of defatting and extracting were conducted by kinesthetic maceration. Identification of flavonoid content using KLT and an assay of the antioxidant power of soybean were carried out qualitatively and quantitavely. Qualitative analysis, the color of DPPH solution was fading from violet into yellowish. Quantitative analysis showed that the maximum wave-length of DPPH in methanol was 516,00 nm within 15-minute reaction time. The effective concentration 50% (EC50) of each extract was alsa determined. Results of this study revealed that the methanolic extract of soybean taken from varieties of Argomulyo, Burangrang, Ijen, and Kaba contained flavonoid, with EC50 value of each variety subsequently ranging from 3620.22 bpj; 5290.71 bpj; 4145.99 bpj; and 4253.50 bpj. Argomulyo variety showed the highest antioxidant power.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/28</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.28</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 122-131</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 122-131</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/28/23</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/29</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Comparison of Effectivity of Health Education towards Motherâ€™s Knowledge and Ability in Caring Children with Acute respiratory infection in Health Center Padang Pasir and Pauh</dc:title>
	<dc:title xml:lang="id-ID">Perbandingan Efektivitas Pendidikan Kesehatan terhadap Pengetahuan dan Kemampuan Ibu Merawat Balita ISPA di Puskesmas Padang Pasir dan Pauh</dc:title>
	<dc:creator>Novrianda, Dwi</dc:creator>
	<dc:creator>Lucida, Henny</dc:creator>
	<dc:creator>Soumariris, Irfandy</dc:creator>
	<dc:subject xml:lang="id-ID">pendidikan kesehatan</dc:subject>
	<dc:subject xml:lang="id-ID">pengetahuan</dc:subject>
	<dc:subject xml:lang="id-ID">kemampuan merawat</dc:subject>
	<dc:subject xml:lang="id-ID">infeksi saluran pernafasan akut</dc:subject>
	<dc:subject xml:lang="en-US">health education</dc:subject>
	<dc:subject xml:lang="en-US">knowledge</dc:subject>
	<dc:subject xml:lang="en-US">caring ability</dc:subject>
	<dc:subject xml:lang="en-US">acute respiratory infection</dc:subject>
	<dc:description xml:lang="en-US">Health education with booklet media is an effort to increase knowledge and ability in caring Acute respiratory infection (ARI). This study aimed to identify comparison effectivity in health education towards knowledge and ability in caring between Padang Pasir and Pauh Health Center. Method used pre experimental with pretest posttest design. Subject was mothers with children having ARI amount 15 samples. Data was collected by questionnaires. Data analysis used wilcoxon to identify difference pre and posttest of motherâ€™s knowledge and ability in caring, mann whitney-U to know difference between both of them. Study showed there was difference of knowledge and ability in caring between pre and posttest (p=0,002). There was difference in effectivity of health education between Padang Pasir and Pauh on ability in caring (p=0,004).It suggested health education with more interesting media like booklet must be given especially for mothers so ARIâ€™s rate can be reduced in children.</dc:description>
	<dc:description xml:lang="id-ID">Pendidikan kesehatan dengan media booklet merupakan upaya meningkatkan kemampuan merawat Infeksi Saluran Pernapasan Akut (ISPA). Penelitian ini bertujuan untuk mengetahui perbandingan efektivitas pendidikan kesehatan terhadap pengetahuan dan kemampuan ibu dalam perawatan balita ISPA antara Puskesmas Padang Pasir dan Pauh. Metode yang digunakan adalah preeksperimental dengan pretest posttest design. Subjek penelitian adalah ibu dengan balita ISPA berjumlah 15. Pengumpulan data menggunakan kuesioner. Analisis data menggunakan uji Wilcoxon untuk menilai perbedaan pengetahuan dan kemampuan merawat pada pretest posttest dan Mann Whitney-U untuk menilai perbandingan antar Puskesmas. Hasil penelitian diperoleh perbedaan pengetahuan dan kemampuan merawat balita ISPA sebelum dan setelah pendidikan kesehatan dengan (p=0,002). Lebih lanjut terdapat perbedaan efektivitas pendidikan kesehatan antara Puskesmas Padang Pasir dengan Pauh pada kemampuan merawat (p=0,004). Oleh karena itu pendidikan kesehatan tentang ISPA dengan media yang lebih menarik seperti booklet perlu diberikan terutama pada ibu untuk meningkatkan pengetahuan dan kemampuan merawat balita dengan ISPA.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/29</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.29</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 159-169</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 159-169</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/29/24</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/30</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Determination of Profenofos Pesticidal Residue in Lettuce (Lactuca sativa L.) by Gas Chromatographic Method</dc:title>
	<dc:title xml:lang="id-ID">Pemeriksaan Residu Pestisida Profenofos pada Selada (Lactuca sativa L.) dengan Metode Kromatografi Gas</dc:title>
	<dc:creator>Alen, Yohannes</dc:creator>
	<dc:creator>Zulhidayati, Zulhidayati</dc:creator>
	<dc:creator>Suharti, Netty</dc:creator>
	<dc:subject xml:lang="id-ID">residu pestisida</dc:subject>
	<dc:subject xml:lang="id-ID">profenofos</dc:subject>
	<dc:subject xml:lang="id-ID">Lactuca sativa L</dc:subject>
	<dc:subject xml:lang="id-ID">kromatografi gas</dc:subject>
	<dc:subject xml:lang="en-US">pesticide residue</dc:subject>
	<dc:subject xml:lang="en-US">profenofos</dc:subject>
	<dc:subject xml:lang="en-US">Lactuca sativa L.</dc:subject>
	<dc:subject xml:lang="en-US">gas chromatography</dc:subject>
	<dc:description xml:lang="en-US">The determination of profenofos pesticidal residue in the lettuce (Lactuca sativa L.) by using gas chromatography using flame photometric detector (FPD) had been investigated. The lettuce was collected from Padang Luar area, Agam distric, West Sumatera. Sample for determination of profenofos residue divided into three groups: unwashed (A), washed with water (B), and washed with detergent (C). Maceration with sonication was used for the extraction using ethylacetateas a solvent. The results showed that profenofos pesticide residue in sample A, B and C were 0.204, 0.080 and 0.061 ppm, respectively. These profenofos pesticidal residue are over than the Maximum Residue Limits (MRL) that established by The Japan Food Chemical Research Foundation (0.05 ppm) even though World Health Organization (WHO) has not established Maximum Residue Limits (MRL) profenofos on lettuce. Based on the statistical analysis one-way method (Anova) using SPSS 20.0 showed that there was a significant concentrations difference between lettuce A from lettuce B and lettuce C with p &lt; 0.05.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan pemeriksaan residu pestisida profenofos pada selada (Lactuca sativa L.) menggunakan metode kromatografi gas detektor fotometri nyala. Sampel sayuran selada di ambil dari daerah Padang Luar, Kabupaten Agam, Sumatera Barat. Sampel untuk penentuan kadar residu profenofos dibagi atas tiga kelompok yaitu tidak dicuci (A), dicuci dengan air (B), dan dicuci dengan deterjen pencuci sayuran (C). Maserasi dengan sonikasi digunakan untuk ekstraksi menggunakan pelarut etil asetat. Hasil penelitian menunjukkan bahwa residu pestisida profenofos pada selada A, B dan C berturut-turut adalah 0,204; 0,080 dan 0,061 ppm. Residu pestisida profenofos ini melewati Batas Maksimum Residu (BMR) yang ditetapkan oleh The Japan Food Chemical Research Foundation (0,05 ppm) sedangkan World Health Organization (WHO) belum menetapkan Batas Maksimum Residu (BMR) profenofos pada selada. Hasil analisis statistik Anova satu arah menggunakan SPSS 20.0 menunjukkan bahwa terdapat perbedaan konsentrasi yang signifikan antara selada A dengan selada B dan selada C dengan nilai p &amp;lt; 0,05.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/30</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.30</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 140-149</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 140-149</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/30/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/31</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Ethanolic Extract of Dracaena angustifolia Roxb. as Active Cutaneous Anti Anaphylactic on Male White Mice</dc:title>
	<dc:title xml:lang="id-ID">Aktivitas Ekstrak Daun Suji (Dracaena angustifolia Roxb.) sebagai Antianafilaksis Kutan Aktif pada Mencit Putih Jantan</dc:title>
	<dc:creator>Aldi, Yufri</dc:creator>
	<dc:creator>Syafrudin, Muhammad</dc:creator>
	<dc:creator>Elisma, Elisma</dc:creator>
	<dc:subject xml:lang="id-ID">ekstrrak etanol daun suji</dc:subject>
	<dc:subject xml:lang="id-ID">anafilaksis</dc:subject>
	<dc:subject xml:lang="id-ID">waktu</dc:subject>
	<dc:subject xml:lang="id-ID">diameter dan intensitas warna.</dc:subject>
	<dc:subject xml:lang="en-US">Extract Dracaena angustifolia Roxb</dc:subject>
	<dc:subject xml:lang="en-US">anaphylactic</dc:subject>
	<dc:subject xml:lang="en-US">time</dc:subject>
	<dc:subject xml:lang="en-US">diameter</dc:subject>
	<dc:subject xml:lang="en-US">color intensity.</dc:subject>
	<dc:description xml:lang="en-US">An assay of the active cutaneous anti anaphylactic of the ethanolic extract of the Dracaena angustifolia Roxb. On male white mice has been studied. The assay was done by giving three different doses (100,300, 900 mg per/kg bw). Allergic reaction was induced by giving eggâ€™s albumin as antigen. The anti anaphylactic effect was determined by measurement of the pro long of occurrence time, the dereased in diameter and the color intensity of the blue bump formed by using blue evanâ€™s solution as indicator which was given intravenously. Result indicated the ethanolic extract of Dracaena angustifolia Roxb. (100, 300, 900 mg/kg bw) had significant effect for each dose (p&amp;lt;0.01). The dose of 900 mg per kg body weight showed best effect.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan pengujian efek anti anafilaksis kutan aktif dari ekstrak etanol daun suji (Dracaena angustifolia Roxb.) pada mencit putih jantan. Pengujian dilakukan dengan tiga variasi dosis ekstrak (100, 300 dan 900 mg/kg BB) yang diberikan secara oral. Adanya efek anti anafilaksis ditandai dengan perpanjangan waktu timbul, penurunan diameter dan intensitas warna bentolan biru yang terbentuk pada punggung mencit dengan menggunakan larutan biru Evans sebagai indikator yang disuntikan secara intra vena. Hasil penelitian menunjukan bahwa ekstrak etanol daun suji (Dracaena angustifolia Roxb). (100, 300, 900 mg/kg BB) memberikan efek yang berbeda nyata antara masing-masing dosis (p&amp;lt;0,01). Efek yang paling baik diberikan pada dosis 900 mg/kg BB.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/31</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.31</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 150-158</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 150-158</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/31/26</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/32</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Development of the Instrument Patient Satisfaction for Pharmaceutical Services in Hospital</dc:title>
	<dc:title xml:lang="id-ID">Pengembangan Instrumen Penilaian Kepuasan Pasien terhadap Pelayanan Kefarmasian di Rumah Sakit</dc:title>
	<dc:creator>Almasdy, Dedy</dc:creator>
	<dc:creator>Yulihasri, Yulihasri</dc:creator>
	<dc:creator>Putri, Dila Deria</dc:creator>
	<dc:subject xml:lang="id-ID">pengembangan instrumen</dc:subject>
	<dc:subject xml:lang="id-ID">kepuasan pasien</dc:subject>
	<dc:subject xml:lang="id-ID">pelayanan kefarmasian</dc:subject>
	<dc:subject xml:lang="id-ID">farmasi rumah sakit</dc:subject>
	<dc:subject xml:lang="en-US">instrument development</dc:subject>
	<dc:subject xml:lang="en-US">patient satisfaction</dc:subject>
	<dc:subject xml:lang="en-US">hospital pharmacy</dc:subject>
	<dc:subject xml:lang="en-US">clinical pharmacy.</dc:subject>
	<dc:description xml:lang="en-US">Instrument to assessing patient satisfaction to hospital pharmacy services has developed. The instrument consists of two dimensions which are friendly explanation and managing theraphy. The result of instrument developing are a instrument which have fair to good of the level of agreement (Ä¸ = 0.53), fair to good validity (r &gt; 0.632) and good reliability (cronbach alpha = 0.97).</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan pengembangan insrumen untuk pengukuran kepuasan pasien terhadap pelayanan kefarmasian yang diberikan oleh suatu rumah sakit. Instrumen terdiri atas dua dimensi yaitu penjelasan yang bersahabat (friendly explanation) dan pengelolaan terapi (managing theraphy). Hasil pengembangan didapatkan suatu instrumen dengan tingkat kesepahaman yang cukup baik (Ä¸ = 0.53), valid (r &amp;gt; 0,632) dan reliabel (cronbach alpha = 0,97)</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/32</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.32</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 170-175</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 170-175</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/32/27</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/33</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Dissolution Profile of Sustained Release Tablet of Diclofenac Sodium Using Metolose 90 SH 4000 Matrix</dc:title>
	<dc:title xml:lang="id-ID">Profil Disolusi Tablet Sustained Release Natrium Diklofenak dengan Menggunakan Matriks Metolose 90 SH 4000</dc:title>
	<dc:creator>Agustin, Rini</dc:creator>
	<dc:creator>Ratih, Hestiary</dc:creator>
	<dc:subject xml:lang="id-ID">sustained release</dc:subject>
	<dc:subject xml:lang="id-ID">natrium diklofenak</dc:subject>
	<dc:subject xml:lang="id-ID">metolose 90 SH 4000</dc:subject>
	<dc:subject xml:lang="id-ID">profil disolusi</dc:subject>
	<dc:subject xml:lang="en-US">sustained release</dc:subject>
	<dc:subject xml:lang="en-US">diclofenac sodium</dc:subject>
	<dc:subject xml:lang="en-US">metolose 90 SH 4000</dc:subject>
	<dc:subject xml:lang="en-US">dissolusion profile.</dc:subject>
	<dc:description xml:lang="en-US">Diclofenac sodium (Na-diclofenac) is a non-steroidal anti-inflammatory drug that is commonly used for arthritis patients. However, its short half-life time which is about 1-2 hours causes the drug should be administered repeatedly over a short time interval for oral administration. Therefore, the purpose of this study was to formulate a sustained release tablet of diclofenac sodium with metolose 90 SH 4000 as the matrix. In order to see the influence metolose 90 SH 4000 to the dissolution profile of diclofenac sodium tablet, metolose 90 SH 4000 was added with a ratio of 0% (F0), 5% (F1), 10% (F2), 15% (F3), 25% (F4). The tablets was prepared by wet granulation method. The dissolution results showed the formula F0, F1, F2, and F3 can be reached within 120, 240, 300, and 480 minutes, respectively. Meanwhile, F4 did not reach the dissolution for 480 minutes. According to the USP 26, only F3 qualified the dissolution of sustained release tablet.</dc:description>
	<dc:description xml:lang="id-ID">Natrium diklofenak (Na-diklofenak) adalah obat anti inflamasi non steroid yang umumnya digunakan untuk penderita radang sendi. Namun, waktu paruh yang pendek sekitar 1-2 jam menyebabkan obat diberikan berulang kali dalam interval waktu yang pendek untuk pemberian secara oral. Oleh karena itu, tujuan penelitian ini yaitu memformulasi Na-diklofenak tablet sustained release menggunakan metolose 90 SH 4000 sebagai matriks. Untuk melihat pengaruh metolose 90 SH 4000 terhadap profil disolusi Na-diklofenak tablet sustained release, metolose 90 SH 4000 ditambahkan dengan perbandingan 0% (F0), 5% (F1), 10% (F2), 15% (F3), 25% (F4). Tablet Na-diklofenak dibuat dengan metode granulasi basah. Hasil disolusi menunjukkan formula F0, F1, F2 dan F3 dapat dicapai dalam waktu 120, 240, 300 dan 480 menit, berturut-turut, namun F4 tidak mencapai disolusi selama 480 menit. Bedasarkan USP 26, hanya F3 yang memenuhi syarat disolusi tablet sustained release.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/33</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.33</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 176-183</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 176-183</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/33/28</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/34</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Isolation and BSLT test of ethyl acetate extract of Shorea ovalis [Kort.] leaves</dc:title>
	<dc:title xml:lang="id-ID">Isolasi dan Uji BSLT Ekstrak Etil Asetat Daun Meranti Sabut (Shore Ovalis (Korth.))</dc:title>
	<dc:creator>Mora, Enda</dc:creator>
	<dc:creator>Nst, Musyirna Rahma</dc:creator>
	<dc:creator>Susanti, Emma</dc:creator>
	<dc:creator>Zasliadi, Arfan</dc:creator>
	<dc:subject xml:lang="id-ID">Isolasi</dc:subject>
	<dc:subject xml:lang="id-ID">karakterisasi</dc:subject>
	<dc:subject xml:lang="id-ID">ekstraks etil asetat daun meranti sabut</dc:subject>
	<dc:subject xml:lang="id-ID">uji BSLT.</dc:subject>
	<dc:subject xml:lang="en-US">Isolation</dc:subject>
	<dc:subject xml:lang="en-US">characterization</dc:subject>
	<dc:subject xml:lang="en-US">ethyl acetate extract of Shorea ovalis (Kort.) leaves</dc:subject>
	<dc:subject xml:lang="en-US">BSLT test.</dc:subject>
	<dc:description xml:lang="en-US">Isolation and test of Brine Shrimp Lethality Test (BSLT) of ethyl acetate extract of Shorea ovalis [Kort.]) leaves have been done. The isolation method used was column chromatography by Step Gradient Polarity (SGP). The aim of this research was to isolate the metabolite secondary compound and examine the activity test of Brine Shrimp Lethality Test (BSLT) from ethyl acetate extract of Shorea ovalis [Kort.]) leaves. The result showed that pure compound was IÂ¬A which characterized by spectrum of IR, H-NMR, C-NMR, HSQC, HMBC and colour reaction of Liebermann-Burchard test. The characterization of the isolate was phytosterol with estimated molecular formula C27H48O. Result of BSLT test revealed that of ethyl acetat extract of meranti sabut leaves at 100, 10, and 1 ppm had value of LC50= 40.45 ppm with death of larva of Artemia salina equal to 56,6 % and was considered as very toxic.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan isolasi dan uji BSLT ekstrak etil asetat daun meranti sabut (Shorea ovalis [Kort.]). Isolasi menggunakan metode kromatografi kolom dengan cara Step Gradient Polarity (SGP). Penelitian ini bertujuan mengisolasi senyawa metabolit skunder dan uji BSLT ekstraks etil asetat daun meranti sabut (Shorea ovalis [Kort.]). Dari hasil penelitian didapatkan senyawa murni IA dan dikarakterisasi dengan spektrum IR, H-NMR, C-NMR, HSQC dan HMBC serta reaksi warna menggunakan pereaksi Liebermann-burchard. Hasil karakterisasi senyawa IA disimpulkan adalah senyawa golongan fitosterol dengan perkiraan rumus molekul C27H48O. Hasil uji BSLT ekstrak etil asetat daun meranti sabut pada konsentrai 100, 10 dan 1 ppm diperoleh nilai LC50= 40.45 ppm dengan persen kematian larva Artemia salina sebesar 56,6 %, tergolong sangat toksik.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/34</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.34</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 184-194</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 184-194</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/34/29</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/35</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Effect of Combination of Magnesium Stearate and Talc as a Lubricant on Dissolution Profile of Ibuprofen Tablets</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Kombinasi Magnesium Stearat dan Talkum sebagai Lubrikan terhadap Profil Disolusi Tablet Ibuprofen</dc:title>
	<dc:creator>Syofyan, Syofyan</dc:creator>
	<dc:creator>Yanuarto, Tri</dc:creator>
	<dc:creator>Octavia, Maria Dona</dc:creator>
	<dc:subject xml:lang="id-ID">Magnesium stearat</dc:subject>
	<dc:subject xml:lang="id-ID">Talcum</dc:subject>
	<dc:subject xml:lang="id-ID">lubrikan</dc:subject>
	<dc:subject xml:lang="id-ID">Disolusi.</dc:subject>
	<dc:subject xml:lang="en-US">Magnesium stearat</dc:subject>
	<dc:subject xml:lang="en-US">talcum</dc:subject>
	<dc:subject xml:lang="en-US">lubricant</dc:subject>
	<dc:subject xml:lang="en-US">disolution.</dc:subject>
	<dc:description xml:lang="en-US">A research has been conducted on the combination effect of magnesium stearate and talc as a lubricant to the dissolution profile of Ibuprofen tablets. Of the three formulas made Ibuprofen tablets with wet granulation method. Evaluation of tablets include uniformity of size, weight uniformity, tablet hardness, disintegration, friability of tablets, assay and dissolution. Results of dissolution percentage was done up to 60 indicated that the dissolution the average was 95,72%, 97,65% and 99,93% consecutively for F I, F II and F III. In addition, result of the dissolution efficiency up to 60 minutes for each formula was 82,10%, 87,58%, and 90,76%. According to the dissolution of the data, formula III which had the highest dissolution results compared to formula I and formula II, which likely due to the ratio of the combination of magnesium stearate and talc as a lubricant smaller levels of magnesium stearate.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian tentang pengaruh kombinasi magnesium stearat dan talkum sebagai lubrikan terhadap profil disolusi tablet Ibuprofen. Dari ketiga formula dibuat tablet Ibuprofen dengan metoda granulasi basah. Evaluasi tablet meliputi keseragaman ukuran, keseragaman bobot, kekerasan tablet, waktu hancur, kerapuhan tablet, penetapan kadar dan disolusi. Hasil persen terdisolusi menit ke 60 menunjukkan bahwa disolusi rata-rata berturut-turut adalah 95,7209%, 97,6474% dan 99,9373%. Dan untuk hasil efisiensi disolusi pada menit ke 60 masing-masing formula adalah 82,1089%, 87,5888% dan 90,7635%. Dari data disolusi, formula III yang mempunyai hasil disolusi yang tinggi dibandingkan formula I dan formula II yang disebabkan oleh perbandingan kombinasi magnesium stearat dan talkum sebagai lubrikan lebih kecil kadar magnesium stearatnya.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/35</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.35</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 195-206</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 195-206</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/35/30</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/36</identifier>
				<datestamp>2019-06-30T21:27:48Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Production and evaluation of modified taro (Colocasia esculenta Schott) starch by lactic acid bacteria (Lactobacillus sp)</dc:title>
	<dc:title xml:lang="id-ID">Pembuatan Dan Evaluasi Pati Talas (Colocasia esculenta Schoot) Termodifikasi dengan Bakteri Asam Laktat (Lactobacillus sp)</dc:title>
	<dc:creator>Suhery, Wira Noviana</dc:creator>
	<dc:creator>Anggraini, Deni</dc:creator>
	<dc:creator>Endri, Novtafia</dc:creator>
	<dc:subject xml:lang="id-ID">Pati Talas Termodifikasi</dc:subject>
	<dc:subject xml:lang="id-ID">Bakteri Asam Laktat</dc:subject>
	<dc:subject xml:lang="id-ID">SEM</dc:subject>
	<dc:subject xml:lang="en-US">Modified Taro Starch</dc:subject>
	<dc:subject xml:lang="en-US">Lactic Acid Bacteria</dc:subject>
	<dc:subject xml:lang="en-US">SEM</dc:subject>
	<dc:description xml:lang="en-US">Production and evaluation of modified taro (Colocasia esculenta Schott) starch by lactic acid bacteria (Lactobacillus sp) has been done. The purpose of this study was to observe the effect of lactic acid bacteria to the yield of taro starch and to evaluate physicochemical of starch. The evaluation which includes organoleptic, moisture content, pH, angle of repose, swelling power, gelatination temperature, amylose content, and examination of the surface shape of starch granules using SEM (Scanning Electron Microscope). The result showed that modified taro starch yield higher (19,12%) than native taro starch (11,79%). Modified taro starch of organoleptic examination showed better results where the smell was slighly reduced and the colour was white. Meanwhile, from the results of the evaluation of swelling power, gelatination temperature, and amylose content showed an increase. In addition, the modified taro starch granule were rougher due to some holes presented distinctively.</dc:description>
	<dc:description xml:lang="id-ID">Pembuatan dan evaluasi pati talas (Colocasia escuenta Schott) termodifikasi dengan bakteri asam laktat (Lactobacillus sp) telah dilakukan. Tujuan penelitian ini adalah untuk melihat pengaruh modifikasi pati talas dengan bakteri asam laktat terhadap rendemen pati talas dan sifat fisikokimia pati. Evaluasi yang dilakukan meliputi organoleptik, kadar air, pH, sudut angkat, daya pengembangan, temperatur gelatinasi, kadar amilosa, dan pemeriksaan bentuk permukaan granula pati menggunakan SEM (Scanning Electron Microscope). Hasil penelitian menunjukkan rendemen pati talas termodifikasi lebih tinggi (19,24%) daripada pati alami (11,79%). Pemeriksaan organoleptik pati talas termodifikasi menunjukkan hasil yang lebih baik dibandingkan pati talas alami, dimana bau khas talas agak sedikit berkurang dan warnanya lebih putih. Selain itu daya pengembangan dan kadar amilosa pati talas termodifikasi mengalami peningkatan. Hasil lainnya menunjukkan bahwa pada pati talas termodifikasi terdapat perlubangan pada permukaan granulanya.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-05-05</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/36</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.1.2.36</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 1 No. 2 (2015); 207-214</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 1 No 2 (2015): J Sains Farm Klin 1(2), Mei 2015; 207-214</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/36/31</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/41</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Chemical study of ethyl Acetate fraction of Picrasma Javanica Bl.</dc:title>
	<dc:title xml:lang="id-ID">Kajian Kimia Dari Fraksi Etil Asetat Kulit Batang Kayu Pahit (Picrasma Javanica Bl.)</dc:title>
	<dc:creator>Hainil, Sri</dc:creator>
	<dc:creator>Arbain, Dayar</dc:creator>
	<dc:creator>Putra, Deddi Prima</dc:creator>
	<dc:subject xml:lang="en-US">elution structures</dc:subject>
	<dc:subject xml:lang="en-US">Picrasma javanica</dc:subject>
	<dc:subject xml:lang="id-ID">elusidasi struktur</dc:subject>
	<dc:subject xml:lang="id-ID">Picrasma javanica Bl.</dc:subject>
	<dc:description xml:lang="en-US">N-1 main compound from ethyl acetate fraction of kayu pahit bark (Picrasma Javanica B1) has been isolated and characterized with colom chromatography and continued with preparative chromatography. According to analized from spectrum data used ultraviolet (UV) spectroscopy, infra red (IR), 1H RMI (Resonansi Magnet Inti), 13 C RMI, Massa , COSY (Correlated Spectroscopy), HSQC (Heteronuclear Single Quantum Correlation), HMBC ( Heteronuclear Multiple Bond Correlation) and literature study showed that the compound of isolation was javanicin A.Â </dc:description>
	<dc:description xml:lang="id-ID">Â Senyawa utama N-1 dari fraksi etil asetat kulit batang kayu pahit (Picrasma Javanica Bl) telah diisolasi dan dikarakterisasi dengan kromatografi kolom dan dilanjutkan dengan kromatografi preparatif. elusidasi struktur dan analisis data spektrum yang digunakan ultraviolet (UV) spektroskopi, infra merah (IR), 1H RMI (Resonansi Magnet Inti), 13C RMI, Massa, COSY (Correlated Spectroscopy), HSQC (Heteronuclear Single Quantum Correlation), HMBC (Heteronuclear Multiple Bond Correlation) dan studi literatur menunjukkan bahwa senyawa yang isolasi adalah Javanicin A.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/41</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.41</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 1-7</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 1-7</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/41/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/42</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Validation for The Quantification of Andrographolide Isolated from Andrographis paniculata Nees Plant Using HPLC</dc:title>
	<dc:title xml:lang="id-ID">Validasi Penetapan Kadar Isolat Andrografolid  dari Tanaman Sambiloto (Andrographis paniculata Nees)  Menggunakan HPLC</dc:title>
	<dc:creator>Syukri, Yandi</dc:creator>
	<dc:creator>Nugroho, Agung Endro</dc:creator>
	<dc:creator>Martien, Ronny</dc:creator>
	<dc:creator>Lukitaningsih, Endang</dc:creator>
	<dc:subject xml:lang="en-US">andrographolide</dc:subject>
	<dc:subject xml:lang="en-US">validation</dc:subject>
	<dc:subject xml:lang="en-US">HPLC</dc:subject>
	<dc:subject xml:lang="en-US">SNEDDS</dc:subject>
	<dc:subject xml:lang="id-ID">andrografolid</dc:subject>
	<dc:subject xml:lang="id-ID">KCKT</dc:subject>
	<dc:subject xml:lang="id-ID">validasi</dc:subject>
	<dc:subject xml:lang="id-ID">SNEDDS</dc:subject>
	<dc:description xml:lang="en-US">The aim of study was to develop quantitative analysis of isolated andrographolide from Andrographis paniculata and different solvent for prelimenary studies to preperation Self Nano Emulsifying Drug Delivery System (SNEDDS) using HPLC. The separation was acquired on Sunfire C18 column with an isocratic mixture of methanol and water at a ratio of 6:4, v/v as a mobile phase. The method to determine the content of isolated andrographolide showed an adequate precision, with a RSD smaller than 1%. The accuracy was analyzed by adding the standard andrographolide, and good recovery values were obtained for all concentrations used. The HPLC method developed in this study showed specificity and selectivity with linearity in the working range and good precision and accuracy, making it very suitable for the quantification of isolated andrographolide. Compared to the standard, the purity of the isolated andrographolide was 95.74 Â± 0.29 %. Prelimenary study to determined the highest solubility of isolated andrographolide in oil, surfactant and co-surfactant phases for preperation of SNEDDS were obtained 1.226 Â± 0.009 of Capryol-90, 2.965 Â± 0.014 of tween 20, andÂ  6.074 Â± 0.101 mg mL-1 of PEG 400, respectively. Conclusion, this method suitable used to determination solublity of isolated andrographolide for preperation SNEDDS.Â </dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk mengembangkan analisis kuantitatif untuk penentuan kadar isolat andrographolide dari tanaman sambiloto (Andrographis paniculata) dan pelarut yang berbeda untuk studi awal untuk pembuatan Self Nanoemulsifying Drug Delivery System (SNEDDS) menggunakan KCKT. Pemisahan menggunakan kolom Sunfire C18 dengan campuran isokratik metanol dan air dengan perbandingan 6: 4, v / v sebagai fase gerak. Metode untuk menentukan isolat andrographolide menunjukkan presisi yang memadai, dengan RSD lebih kecil dari 1%. Akurasi dianalisis dengan menambahkan andrografolid standar, dan didapatkan nilai perolehan kembali yang baik untuk semua konsentrasi yang digunakan. Metode HPLC yang dikembangkan dalam penelitian ini menunjukkan spesifisitas dan selektivitas dengan linearitas dalam rentang kerja dan presisi dan akurasi yang baik, sehingga sangat cocok untuk menentukan kandungan isolat andrografolida. Dibandingkan dengan standar, kemurnian isolat andrografolida adalah 95,74 Â± 0,29%. Penelitian awal untuk menentukan kelarutan tertinggi isolat andrographolid adalah dalam fasa minyak Capryol-90 1,226 Â± 0,009 mg mL-1, surfaktan tween 80 2,965 Â± 0.014 mg mL-1 dan co-surfaktan PEG 400 6,074 Â± 0,101 mg mL-1. Dapat disimpulkan, metode ini cocok digunakan untuk penentuan kelarutan dari isolat andrographolide untuk pembuatan SNEDDS.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/42</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.42</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 8-14</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 8-14</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/42/pdf_1</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/43</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Development and Validation Of Thin Layer Chromatograpy-Densitometry Method for Determinationa and Quantification of Sinthetic Red Coloring Agent in Sauce Sambel Sachet</dc:title>
	<dc:title xml:lang="id-ID">Pembangan dan Validasi Metode Kromatografi Lapis TipisÂ–Densitometri untuk Analisis Pewarna Merah Sintentik pada Beberapa Merek Saus Sambal Sachet</dc:title>
	<dc:creator>Armin, Fithriani</dc:creator>
	<dc:creator>Revira, Bita</dc:creator>
	<dc:creator>Adnan, Adek Zamrud</dc:creator>
	<dc:subject xml:lang="en-US">TLC-densitometry</dc:subject>
	<dc:subject xml:lang="en-US">sauce sambel</dc:subject>
	<dc:subject xml:lang="en-US">coloring agent</dc:subject>
	<dc:subject xml:lang="id-ID">KLT-densitometri</dc:subject>
	<dc:subject xml:lang="id-ID">saus sambel</dc:subject>
	<dc:subject xml:lang="id-ID">pewarna sintetik</dc:subject>
	<dc:description xml:lang="en-US">Chili sauce sachet A, B and C containing synthetic red coloring agentÂ  were taken from three fast food premises in Padang. Synthetic red coloring agentÂ  were a food additives used by food manufacturers to enhance color of food products. The use of food coloring agent in Indonesia were regulatedÂ Â  in The Rule of Head of the Supervisory Food Board of the Republic of Indonesia Number 37 Year 2013 about the Limit Use of Food Coloring Agent. Thin-layer chromatography (TLC) -densitometry wasÂ  a precision method for the analysis of food additives. Development and validation of TLC method for chromatographic separation used GF254 silica plate eluted with a mixture of ethanol: butanol: distilled water (4: 5: 5) and spots were detected visually. A red spots on the sample B was identified as Ponceau 4R with Rf value of 0.76. It was then followed by quantitative analysis using densitometry. The linearity of the methodÂ  was found in the range of 2-10Î¼g/ml with a correlation coefficient of 0.994. Precision intra-day and inter-day relative standard deviation was shown from 1.11% and 2.69% respectively. Accuracy of the method was shown on the percentage of recovery of the 3 different concentrations of solution which gave the average percentage of 108.17%. Limit of detection and limit quantitation was 0.8306Î¼g/ml and 2.7687Î¼g/ml.Â  The concentration of Ponceau 4R in the sample B was 11.9520mg/kg of material. This value was not exceeded theÂ  maximum concentration of food coloring agent as stated in the rule which should not be above 70mg/kg of material.</dc:description>
	<dc:description xml:lang="id-ID">Saus sambel sachet A,Â B dan C yang mengandung pewarna merah sintetik diambil ditiga tempat makanan cepat saji dikota padang. Pewarna merah sintetik merupakan salah satu bahan tambahan pangan yang digunakan oleh produsen pangan untuk memberikan sensasi warna pada produk pangannya. Penggunaan pewarna pangan ini diatur dalam Peraturan Kepala Badan Pengawas Makanan Republik Indonesia Nomor 37 Tahun 2013 Tentang Batas Maksimum Penggunaan Bahan Tambahan Pangan Pewarna. Metoda yang presisi untuk analisis bahan tambahan pangan ini adalah kromatografi lapis tipis (KLT)-densitometri. Pengembangan dan validasi metoda KLT untuk pemisahan secara kromatografi digunakan plat silica GF254 dengan fasa gerak campuran etanol:butanol:aquadest (4:5:5) dan bercak yang nampak dideteksi secara visual. Sebuah bercak merah pada sampel B teridentifikasi mengandung ponceau 4R dengan nilai Rf 0,76 dan dilanjutkan dengan analisis kadar dengan densitometry. Linieritas metode yang dilakukan ditemukan pada rentang 2-10 Î¼g/ml dengan koefisien korelasi 0,994. Presisi intra-day ditunjukkan dari standar deviasi relative 1,11% dan inter-day 2,69%. Akurasi metode ditunjukkan dari persentase perolehan kembali terhadap 3 konsentrasi yang berbeda dengan persentase rata-rataÂ  108,17%. Batas deteksi dan batas kuatitasi yang didapatkan adalah 0,8306Î¼g/ml dan 2,7687Î¼g/ml. Kadar ponceau 4R yang dikandung dalam sampel B adalah 11,9520 mg/kg bahan yang tidak melebihi batas maksimum penggunaan bahan pewarna menurut peraturan diatas yakni 70mg/kg bahan.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/43</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.43</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 60-65</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 60-65</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/43/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/44</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Effect of Ethanolic Extract of Soursop Bark in Reducing Blood Sugar and Cholesterol Levels</dc:title>
	<dc:title xml:lang="id-ID">Efek Ekstrak Etanol Kulit Batang Sirsak Terhadap Penurunan Kadar Gula Darah dan Kolesterol</dc:title>
	<dc:creator>Juwita, Dian Ayu</dc:creator>
	<dc:creator>Muchtar, Husni</dc:creator>
	<dc:creator>Martha, Dolly</dc:creator>
	<dc:subject xml:lang="id-ID">glukosa darah</dc:subject>
	<dc:subject xml:lang="id-ID">kolesterol</dc:subject>
	<dc:subject xml:lang="id-ID">ekstrak etanol</dc:subject>
	<dc:subject xml:lang="id-ID">kulit batang</dc:subject>
	<dc:subject xml:lang="id-ID">sirsak</dc:subject>
	<dc:description xml:lang="en-US">This study aims to determine effect of the ethanolic extract of soursop stembarks in the increasing of blood glucose and cholesterol levels. Maceration technique has been used to extract the soursop stembarks with ethanol 96% as a solvent extraction. Furthermore, the ethanolic extract of soursop stembarks was prepared in a suspension form with Na CMC 0.5 % as a suspending agent. The suspension was administered orally at dose of 50, 100, 300, 1000 mg/kg BW daily to white male mice for seven days. The level of blood sugar and cholesterol were measured at 8th day using digital tools NescoÂ®Multicheck. The result showed that the blood glucose level in mice at dose of 50, 100, 300, 1000 mg/KgBW were 123.25, 129.75, 132.25, 121.25 mg/dl. The cholesterol level mice at dose of 50, 100. 300, 1000 mg/kg BW were 156.5, 118.5, 149.75, 156.75 mg/dl respectively. Biostatistically, the ethanolic extract of soursop stembark showed the decreasing of cholesterol level significantly (p &amp;lt;0.05), but not significant to reduce the blood glucose level (p &amp;gt;0.05).</dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk mengetahui efek ekstrak etanol kulit batang sirsak dalam menurunkan kadar glukosa darah dan kolesterol. Pengekstrakan kulit batang sirsak dilakukan dengan metoda maserasi menggunakan etanol 96%. Selanjutnya ekstrak etanol kulit batang sirsak dibuat dalam bentuk suspensi menggunakan Na CMC 0,5% dan diberikan kepada mencit putih jantan secara oral satu kali sehari selama 7 hari dengan dosis 50, 100, 300, 1000 mg/kg BB. Kadar gula darah dan kolesterol diukur pada hari ke delapan menggunakan alat digital NescoÂ®Multicheck. Hasil penelitian memperlihatkan kadar glukosa darah mencit putih jantan pada kelompok dosis ekstrak 50, 100, 300, 1000 mg/kg BB adalah 123,25, 129,75, 132,25, 121,25 mg/dl. Kadar kolesterol darah rata-rata mencit putih jantan pada kelompok dosis ekstrak 50, 100, 300, 1000 mg/kg BB adalah 156,5, 118,5, 149,75, 156,75 mg/dl. Analisa statistik menunjukkan bahwa pemberian ekstrak etanol kulit batang sirsak berpengaruh signifikan terhadap penurunan kadar kolesterol (p&amp;lt;0,05), namun tidak berpengaruh signifikan terhadap penurunan kadar glukosa darah (p&amp;gt;0,05).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/44</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.44</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 36-39</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 36-39</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/44/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/45</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Physicochemical characterization of Binary System of Ciprofloxacin HCl - PEG 4000</dc:title>
	<dc:title xml:lang="id-ID">Karakterisasi Fisikokimia Sistem Biner  Siprofloksasin HCl â€“ PEG 4000</dc:title>
	<dc:creator>Meinisasti, Resva</dc:creator>
	<dc:creator>Halim, Auzal</dc:creator>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:subject xml:lang="en-US">ciprofloxacin HCl</dc:subject>
	<dc:subject xml:lang="en-US">PEG 4000</dc:subject>
	<dc:subject xml:lang="en-US">binary system</dc:subject>
	<dc:subject xml:lang="id-ID">siprofloksasin</dc:subject>
	<dc:subject xml:lang="id-ID">PEG 4000</dc:subject>
	<dc:subject xml:lang="id-ID">sistem biner</dc:subject>
	<dc:description xml:lang="en-US">&quot;Physicochemical Characterization of Binary Systems Ciprofloxacin HCl - PEG 4000&quot; has been reseach. This study aimed to characterize ciprofloxacin HCl formula that was developed to 9, with a comparison between ciprofloxacin - PEG 4000 following formula I (1: 9), formula II (2: 8), formula III (3: 7), formula IV (4: 6), formula V (5: 5), formula VI (6: 4), formula VII (7: 3), formula VIII (8: 2) and formula IX (9: 1). Binary system made by the manufacture of solid dispersion by melting method. The results of the binary System were characterized by analysis Differential Thermal Analysis (DTA), X-ray diffraction, IR spectrophotometry, and Scanning Electron Microscope (SEM). The results of this analysis have results of the binary solid dispersion systems a good formula this VII.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian dengan judul &quot;Karakterisasi Fisikokimia Sistem Biner Siprofloksasin HCl â€“ PEG 4000&quot;. Penelitian ini bertujuan untuk mengkarakterisasi siprofloksasin HCl yang dikembangkan menjadi 9 formula, dengan perbandingan antara siprofloksasin â€“ PEG 4000 sebagai berikut formula I (1 : 9), formula II (2 : 8), dan formula III (3 : 7), formula IV (4 : 6), formula V (5 : 5), formula VI (6 : 4), formula VII (7 : 3), formula VIII (8 : 2) dan formula IX (9 : 1). Sistem biner dibuat dengan cara pembuatan disperi padat dengan metoda peleburan. Hasil sistem biner ini dikarakterisasi dengan analisa Differensial Thermal Analysis (DTA), Difraksi Sinar X, Spektrofotometri Infra Red dan Scanning Electron Microscope (SEM). Hasil analisa tersebut menunjukkan bahwa sistem biner dispersi padat yang paling baik terdapat pada formula VII.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/45</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.45</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 30-35</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 30-35</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/45/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/46</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Profile of Drug Information Given By Pharmacist Staff On Self Medication At The Pharmacy Located at Tampan, Pekanbaru-Indonesia</dc:title>
	<dc:title xml:lang="id-ID">Gambaran Tenaga Kefarmasian Dalam Memberikan Informasi Kepada Pelaku Swamedikasi di Apotek-Apotek Kecamatan Tampan, Pekanbaru</dc:title>
	<dc:creator>Muharni, Septi</dc:creator>
	<dc:creator>Aryani, Fina</dc:creator>
	<dc:creator>Mizanni, Maysharah</dc:creator>
	<dc:subject xml:lang="id-ID">apotek</dc:subject>
	<dc:subject xml:lang="id-ID">swamedikasi</dc:subject>
	<dc:subject xml:lang="id-ID">pemberian informasi obat</dc:subject>
	<dc:subject xml:lang="id-ID">nyeri gigi</dc:subject>
	<dc:subject xml:lang="en-US">pharmacy</dc:subject>
	<dc:subject xml:lang="en-US">self medication</dc:subject>
	<dc:subject xml:lang="en-US">drug information given</dc:subject>
	<dc:subject xml:lang="en-US">tooth pain</dc:subject>
	<dc:description xml:lang="en-US">The performance of all pharmacist staff including pharmacist, pharmacist assistance and pharmacist technician in drug information service towards self medication patient affect the therapeutic success. Self medication is the way of therapy with drug medication which drugs can be obtained at pharmacy without needing doctorâ€™s prescription. The research aims to evaluate the description of drug information service given by all pharmacist staff on self medication of tooth pain patient at the pharmacy located around Kecamatan Tampan, Pekanbaru. It was conducted using cross sectional planning survey by participative observational method. 30 pharmacist staffs who give mefenamic acid as tooth pain drug were selected as respondent. The assessment was done using Likert scale. The result showed that drug information service given by all pharmacist staffs was in good scale (63.10%) and still conducting passively or they gave drug information if only the patient asked. The detail result demonstrated that 63.20% of pharmacist afforded adequate scale of drug information service, the pharmacist assistant gave 60% of adequate scale, while the pharmacist technician exhibited 63.80% good scale. The route of drug usage was the most common information with very good category (85.33%).</dc:description>
	<dc:description xml:lang="id-ID">Tenaga farmasi dalam memberikan informasi kepada pelaku swamedikasi, dapat menentukan keberhasilan terapi. Swamedikasi adalah mengobati segala keluhan dengan obat-obatan yang dapat dibeli di apotek dengan inisiatif sendiri tanpa resep dokter. Penelitian ini bertujuan melihat gambaran pemberian informasi oleh tenaga kefarmasian pada swamedikasi nyeri gigi di apotek-apotek Kecamatan Tampan. Penelitian ini menggunakan rancagan survei cross-sectional dengan metoda observational partisifatif, Responden yang digunakan adalah tenaga farmasi yang memberikan asam mefenamat sebagai obat nyeri gigi, penilaian menggunakan skala likert. Hasil penelitian menunjukkan bahwa pemberian informasi yang dilakukan tenaga kesehatan adalah baik (63,10%) dan masih bersifat pasif atau hanya akan memberikan informasi ketika ditanya, dengan rincian pemberian informasi oleh apoteker cukup baik (63,20%), tenaga teknis kefarmasian cukup baik (60%) dan asisten tenaga kefarmasian dengan nilai baik (63,80%). Informasi yang paling sering disampaikan yaitu cara pemakaian obat kategori sangat baik (85,33%).Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/46</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.46</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 47-53</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 47-53</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/46/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/47</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Subchronic Toxicity Of Ethanolic Extract of Cassytha filiformis L. on The Renal Function of Rat</dc:title>
	<dc:title xml:lang="id-ID">Uji Toksisitas Subkronis Ekstrak Etanol Tali Putri (Cassytha filiformis L.) Terhadap Fungsi Ginjal Tikus</dc:title>
	<dc:creator>Yuliandra, Yori</dc:creator>
	<dc:creator>Armenia, Armenia</dc:creator>
	<dc:creator>Salasa, Annisa Nur</dc:creator>
	<dc:creator>Ismed, Friardi</dc:creator>
	<dc:subject xml:lang="en-US">cassytha filiformis</dc:subject>
	<dc:subject xml:lang="en-US">tali putri</dc:subject>
	<dc:subject xml:lang="en-US">subchronic toxicity</dc:subject>
	<dc:subject xml:lang="en-US">renal function</dc:subject>
	<dc:subject xml:lang="en-US">creatinine clearance</dc:subject>
	<dc:subject xml:lang="id-ID">cassytha filiformis</dc:subject>
	<dc:subject xml:lang="id-ID">tali putri</dc:subject>
	<dc:subject xml:lang="id-ID">toksisitas subkronis</dc:subject>
	<dc:subject xml:lang="id-ID">fungsi ginjal</dc:subject>
	<dc:subject xml:lang="id-ID">bersihan kreatinin</dc:subject>
	<dc:description xml:lang="en-US">Sub-chronic toxicity test of the deffated ethanolic extract ofÂ  tali putri (Cassytha filiformis L.) on the rat renal function has been carried out. A number of 16 male rats aged 2-3 months, weighing Â±250 g were used as experimental animals. The rats were divided into 4 groups which consisted of 1 control group and 3 extract-treated groups given 1.25, 2.5, and 5 mg/kg extract administrated intraperitoneally once a day for 14 days. The creatinine clearance, renal function, and the ratio of renal were calculated and analyzed by two-way ANOVA followed by Duncanâ€™s test. The study showed that the creatinine clearance and renal function decreased significantly during treatment (p&amp;lt;0.05). The kidney weight ratio of groups treated with extract, especially with greater doses, showed a very significant increase as compared with control (p&amp;lt;0,01). These indicated that the ethanolic extract ofÂ  C. filiformis on the doses of 1.25 â€“ 5 mg/kg might decrease the renal function, althought it seemed to be relatively safe when used for 14 days.</dc:description>
	<dc:description xml:lang="id-ID">Pengujian toksisitas subkronis ekstrak etanol tali putri (Cassytha filiformis L.) terhadap fungsi ginjal tikus telah dilakukan. Sebanyak 16 ekor tikus jantan berusia 2-3 bulan dengan berat badan Â±250 gram digunakan sebagai hewan uji. Hewan dibagi menjadi 4 kelompok, yaitu 1 kelompok kontrol dan 3 kelompok perlakuan yang diberi ekstrak etanol tali putri dengan dosis 1,25; 2,5; dan 5 mg/kg sekali sehari secara intraperitoneal selama 14 hari. Data bersihan kreatinin, persentase fungsi ginjal, dan rasio organ ginjal dianalisis dengan ANOVA dua arah dan dilanjutkan dengan uji Duncanâ€™s post hoc test. Hasil penelitian menunjukkan bahwa bersihan kreatinin dan persentase fungsi ginjal rata-rata tikus mengalami penurunan secara bermakna selama perlakuan (p&amp;lt;0,05). Rasio berat organ ginjal kelompok ekstrak, terutama pada dosis besar mengalami peningkatan dengan sangat bermakna (p&amp;lt;0,01) dibandingkan dengan kelompok kontrol. Ini menunjukkan bahwa ekstrak etanol tali putri dengan dosis 1,25-5 mg/kg dapat menyebabkan penurunan fungsi ginjal, tetapi masih relatif aman bila digunakan selama 14 hari.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/47</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.47</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 54-59</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 54-59</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/47/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/48</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Study on Dosage Regimens of Asthma Medications in Pediatric Patients of Dr. M. Djamil Padang Hospital</dc:title>
	<dc:title xml:lang="id-ID">Kajian Regimen Dosis Penggunaan Obat Asma pada Pasien Pediatri Rawat Inap di Bangsal Anak RSUP. Dr. M. Djamil Padang</dc:title>
	<dc:creator>Yosmar, Rahmi</dc:creator>
	<dc:creator>Andani, Meri</dc:creator>
	<dc:creator>Arifin, Helmi</dc:creator>
	<dc:subject xml:lang="en-US">asthma</dc:subject>
	<dc:subject xml:lang="en-US">pediatric</dc:subject>
	<dc:subject xml:lang="en-US">dosage regimen</dc:subject>
	<dc:subject xml:lang="id-ID">asma</dc:subject>
	<dc:subject xml:lang="id-ID">pediatri</dc:subject>
	<dc:subject xml:lang="id-ID">regimen dosis</dc:subject>
	<dc:description xml:lang="en-US">Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â  A study on dosage regimens of asthma medications in pediatric patients hospitalized at the pediatrics ward DR. M. Djamil Padang hospital has been carried out. The purpose of this study was to determine and compare the suitability of dosage regimen given to pediatric patients in the pediatrics ward of Dr. M. Djamil Padang hospital with the literature. This study was conducted retrospectively with consecutive sampling technique. Samples were obtained from medical records during 2013. The results showed that the appropriate dosage administration of asthma medication for the prednisone, CombiventÂ® and ambroxol were 100%, salbutamol 75%, and theophylline 0%. On the other hand, the entire medications showed 100% suitability concerning the route of administration. While for the interval of administration, the study showed that dexamethasone, prednisone, salbutamol, theophylline and ambroxol were 100% appropriate, but CombiventÂ® was lower at 95.24%. The study concludes that the dose and interval of administration are not in accordance with the literature, while the route of administration is considered to be in accordance with the literature.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian tentang kajian regimen dosis penggunaan obat asma pada pasien pediatri rawat inap di bangsal anak RSUP. DR. M. Djamil Padang yang bertujuan untuk membandingkan kesesuaian regimen dosis obat asma yang diberikan dengan regimen dosis pada literatur. Penelitian ini dilakukan secara retrospektif dengan teknik konsekutif sampling. Sampel diperoleh dari data rekam medik pasien selama tahun 2013. Hasil penelitian menunjukkan bahwa Prednison, CombiventÂ® dan Ambroxol memenuhi tepat dosis pemberian 100%, Deksametason 7,14%, Salbutamol 75%, dan pemberian teofilin tidak ada yang tepat dosis. Untuk kriteria rute pemberian 100% dinyatakan tepat untuk semua obat. Sedangkan untuk kriteria interval pemberian, Deksametason, Prednison, Salbutamol, Teofilin, dan Ambroxol dinilai 100% tepat interval, namun CombiventÂ® hanya 95,24%. Dari hasil penelitian disimpulkan bahwa dosis dan interval pemberian obat asma belum sepenuhnya sesuai dengan literatur, sedangkan untuk rute pemberian dinilai sudah sesuai dengan literatur.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/48</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.48</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 22-29</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 22-29</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/48/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/49</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Toxicity Studies of Mahogany Seeds on The Development of Behavior,  Liver Histology and Hematology of Mouse Pups</dc:title>
	<dc:title xml:lang="id-ID">Kajian Toksisitas Serbuk Biji Mahoni terhadap Perkembangan Tingkah Laku, Histologi Hati serta Hematologi Anak Mencit</dc:title>
	<dc:creator>Hilmarni, Hilmarni</dc:creator>
	<dc:creator>Almahdy, Almahdy</dc:creator>
	<dc:creator>Arifin, Helmi</dc:creator>
	<dc:subject xml:lang="id-ID">serbuk biji mahoni</dc:subject>
	<dc:subject xml:lang="id-ID">swietenia macrophylla</dc:subject>
	<dc:subject xml:lang="id-ID">toksisitas.</dc:subject>
	<dc:subject xml:lang="en-US">swietenia macrophylla</dc:subject>
	<dc:subject xml:lang="en-US">toxycity</dc:subject>
	<dc:subject xml:lang="en-US">histology of liver.</dc:subject>
	<dc:description xml:lang="en-US">This study aims to determine the effect of seed powder mahogany (Swietenia macrophylla King) on the development of behavior, liver histology and hematology of pups mice. Experimental animals used were 45 female mice were divided randomly into 5 groups. Group 1 as a control group. Groups 2, 3, 4, and 5, respectively mahogany seed powder given at a dose of 5, 10, 15, and 20 mg/20g/day from fetal life until lactation is completed. Developmental toxicity test carried out by behavioral test battery, observation of histology and hematology profile. The results showed that the provision of mahogany seed powder causes abnormal in the conduct reflex test and motor test on post natal day of 8 and 10, as well as the vision test on post natal day of 14-18. While the observation of liver histology and hematology profile did not show any effect.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan mengetahui pengaruh pemberian serbuk biji mahoni (Swietenia macrophylla King) terhadap perkembangan tingkah laku, gambaran histologi hati serta profil hematologi anak mencit. Hewan percobaan yang digunakan adalah mencit putih betina sebanyak 45 ekor dibagi secara acak menjadi 5 kelompok. Kelompok 1 sebagai kelompok kontrol diberi NaCMC 0,5%. Kelompok 2, 3, 4, dan 5 berturut-turut diberi serbuk biji mahoni dengan dosis 5, 10, 15, dan 20 mg/ 20gBB/hari mulai masa janin hingga masa laktasi selesai. Toksisitas perkembangan dilakukan dengan metoda test perilaku berurutan, observasi terhadap histologi dengan pewarnaan Hematoxilin-Eosin serta penghitungan profil hematologi. Hasil penelitian menunjukan pemberian serbuk biji mahoni menyebabkan penyimpangan tingkah laku pada uji refleks dan uji motorik PND-8 dan PND-10, serta pada uji penglihatan PND-14 hingga PND-18. Sedangkan pada pengamatan histologi hati dan profil hematologi anak mencit tidak menunjukan adanya pengaruh.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/49</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.49</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 15-21</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 15-21</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/49/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/50</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Impact of social demography characteristics, and antihypertensive medication adherence to the HRQoL on the congestive heart failure patients</dc:title>
	<dc:title xml:lang="id-ID">Dampak Karakteristik Sosiodemografi dan Tingkat Kepatuhan Terapi Antihipertensi Terhadap HRQoL  Pasien Gagal Jantung Kongestif</dc:title>
	<dc:creator>Rosa, Maryorie</dc:creator>
	<dc:creator>Armenia, Armenia</dc:creator>
	<dc:creator>Almasdy, Dedy</dc:creator>
	<dc:subject xml:lang="en-US">HRQoL</dc:subject>
	<dc:subject xml:lang="en-US">adherence</dc:subject>
	<dc:subject xml:lang="en-US">social demography characteristics</dc:subject>
	<dc:subject xml:lang="en-US">congestive heart failure</dc:subject>
	<dc:subject xml:lang="id-ID">HRQoL</dc:subject>
	<dc:subject xml:lang="id-ID">kepatuhan</dc:subject>
	<dc:subject xml:lang="id-ID">karakteristik sosiodemografi</dc:subject>
	<dc:subject xml:lang="id-ID">gagal jantung kongestif.</dc:subject>
	<dc:description xml:lang="en-US">Health Realted Qulity Of Life (HRQoL) is the patient perspective to their medication and illnes. The objective of study is to determine the impact of social demography characteristics, and medical adherence to the HRQoL of congestive heart failure patients in M. Djamil Hospital Padang. Data social demography, adherence, and HRQoL of 111 patients were collected by guided interview and completed by their medical record. We used T-test and one-way ANOVA, while 95% confidence intervals was taken for the significance. Patients who completed the education in senior high school possessed the best HRQoL score and the patients with lower level education had a worse HRQoL score (P&amp;lt;0,05). The best HRQoL score was showed by civil servant compared to other professions (P&amp;lt;0,05). While the worse HRQoL performed by the patient who had lower level of medication adherence (P&amp;lt;0,05). While the gender and age of the patients were not significantly affected the HRQoL score (P&amp;gt;0,1).</dc:description>
	<dc:description xml:lang="id-ID">Health Related Quality of Life (HRQoL) merupakan persepsi pasien terhadap efek terapi dan keparahan penyakitnya. Penelitian ini bertujuan untuk melihat dampak karakteristik sosiodemografi dan tingkat kepatuhan terapi antihipertensi terhadap HRQoL pasien gagal jantung kongestif (GJK) di RSUP DR. M. Djamil Padang. Data sosiodemografi, tingkat kepatuhan, dan HRQoL 111 pasien GJK yang berpartisipasi dalam penelitian ini dikumpulkan dengan wawancara terpimpin dan dari rekam medis pasien. Metoda T-Test dan Anova satu arah digunakan untuk menganalisa dampak karakteristis sosiodemografi dan tingkat kepatuhan terhadap HRQoL pasien GJK dengan tingkat kepercayaan 95%. Pasien dengan tingkat pendidikan yang lebih tinggi memiliki nilai HRQoL yang lebih baik dibandingkan dengan pasien berpendidikan lebih rendah (P&amp;lt;0,05). Pasien yang berprofesi sebagai pegawai negeri memiliki nilai HRQoL paling baik dibandingkan dengan profesi lainnya (P&amp;lt;0,05). Pasien dengan tingkat kepatuhan kurang baik memiliki nilai HRQoL yang lebih buruk pula (P&amp;lt;0,05). Sedangkan jenis kelamin dan usia tidak berpengaruh terhadap HRQoL pasien (P&amp;gt;0,1).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-12-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/50</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.50</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 40-46</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 40-46</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/50/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2015 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/52</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Effect of gargling by using siwak extract (Salvadora persica) to the saliva pH of oral cavity</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Berkumur dengan Larutan Ekstrak Siwak  (Salvadora persica) Terhadap pH  Saliva Rongga Mulut</dc:title>
	<dc:creator>Adzakiyah, Tiara</dc:creator>
	<dc:creator>Lipoeto, Indrawati</dc:creator>
	<dc:creator>Kasuma, Nila</dc:creator>
	<dc:subject xml:lang="id-ID">saliva</dc:subject>
	<dc:subject xml:lang="id-ID">pH</dc:subject>
	<dc:subject xml:lang="id-ID">Salvadora persica</dc:subject>
	<dc:subject xml:lang="en-US">saliva</dc:subject>
	<dc:subject xml:lang="en-US">pH</dc:subject>
	<dc:subject xml:lang="en-US">Salvadora persica</dc:subject>
	<dc:description xml:lang="en-US">Saliva is a complex body fluid and has important roles that related with biological processes in oral cavity. Saliva has important roles in maintaining health of oral cavity from caries diseases and periodontal diseases. One of saliva functions in maintaining oral health is associated with the degree of salivaâ€™s acidity (pH). Salivary pH can influence oral health by related with caries diseases and periodontal diseases. One of preventive method could be done is chemically preventive by using mouth wash solution. One of natural mouth wash solution could be used is miswak (Salvadora persica) extract mouth wash solution. Chemical contents of Salvadora persica extract can prevent descending of salivary pH because it has bactericidal effect that will prevent acid production from oral bacteria, increase saliva buffer activity by increasing saliva secretion. The purpose of this study was to determine the influence of Â Salvadora persica extract solution on salivary pH. The method used in this research is experimental with one group pre-posttest design. Subjects were 17 students of SMK Muhammadiyah 1 Padang. Measurements before and after mouth rinsing with Salvadora persica extract solution 50% performed on the subjects. The data were analyzed by paired T-test (p&amp;lt;0,05). This research showed the average salivary pH before given Salvadora persica extract solution was 6,565 and the average salivary pH after given miswak extract solution was 7,4. Mouth rinsing with Salvadora persica extract solution can increase salivary pH and can be used as mouth wash solution to maintain oral health.</dc:description>
	<dc:description xml:lang="id-ID">Saliva adalah cairan tubuh yang kompleks dan memiliki peran penting yang terkait dengan proses biologi dalam rongga mulut. Saliva memiliki peran penting dalam menjaga kesehatan rongga mulut dari karies dan penyakit periodontal. Salah satu fungsi saliva dalam menjaga kesehatan mulut berkaitan dengan tingkat keasaman saliva (pH). pH saliva dapat mempengaruhi kesehatan mulut yang berhubungan dengan karies dan penyakit periodontal. Salah satu metode pencegahan yang bisa dilakukan adalah secara kimiawi dengan menggunakan obat kumur. Salah satu obat kumur yang dapat digunakan adalah miswak (Salvadora persica). Kandungan kimia ekstrak Salvadora persica dapat mencegah menurunnya pH saliva karena memiliki efek bakterisida yang akan mencegah produksi asam dari bakteri mulut, meningkatkan aktivitas buffer saliva melalui peningkatkan sekresi saliva. Tujuan dari penelitian ini adalah untuk mengetahui pengaruh ekstrak Salvadora persica pada pH saliva. Metode yang digunakan dalam penelitian ini adalah eksperimental dengan satu kelompok desain pre-posttest. Subyek penelitian adalah 17 siswa dari SMK Muhammadiyah 1 Padang. Pengukuran dilakukan sebelum dan sesudah berkumur dengan larutan ekstrak Salvadora persica 50%. Data dianalisis dengan T-test (p &amp;lt;0,05). Hasil penelitian ini menunjukkan rata-rata pH saliva sebelum diberikan larutan ekstrak Salvadora persica adalah 6,565 dan pH saliva setelah diberi larutan ekstrak miswak adalah 7,4. Berkumur dengan ekstrak Salvadora persica dapat menjadi solusi dalam meningkatkan pH saliva dan dapat digunakan sebagai obat kumur untuk menjaga kesehatan rongga mulut.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-11-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/52</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.52</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 74-77</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 74-77</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/52/44</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/53</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Preliminary study on the profile of medication use and patient compliance  in the treatment of systemic lupus erythematosus</dc:title>
	<dc:title xml:lang="id-ID">Studi Pendahuluan Profil Penggunaan Obat dan Kepatuhan  terhadap Pengobatan pada Pasien Lupus di Komunitas</dc:title>
	<dc:creator>Irawati, Sylvi</dc:creator>
	<dc:creator>Prayitno, Adji</dc:creator>
	<dc:creator>Angel, Angel</dc:creator>
	<dc:creator>Safitri, Rosati Herma</dc:creator>
	<dc:subject xml:lang="id-ID">systemic lupus erythematosus</dc:subject>
	<dc:subject xml:lang="id-ID">lupus</dc:subject>
	<dc:subject xml:lang="id-ID">penggunaan obat</dc:subject>
	<dc:subject xml:lang="id-ID">kepatuhan</dc:subject>
	<dc:subject xml:lang="en-US">systemic lupus erythematosus</dc:subject>
	<dc:subject xml:lang="en-US">drug utilization</dc:subject>
	<dc:subject xml:lang="en-US">compliance</dc:subject>
	<dc:description xml:lang="en-US">This study aimed to describe medications used and compliance in systemic lupus erythematosus (SLE) patients. This was a nonexperimental and prospective study. Patients aged â‰¥18 years old, used medications for SLE and consented to participate were included in this study. Data was collected from September to November 2012 by observation and interview. Pill count method was used to measure patients compliance. All of 15 patients participated in this study were female with median of age 30 years old. Three patients received single medication and the rest received combination drugs. All patients used corticosteroids. In 12 patients it was combined with 1 or 2 of disease-modifying antirheumatic drugs (DMARDs). More than 50% patients did not comply with their medications. Further research is needed to elicit barriers for noncompliance and to produce strategy for improving the medication-taking-related behaviour in SLE patients.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk memberikan gambaran mengenai penggunaan obat dan kepatuhan pasien systemic lupus erythematosus (SLE) terhadap pengobatannya. Desain penelitian ini bersifat observational dan prospektif. Pasien SLE yang berpartisipasi dalam penelitian adalah pasien yang berusia â‰¥18 tahun, sedang menggunakan obat SLE, dan bersedia berpartisipasi. Pengumpulan data dilakukan selama bulan September sampai dengan November 2012. Metode pengumpulan data yang digunakan adalah observasi dan wawancara. Metode pill count digunakan untuk mengukur kepatuhan pasien. Terdapat 15 pasien yang bersedia berpartisipasi dalam penelitian. Seluruh pasien tersebut berjenis kelamin perempuan dengan median usia 30 tahun. Sebanyak 3 pasien menerima 1 macam obat, sementara sisanya menggunakan kombinasi obat. Semua pasien menggunakan corticosteroids. Sebanyak 12 pasien menggunakan kombinasi corticosteroids dengan 1 atau 2 obat dari golongan disease-modifying antirheumatic drugs (DMARDs). Lebih dari 50% pasien tidak patuh terhadap pengobatan. Penelitian lebih lanjut dibutuhkan untuk menggali faktor-faktor yang menghambat kepatuhan pasien terhadap pengobatan serta untuk menghasilkan strategi perbaikan bagi masalah ini.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-11-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/53</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.53</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 78-83</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 78-83</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/53/45</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/54</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Influence of Pharmaceutical Care Intervention  on Inpatient Community Acquired Pneumonia:  A Small Randomized Single Blind Study</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Pemberian Layanan Kefarmasian pada Penderita Pneumonia Komunitas Rawat Inap: A Small Randomized Single Blind Study</dc:title>
	<dc:creator>Presley, Bobby</dc:creator>
	<dc:creator>Setiabudi, I.</dc:creator>
	<dc:creator>Lestiono, Lestiono</dc:creator>
	<dc:creator>Ediyono, Ediyono</dc:creator>
	<dc:subject xml:lang="en-US">pharmaceutical care intervention</dc:subject>
	<dc:subject xml:lang="en-US">community acquired pneumonia</dc:subject>
	<dc:subject xml:lang="id-ID">pelayanan kefarmasian</dc:subject>
	<dc:subject xml:lang="id-ID">pneumonia komunitas</dc:subject>
	<dc:subject xml:lang="id-ID">lama perawatan</dc:subject>
	<dc:description xml:lang="en-US">Pneumonia, one of infectious diseases, becomes a major health care problem in Indonesia. The inappropriateness use of treatment can lead to greater unexpected health outcome and prolonged length of stay. A lot of research has proved that pharmacists, as a part of health care professionals, has important role in assuring patients to get the most optimal treatment benefit. The aim of this study is to identify the influence of pharmaceutical care intervention in reducing the length of stay of inpatients community acquired pneumonia. This experimental study involved 32 subjects with community acquired pneumonia hospitalized without any other infection between 18th August and 31st December 2010. Subjects were divided into two groups, i.e. intervention and control group, by simple random sampling technique. Intervention group received pharmaceutical care services i.e. drug related problems identification and solving based on Pharmaceutical Care Network Europe Classification and therapy guideline. Both group received hospital standard care. The primary outcome of this study was length of stay. All subjects were followed until 31 December 2010. Most of drug related problems identified in this study were classified as treatment effectiveness (intervention group 76.19% and control group 81.82%) and treatment cost (intervention group 23.81% and control group 18.18%). Inappropriate use of antibiotic was the main cause for this drug related problems based on the pneumonia guideline. Ceftriaxone and ciprofloxacin (28.21%) were the most inappropriate used antibiotics found in this study. The mean of length of stay between intervention (6 days) and control group (8 days) was significantly different (P&amp;lt;0.05). Pharmaceutical care intervention significantly improved the length of stay of inpatients community acquired pneumonia.</dc:description>
	<dc:description xml:lang="id-ID">Pneumonia merupakan salah satu masalah kesehatan terkait infeksi yang banyak terjadi di Indonesia. Ketidaktepatan pemilihan terapi dapat mengakibatkan keluaran kesehatan yang tidak terduga dan memperpanjang lama perawatan. Apoteker sebagai salah satu tenaga kesehatan profesional memiliki perang penting dalam menjamin terapi obat yang optimal bagi penderita. Tujuan dari penelitian ini adalah untuk melihat pengaruh pemberian layanan kefarmasian dalam mengurangi rata-rata lama perawatan pasien pneumonia komunitas rawat inap. Studi ini melibatkan 32 penderita pneumonia komunitas tanpa penyakit infeksi lain antara 18 Agustus â€“ 31 Desember 2010. Pasien terbagi menjadi dua kelompok, kelompok uji dan kelompok kontrol, dengan metode simple random sampling. Kedua kelompok tersebut mendapat pelayanan kesehatan standar, namun kelompok uji mendapatkan layanan kefarmasian berupa identifikasi masalah terkait obat dan rekomendasi terapi berdasarkan Pharmaceutical Care Network Europe Classification dan pedoman terapi. Keluaran utama pada penelitian ini adalah rata-rata lama perawatan penderita. Semua penderita dimonitor hingga 31 Desember 2010. Efektivitas terapi (kelompok uji 76,19% dan kelompok kontrol 81,82%) dan biaya terapi ( kelompok uji 23,81% dan kelompok kontrol 18,18%) merupakan masalah terkait obat yang paling banyak ditemukan. Seftriakson dan siprofloksasin (28,21%) merupakan antibiotik yang paling banyak ditemukan tidak sesuai dengan pedoman terapi pneumonia komunitas. Perbedaan yang signifikan ditemukan antara rata-rata lama perawatan pasien kelompok uji (6 hari) dan kelompok kontrol (8 hari) (P&amp;lt; 0,05). Hasil penelitian ini menunjukkan bahwa pemberian layanan kefarmasian dapat menurunkan secara signifikan rata-rata lama perawatan penderita pneumonia komunitas rawat inap.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-11-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/54</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.54</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 84-90</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 84-90</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/54/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/55</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Perception and the likelihood to practice medication reconciliation among community pharmacists</dc:title>
	<dc:title xml:lang="id-ID">Persepsi dan Kecenderungan Keterlibatan Apoteker di Apotek pada Proses Rekonsiliasi Obat</dc:title>
	<dc:creator>Setiawan, Eko</dc:creator>
	<dc:creator>Irawati, Sylvi</dc:creator>
	<dc:creator>Presley, Bobby</dc:creator>
	<dc:creator>Wardhani, Susilo Ari</dc:creator>
	<dc:subject xml:lang="id-ID">rekonsiliasi obat</dc:subject>
	<dc:subject xml:lang="id-ID">apoteker</dc:subject>
	<dc:subject xml:lang="id-ID">apotek</dc:subject>
	<dc:description xml:lang="en-US">The objective of this study was to gain insight into the perception and the likelihood to practice medication reconciliation among pharmacists working at the apotek. Two guiding questions were given to each participant and participants were asked to write the answer on the paper. Thematic analysis was used to analyse the data. There were 31 pharmacists involved in this study. All of participants perceived that medication reconciliation was important to be implemented. Almost all of participants (i.e 30 from 31 pharmacists) clearly stated that they would like to implement medication reconciliation. And, there were 3 themes found as the main motivation factors in implementing the medication reconciliation. Pharmacists who were working at the apotek had a good perception about medication reconciliation and also showed the likelihood to implement medication reconciliation. Further research need to be conducted in order to explore the barriers in implementing medication reconciliation.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk memotret persepsi dan kecenderungan kesediaan apoteker yang bekerja di apotek di sebuah kabupaten untuk terlibat dalam program rekonsiliasi obat. Dua buah pertanyaan panduan tertulis diberikan kepada setiap peserta dan peserta diminta kesediaannya untuk menjawab pertanyaan tersebut pada lembar yang telah disediakan. Analisis dilakukan dengan menggunakan metode thematic analysis. Total terdapat 31 apoteker yang bersedia terlibat dalam penelitian ini. Seluruh peserta penelitian berpersepsi bahwa proses rekonsiliasi obat penting untuk diimplementasikan. Hampir seluruh peserta (30 dari 31 apoteker) memiliki kecenderungan untuk bersedia terlibat dalam proses rekonsiliasi obat. Terdapat 3 tema utama pertimbangan yang mendasari kecenderungan apoteker di apotek untuk bersedia terlibat dalam proses rekonsiliasi obat. Apoteker peserta penelitian yang bekerja di apotek memiliki persepsi dan kecenderungan yang baik untuk berkontribusi dalam proses rekonsiliasi obat. Identifikasi faktor-faktor yang berpotensi menjadi penghalang implementasi proses rekonsiliasi obat oleh apoteker di apotek perlu dilakukan sebelum program rekonsiliasi obat ini diimplementasikan dalam suatu daerah.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-11-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/55</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.55</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 91-98</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 91-98</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/55/46</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/56</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Effect of carrot decoction on the gasric ulcer of white male rats</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Pemberian Sari Wortel (Daucus carota L.)  terhadap Tukak Lambung Pada Tikus Putih Jantan</dc:title>
	<dc:creator>Suhatri, Suhatri</dc:creator>
	<dc:creator>Rusdi, Rusdi</dc:creator>
	<dc:creator>Sugesti, Emi</dc:creator>
	<dc:subject xml:lang="id-ID">sari wortel</dc:subject>
	<dc:subject xml:lang="id-ID">betakaroten</dc:subject>
	<dc:subject xml:lang="id-ID">etanol absolut</dc:subject>
	<dc:subject xml:lang="id-ID">tukak lambung</dc:subject>
	<dc:subject xml:lang="en-US">carrot decoction</dc:subject>
	<dc:subject xml:lang="en-US">betacaroten</dc:subject>
	<dc:subject xml:lang="en-US">absolut ethanol</dc:subject>
	<dc:subject xml:lang="en-US">gastric ulcer</dc:subject>
	<dc:description xml:lang="en-US">A study on the effect of carrot decoction to the gastric ulcer of white male rats induced by absolute ethanol 1 ml/200 g orally has been conducted. The study showed that carrot decoction in the doses of 3; 6; and 12 ml/kg could improve the ulcer by amount of 28.41; 46.79; and 75.76 %, respectively. The decoction could also reduce the pH of gastric juice significantly toward the normal level (P&amp;lt;0.01).</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan pengujian pengaruh sari wortel (Daucus carota L.) terhadap tukak lambung pada tikus putih jantan yang diinduksi dengan etanol absolut 1 ml/200 gram berat badan secara oral. Hasil penelitian ini menunjukkan bahwa sari wortel dengan dosis 3, 6 dan 12 ml/kgBB dapat memulihkan tukak lambung dengan persentase pengobatan masing-masing adalah 28,412%; 46,797% dan 75,766%. Sari wortel ini juga dapat menurunkan pH cairan lambung tikus yang diberi etanol absolut menuju pH cairan lambung tikus normal secara signifikan (P&amp;lt;0,01).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-11-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/56</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.56</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 99-103</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 99-103</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/56/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/57</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antioxidant compound of metanolic extract of Detam 1 Glycine max (L.) Merr  from ultrasonic extraction</dc:title>
	<dc:title xml:lang="id-ID">Senyawa Antioksidan Ekstrak Metanol Glycine max (L.) Merr Varietas Detam 1 Hasil Estraksi Ultrasonik</dc:title>
	<dc:creator>Yulia, Rika</dc:creator>
	<dc:creator>Wijaya, Ivon Sindu</dc:creator>
	<dc:subject xml:lang="id-ID">glycine max varietas detam 1</dc:subject>
	<dc:subject xml:lang="id-ID">senyawa antioksidan</dc:subject>
	<dc:subject xml:lang="id-ID">ekstrak metanol</dc:subject>
	<dc:subject xml:lang="id-ID">ultrasonik.</dc:subject>
	<dc:subject xml:lang="en-US">glycine max detam 1 variety</dc:subject>
	<dc:subject xml:lang="en-US">antioxidant compounds</dc:subject>
	<dc:subject xml:lang="en-US">methanol extract</dc:subject>
	<dc:subject xml:lang="en-US">ultrasonic.</dc:subject>
	<dc:description xml:lang="en-US">The objective of this study is to find antioxidant compounds which are contained in methanol extract of Glycine max Detam 1 variety from Ultrasound extraction method. Extraction has done by two solvents; Â¬n-hexane solvent to eliminate the soy fat which can affect the analysis result and methanol 80% to take the active compounds in soybean. The result of extraction was concentrated by using Rotary evaporator (BUCHI Rotavapor R-114) and BUCHI Water bath B-480. As the result of this study, there were three antioxidant compounds detected, i.e. Methyl-10-trans,12-cis-octadecadienoate, Methyl 9-cis,11-trans-octadecadienoate, and 9,12-Octadecadinoic acid.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk mengetahui kandungan senyawa antioksidan yang terkandung dalam ekstrak metanol Glycine max varietas Detam 1 hasil dari ekstraksi dengan metode ultrasonik. Ekstraksi dilakukan dengan 2 pelarut yaitu pelarut n-heksan untuk menghilangkan lemak yang mungkin dapat mempengaruhi hasil selama analisis dan metanol 80% untuk mengambil senyawa aktif dalam kedelai. Hasil ekstraksi kemudian dipekatkan dengan Rotary evaporator (BUCHI Rotavapor R-114) dan BUCHI Waterbath B-480. Analisis dilakukan secara kualitatif dengan menggunakan Gas Chromatography-Mass Spectra (GS-MS). Analisis terhadap senyawa antioksidan menggunakan GC-MS menunjukkan terdapat tiga senyawa antioksidan yaitu Methyl-10-trans,12-cis-octadecadienoate, Methyl 9-cis,11-trans-octadecadienoate, dan 9,12-Octadecadinoic acid.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-11-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/57</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.57</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 66-73</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 66-73</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/57/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/58</identifier>
				<datestamp>2019-06-30T21:27:53Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antidiabetic Use Evaluation in Type-2 Diabetes Mellitusâ€™ Patients on a Public Hospital at Padang City â€“ West Sumatera</dc:title>
	<dc:title xml:lang="id-ID">Evaluasi Penggunaan Obat Antidiabetik Pada Pasien Diabetes Melitus Tipe-2  di Suatu Rumah Sakit Pemerintah Kota Padang â€“ Sumatera Barat</dc:title>
	<dc:creator>Almasdy, Dedy</dc:creator>
	<dc:creator>Sari, Dita Permata</dc:creator>
	<dc:creator>Suhatri, Suhatri</dc:creator>
	<dc:creator>Darwin, Deswinar</dc:creator>
	<dc:creator>Kurniasih, Nina</dc:creator>
	<dc:subject xml:lang="id-ID">antidiabetik</dc:subject>
	<dc:subject xml:lang="id-ID">evaluasi penggunaan obat</dc:subject>
	<dc:subject xml:lang="id-ID">farmasi rumah sakit</dc:subject>
	<dc:subject xml:lang="en-US">antidiabetic</dc:subject>
	<dc:subject xml:lang="en-US">drug use evaluation</dc:subject>
	<dc:subject xml:lang="en-US">hospital pharmacy</dc:subject>
	<dc:description xml:lang="en-US">The appropriateness of antidiabetic usege on a public hospital in Padang - West Sumatra has been studied. This study was a descriptive study, which used patientâ€™s medical record as data resources. The appropriateness of antidiabetic usage based on criterion which was established earlier, such as the appropriateness of indication, the appropriateness of patient, the appropriateness of regiment, and the appropriateness of drug administration. Evaluation also has been done to the potential of drug interaction. The results showed that antidiabetic usage on that hospital were 100% appropriate in term of indication and drug administration. While evaluation to appropriateness of patient and drug regiment were 95.59% and 40.82% respectively.</dc:description>
	<dc:description xml:lang="id-ID">Kajian terhadap ketepatan penggunaan antidiabetik pada suatu rumah sakit pemerintah di Padang, Sumatera Barat telah dilakukan. Penelitian ini berupa kajian deskriptif, menggunakan rekam medis sebagai sumber data. Ketepatan penggunaan obat didasarkan pada kriteria yang telah ditetapkan terlebih dahulu, meliputi beberapa indikator, yaitu; ketepatan indikasi, ketepatan penderita, ketepatan regimen dosis dan ketepatan rute pemberian. Kajian juga dilakukan terhadap potensi terjadinya interaski obat. Hasil penelitian menunjukkan bahwa penggunaan obat antidiabetik pada rumah sakit tersebut 100% tepat indikasi dan tepat rute pemberian. Sedangkan kajian terhadap ketepatan penderita dan regimen dosis masing-masingnya hanya sebesar 95.59% dan 40.82%. Selain itu juga ditemukan potensi interaksi obat.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2015-11-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/58</dc:identifier>
	<dc:identifier>10.29208/jsfk.2015.2.1.58</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 1 (2015); 104-110</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 1 (2015): J Sains Farm Klin 2(1), November 2015; 104-110</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/58/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/60</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Level of Compliance of Tuberculosis Patients at Mayjen H. A Thalib Kerinci Hospital</dc:title>
	<dc:title xml:lang="id-ID">Tingkat Kepatuhan Penggunaan Obat pada Pasien Tuberkulosis di Rumah Sakit Mayjen H. A Thalib Kabupaten Kerinci.</dc:title>
	<dc:creator>Pameswari, Puspa</dc:creator>
	<dc:creator>Halim, Auzal</dc:creator>
	<dc:creator>Yustika, Lisa</dc:creator>
	<dc:subject xml:lang="id-ID">tingkat kepatuhan</dc:subject>
	<dc:subject xml:lang="id-ID">tuberkolosis (tb paru)</dc:subject>
	<dc:subject xml:lang="id-ID">obat tb paru</dc:subject>
	<dc:subject xml:lang="en-US">compliance</dc:subject>
	<dc:subject xml:lang="en-US">tuberculosis</dc:subject>
	<dc:subject xml:lang="en-US">MMAS</dc:subject>
	<dc:description xml:lang="en-US">Kepatuhan pasien dalam mengkonsumsi obat secara teratur sampai tuntas merupakan salah satu faktor yang menentukan keberhasilan dalam pengobatan tuberkulosis paru. Penelitian ini bertujuan untuk mengetahui Tingkat Kepatuhan Pemakaian Obat pada Pasien Penderita TB paru di Rumah Sakit Mayjen H.A Thalib Kabupaten Kerinci, pada bulan Aprilâ€“Juni 2015. Penelitian ini termasuk penelitian observasional (non eksperimental). Pengambilan data menggunakan kuisioner yang dibuat berdasarkan MMAS (Morisky Medication Adherence Scale) dan CSA (Continous Single-Interval Medication Avaibility). Hasil penelitian menunjukkan sebanyak 55,56% responden patuh; 33,33% responden cukup patuh dan 11,11% responden tidak patuh dalam pengunaan obat.</dc:description>
	<dc:description xml:lang="id-ID">Kepatuhan pasien dalam mengkonsumsi obat secara teratur sampai tuntas merupakan salah satu faktor yang menentukan keberhasilan dalam pengobatan tuberkulosis paru. Penelitian ini bertujuan untuk mengetahui Tingkat Kepatuhan Pemakaian Obat pada Pasien Penderita TB paru di Rumah Sakit Mayjen H.A Thalib Kabupaten Kerinci, pada bulan Aprilâ€“Juni 2015. Penelitian ini termasuk penelitian observasional (non eksperimental). Pengambilan data menggunakan kuisioner yang dibuat berdasarkan MMAS (Morisky Medication Adherence Scale) dan CSA (Continous Single-Interval Medication Avaibility). Hasil penelitian menunjukkan sebanyak 55,56% responden patuh; 33,33% responden cukup patuh dan 11,11% responden tidak patuh dalam pengunaan obat.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/60</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.60</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 116-121</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 116-121</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/60/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/61</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Influence of Drug Counseling on Knowledge and Patient Compliance with Congestive Heart Failure</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Konseling Obat Terhadap Pengetahuan dan Kepatuhan Pasien Congestive Heart Failure</dc:title>
	<dc:creator>Neswita, Elfia</dc:creator>
	<dc:creator>Almasdy, Dedy</dc:creator>
	<dc:creator>Harisman, Harisman</dc:creator>
	<dc:subject xml:lang="id-ID">Konseling obat</dc:subject>
	<dc:subject xml:lang="id-ID">CHF</dc:subject>
	<dc:subject xml:lang="id-ID">kepatuhan terapi</dc:subject>
	<dc:subject xml:lang="id-ID">pelayanan kefarmasian</dc:subject>
	<dc:subject xml:lang="en-US">drug counseling</dc:subject>
	<dc:subject xml:lang="en-US">CHF</dc:subject>
	<dc:subject xml:lang="en-US">treatment adherence</dc:subject>
	<dc:subject xml:lang="en-US">pharmacy services</dc:subject>
	<dc:description xml:lang="en-US">Compliance therapy is a very important point in the successful treatment of CHF patients. However, such compliance is very low so do efforts to increase knowledge and treatment adherence through drug counseling by pharmacists. The design of this type of research is a quasi-experimental, one-group pretest-posttest design, with a population of CHF patients in IRNA Heart Hospital DR. M. Djamil Padang in the month from March to December 2014. The sampling technique in the form of purposive sampling (50 patients) with questionnaires and interviews. Data analysis was performed using the Crosstab, Chi-Square, paired-sample t-test, Pearson Product Moment, simple linear regression, multiple linear regression and SPSS version 17. The results of this study indicate that the drug counseling significantly improve patient knowledge and compliance (97,2% and 77.6% (p &amp;lt;0.05)).</dc:description>
	<dc:description xml:lang="id-ID">Kepatuhan terapi merupakan poin yang sangat penting dalam keberhasilan terapi pasien CHF. Namun, kepatuhan tersebut sangat rendah sehingga dilakukan upaya peningkatan pengetahuan dan kepatuhan terapi melalui konseling obat oleh farmasis. Rancangan jenis penelitian ini adalah quasi-eksperimental, one-group pretest-posttest design, dengan populasi pasien CHF di IRNA Jantung RSUP DR. M. Djamil Padang pada bulan Maret â€“ Desember 2014. Teknik pengambilan sampel berupa purposive sampling (50 pasien) dengan kuesioner dan wawancara langsung. Analisis data dilakukan dengan menggunakan Crosstab, Chi-Square, Paired-sample T-test, Pearson Product Moment, regresi linier sederhana, regresi linear berganda dan SPSS versi 17. Hasil penelitian ini menunjukkan bahwa konseling obat secara signifikan meningkatkan pengetahuan dan kepatuhan pasien (97,2% dan 77,6% (p &amp;lt; 0,05)).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/61</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.61</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 195-302</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 195-302</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/61/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/65</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Comparison Method Wet Granulation and Direct Compression of Physical Properties and Disintegration Time of Orally Disintegrating Tablets Piroxicam</dc:title>
	<dc:title xml:lang="id-ID">Perbandingan Metode Granulasi Basah dan Kempa Langsung Terhadap Sifat Fisik dan Waktu Hancur Orally Disintegrating Tablets (ODTs) Piroksikam</dc:title>
	<dc:creator>Suhery, Wira Noviana</dc:creator>
	<dc:creator>Fernando, Armon</dc:creator>
	<dc:creator>Giovanni, Buddy</dc:creator>
	<dc:subject xml:lang="id-ID">orally disintegrating tablets</dc:subject>
	<dc:subject xml:lang="id-ID">ODTs</dc:subject>
	<dc:subject xml:lang="id-ID">granulasi basah</dc:subject>
	<dc:subject xml:lang="id-ID">kempa langsung</dc:subject>
	<dc:subject xml:lang="id-ID">piroksikam</dc:subject>
	<dc:subject xml:lang="en-US">orally disintegrating tablets</dc:subject>
	<dc:subject xml:lang="en-US">disintegration time</dc:subject>
	<dc:subject xml:lang="en-US">odts</dc:subject>
	<dc:subject xml:lang="en-US">wet  granulation</dc:subject>
	<dc:subject xml:lang="en-US">direct compression</dc:subject>
	<dc:subject xml:lang="en-US">piroxicam</dc:subject>
	<dc:description xml:lang="en-US">Study on comparison of wet granulation and direct compression method of physical properties and disintegration time of orally disintegrating tablets piroxicam has been done. This study aims to comparison which method gives better results of physical properties and disintegration time between wet granulation and direct compression method. Both methods are made with the same composition formula of each tablets is Piroxicam 20 mg, PrimelloseÂ® 5%, 1% PVP K30, magnesium stearate 1%, Mannitol 10%, and ComprecelÂ® up to 175 mg. ODTs then evaluated physical properties which include weight variation, thickness, hardness, friability and friksibility, disintegration time, ratio of water absorption, wetting time, drug content and dissolution test. The results showed that both methods produce the physical properties of a good tablets. However, the method of direct compression provides a disintegrating faster 55.51 seconds compared with the wet granulation method. Statistical test using independent sample T test showed that there were significant differences in the disintegration time (P &amp;lt;0.05) between the formula with the method of direct compression and wet granulation.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian mengenai perbandingan penggunaan metode granulasi basah dan kempa langsung terhadap sifat fisik dan waktu hancur orally disintegrating tablets (ODTs) piroksikam. Penelitian ini bertujuan untuk membandingkan metode pembuatan ODTs piroksikam yang menghasilkan sifat fisik tablet dan waktu hancur yang paling baik. Komposisi formula pada metode granulasi basah dan cetak langsung sama tiap tabletnya yaitu Piroksikam 20 mg, PrimelloseÂ® 5%, PVP K30 1%, Mg stearat 1%, Manitol 10%, dan ComprecelÂ® ad 175 mg. Tablet ODTs kemudian dievaluasi sifat fisiknya yang meliputi keseragaman bobot, keseragaman ukuran, kekerasan, friabilitas dan friksibilitas, waktu hancur, rasio penyerapan air, waktu pembasahan dan penetapan kadar serta uji disolusi. Hasil penelitian menunjukkan bahwa kedua metode menghasilkan sifat fisik tablet yang baik. Namun metode kempa langsung memberikan waktu hancur yang lebih cepat yaitu 55,51 detik dibandingkan dengan metode granulasi basah. Hasil uji statistik menggunakan metode independent sample T test menunjukkan terdapat perbedaan bermakna waktu hancur (P&amp;lt;0,05) antara formula dengan metode kempa langsung dengan granulasi basah.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/65</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.65</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 138-144</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 138-144</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/65/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/66</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Caffeine analysis from Luwak Coffee in different types of Coffees, Luwak Species and Processed by using TLC Scanner Method</dc:title>
	<dc:title xml:lang="id-ID">Analisis Kadar Kofein Kopi Luwak  Dengan Variasi Jenis Kopi, Spesies Luwak Dan Cara Pengolahan Dengan Metoda TlC Scanner</dc:title>
	<dc:creator>Yulia, Rahma</dc:creator>
	<dc:creator>Adnan, Adek Zamrud</dc:creator>
	<dc:creator>Putra, Deddi Prima</dc:creator>
	<dc:subject xml:lang="id-ID">kopi</dc:subject>
	<dc:subject xml:lang="id-ID">kofein</dc:subject>
	<dc:subject xml:lang="id-ID">luwak A. binturong</dc:subject>
	<dc:subject xml:lang="id-ID">P. hermophroditus</dc:subject>
	<dc:subject xml:lang="id-ID">TLC Scanner</dc:subject>
	<dc:subject xml:lang="en-US">coffee</dc:subject>
	<dc:subject xml:lang="en-US">caffeine</dc:subject>
	<dc:subject xml:lang="en-US">luwak A. binturong</dc:subject>
	<dc:subject xml:lang="en-US">P. hermophroditus</dc:subject>
	<dc:subject xml:lang="en-US">TLC Scanner</dc:subject>
	<dc:description xml:lang="en-US">Caffeine analysis from Luwak coffee in different types of coffees, Luwak species and processed by using TLC Scanner method had been done. 8 samples of Luwak coffee, that is R.Ab.K ; R.Ab.B ; R.Ph.K ; R.Ph.B ; A.Ab.K ; A.Ab.B ; A.Ph.K ; A.Ph.B which were extracted by dichloromethane (DCM). TLC separation had been done through stationary phase with silica gel GF254 and mobile phase are solute of dichloromethane (DCM) : methanol (9,5 : 0,5). Caffeine content had been counted by using regression equality y = 2715,112 + 4,389x and giving percentage in succession 1,91 ; 2,04 ; 1,30 ; 1,89 ; 1,29 ; 1,45 ; 1,25 ; 1,42 %. The highest of caffeine had been given by Robusta coffee which has been given before to A. binturong luwak and processed wetly 2,04 %. The lowest of caffeine content had been given to Arabica coffee which has been given before to P. hermophroditus luwak 1,25 %. Three way â€“ Anova statistic SPSS 21 tabulation had showed the result that the kind of coffee, variety of Luwak and the way of processing gave significant value toward caffeine content in p &amp;lt; 0,05.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian analisis kadar kofein kopi luwak dengan variasi jenis kopi, spesies luwak dan cara pengolahan dengan metoda TLC Scanner. Analisis dilakukan dengan menggunakan 8 sampel kopi luwak R.Ab.K ; R.Ab.B ; R.Ph.K ; R.Ph.B ; A.Ab.K ; A.Ab.B ; A.Ph.K ; A.Ph.B yang diekstraksi dengan pelarut diklorometana ( DCM ). Pemisahan dengan KLT dilakukan dengan fasa diam plat silika gel GF254 dan fasa gerak campuran diklorometana : metanol ( 9,5 : 0,5 ). Kadar kofein dihitung dengan menggunakan persamaan regresi y = 2715,112 + 4,389x dan memberikan persentase kadar berturut-turut 1,91 ; 2,04 ; 1,30 ; 1,89 ; 1,29 ; 1,45 ; 1,25 ; 1,42 %. Kadar kofein paling tinggi diberikan oleh kopi robusta yang diberikan pada luwak A. binturong dan diolah secara basah dengan persentase 2,04 %. Sedangkan kadar kofein paling rendah diberikan oleh kopi arabika yang diberikan pada luwak P. hermophroditus dengan persentase 1,25 %. Pengolahan data dengan statistik anova tiga jalan SPSS 21 menunjukkan hasil bahwa jenis kopi, variasi luwak dan cara pengolahan memberikan pengaruh yang signifikan terhadap kadar kofein dengan p &amp;lt; 0,05.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/66</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.66</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 171-175</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 171-175</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/66/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/67</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Comparison between Warfarin Dose with Duration Achieving Target INR in Patient with CHF and Atrial Fibrillation</dc:title>
	<dc:title xml:lang="id-ID">Perbandingan Dosis Warfarin terhadap Durasi Tercapainya Target INR pada Pasien CHF dengan Fibrilasi Atrial</dc:title>
	<dc:creator>Agustini, Tiara Tri</dc:creator>
	<dc:creator>Arifin, Helmi</dc:creator>
	<dc:creator>Hanif, Akmal M.</dc:creator>
	<dc:subject xml:lang="en-US">Warfarin</dc:subject>
	<dc:subject xml:lang="en-US">INR</dc:subject>
	<dc:subject xml:lang="en-US">CHF</dc:subject>
	<dc:subject xml:lang="en-US">AF</dc:subject>
	<dc:subject xml:lang="id-ID">warfarin</dc:subject>
	<dc:subject xml:lang="id-ID">INR</dc:subject>
	<dc:subject xml:lang="id-ID">CHF</dc:subject>
	<dc:subject xml:lang="id-ID">AF</dc:subject>
	<dc:description xml:lang="en-US">A study of comparison between warfarin dose with achieving target INR in patients with CHF and atrial fibrillation at RSUP. DR. M. Djamil Padang has been investigated. This study analyzed using one-way ANOVA and if the result is significant then followed by post hoc test. Of the total 27 patients, all the patients suffering from CHF and 11 patients suffering from hypertension. There were 15 patients aged &amp;lt;60 years, 11 patients aged between 60-74 years, and 1 patient aged â‰¥75 years. The number male and female patients are 11 and 16 people. The mean duration of achieving the target INR at dose 2 mg, dose (2 mg and 4 mg) and dose 5 mg are 38.22, 29.33, and 6.56 days. There is a significant difference in the mean duration of achieving the target INR in the dose group. 5 mg dose had a mean duration of achieving the target INR which significantly different compared to the other doses.Â A study of comparison betweenwarfarin dose with achieving target INR in patients with CHF and atrial fibrillation at RSUP. DR. M. Djamil Padang has been investigated. This study analyzed using one-way ANOVA and if the result is significant then followed by post hoc test. Of the total 27 patients,all the patients suffering fromCHF and11 patients suffering from hypertension. There were 15 patients aged &amp;lt;60 years, 11 patients aged between 60-74 years, and 1 patient aged â‰¥75 years. The number male and female patients are11 and 16 people. The mean duration of achieving the target INR at dose 2 mg, dose (2 mg and 4 mg) and dose 5 mg are 38.22, 29.33, and 6.56 days. There is a significant difference in the mean duration of achieving the target INR in the dose group. 5 mg dose had a mean duration of achieving the target INRwhich significantly different compared to the other doses.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian mengenai perbandingan dosis warfarin terhadap durasi tercapainya target INR pada pasien CHF dengan fibrilasi atrial di RSUP DR. M. Djamil Padang. Penelitian ini dianalisis menggunakan metode anova satu arah yang jika bermakna dilanjutkan dengan uji post hoc. Dari total 27 pasien, seluruhnya menderita penyakit CHF dan 11 orang menderita hipertensi. Pasien dengan umur &amp;lt;60 tahun sebanyak 15 orang, 60-74 tahun sebanyak 11 orang, dan â‰¥75 tahun sebanyak 1 orang. Pasien berjenis kelamin laki-laki dan perempuan masing-masing berjumlah 11 dan 16 orang. Rata-rata durasi tercapainya target INR pada dosis 2 mg adalah 38,22 hari; dosis (2 mg dan 4 mg) adalah 29,33 hari; dan dosis 5 mg adalah 6,56 hari. Terdapat perbedaan rerata durasi tercapainya target INR secara bermakna pada kelompok dosis. Dosis 5 mg memiliki rerata durasi tercapainya target INR yang berbeda signifikan dibandingkan dengan dosis lainnya.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/67</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.67</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 162-170</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 162-170</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/67/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/68</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Study of the solid dispersion systems Klaritromisin-Eudragit L100</dc:title>
	<dc:title xml:lang="id-ID">Studi Sistem Dispersi Padat Klaritromisin â€“ Eudragit L100</dc:title>
	<dc:creator>Noviyanty, Yuska</dc:creator>
	<dc:creator>Ben, Elfi Sahlan</dc:creator>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:subject xml:lang="id-ID">dispersi padat</dc:subject>
	<dc:subject xml:lang="id-ID">klaritromisin</dc:subject>
	<dc:subject xml:lang="id-ID">eudragit l100</dc:subject>
	<dc:subject xml:lang="en-US">solid dispersion</dc:subject>
	<dc:subject xml:lang="en-US">clarithromycin</dc:subject>
	<dc:subject xml:lang="en-US">eudragit L100</dc:subject>
	<dc:description xml:lang="en-US">Solid dispersion made with the weight ratio (b/b) using the dissolving method. DTA analysis of the solid dispersion obtained in Eudragit L 100 affects the position and sharpness of the peak. X-ray diffraction analysis showed that of clarithromycin - Eudragit L 100 is in amorphous form and did not produce a new crystalline phase. SEM analysis showed that crystalline of Eudragit L 100 is smaller (amorphous) and stick to the surface of the clarithromycin crystal. IR spectrophotometer analysis showed that there is no chemical interaction between clarithromycin and Eudragit L 100. Clarithromycin assay was done by HPLC method, using mobile phase methanol and 0.067 M KH2PO4 (13:7) plus fospat acid pH 4.0. The dissolution profile by the time of 60 minutes are clarithromycin 45.73%, CF (1:1) 49.86%, DP (1:1) 51.53%, DP (2:1) 55.87% and DP (1:2) 58.97% respectively. Solid dispersion 1:2 (w/w) have an increased dissolution rate compared to clarithromycin.</dc:description>
	<dc:description xml:lang="id-ID">Â  Â  Â  Â  Â  Â Â Telah dilakukan penelitian pembentukan sistem dispersi padat klaritromisin-Eudragit L100. Dispersi padat dibuat denganÂ  perbandingan berat (b/b) menggunakan metode pelarutan. Analisa DTA dispersi padat diperoleh pada Eudragit L 100 mempengaruhi posisi dan ketajaman puncak. Analisa difraksi sinar-x menunjukkan bahwa dispersi padat klaritromisin â€“ Eudragit L 100 berupa amorf dan tidak menghasilkan fase kristalin baru. Hasil analisis SEM dispersi padat menunjukkan kristal Eudragit L 100 lebih kecil (amorf) dan menempel pada permukaan kristal klaritromisin. Analisis spektrofotometer IR menunjukkan tidak ada interaksi kimia antara klaritromisin â€“ Eudragit L 100. Penetapan kadar klaritromisin dengan KCKT fase gerak metanol dan 0,067 M KH2PO4 13:7 ditambah asam fospat pH 4,0. Hasil profil disolusi pada waktu 60 menit berturut-turut untuk klaritromisinÂ  45,73%, CF (1:1) 49,86 %,Â  DP (1:1) 51,53 %, DP (2:1) 55,87 % dan DP (1:2) 58,97 % Dispersi padat 1:2 (b/b) memiliki peningkatan laju disolusi jika dibandingkan dengan klaritromisin.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/68</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.68</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 183-190</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 183-190</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/68/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/69</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Relationship of Switch Therapy Toward Wound Healing, Lenght of Stay and Antibiotic Expenditure of Patients Appendicitis</dc:title>
	<dc:title xml:lang="id-ID">Hubungan Ketepatan Switch Therapy Terhadap Kesembuhan Luka, Lama Rawatan dan Biaya Pengobatan Antibiotik Pasien Appendisitis</dc:title>
	<dc:creator>Masyithah, Lathvi</dc:creator>
	<dc:creator>Armenia, Armenia</dc:creator>
	<dc:creator>Almahdy, Almahdy</dc:creator>
	<dc:subject xml:lang="id-ID">switch therapy</dc:subject>
	<dc:subject xml:lang="id-ID">kesembuhan luka</dc:subject>
	<dc:subject xml:lang="id-ID">lama rawatan</dc:subject>
	<dc:subject xml:lang="id-ID">biaya pengobatan</dc:subject>
	<dc:subject xml:lang="id-ID">appendisitis</dc:subject>
	<dc:subject xml:lang="en-US">switch therapy</dc:subject>
	<dc:subject xml:lang="en-US">wound healing</dc:subject>
	<dc:subject xml:lang="en-US">lenght of stay</dc:subject>
	<dc:subject xml:lang="en-US">antibiotic expenditure</dc:subject>
	<dc:subject xml:lang="en-US">appendicitis</dc:subject>
	<dc:description xml:lang="en-US">AntibioticÂ Switch therapyÂ is defined by the switch of intravenous antibiotic therapy to oral form. This research aimed to learn about the relationship of switch therapy toward the value of wound healing, lenght of stay and the antibiotic expenditure. The data of this cross sectional study was collected from medical record and by direct investigation to patients for their macroscopis the wound healings value. T-test was used to compared the relationship of the patient wound healings value, lenght of stay and the antibiotic expenditure between the those with and accurate switch therapy and those without it. The result showed that there was no different of wound healing value between those groups of patients (P&amp;gt;0,1). On the other hand, lenght of stay and antibiotic expenditure of the patient with the accurate switch therapy was cuted on the patient with the accurate switch therapy. These indicated that accuracy of switch therapy will proceed a benefit outcome to the patient with appendicitis, especially to there lenght of stay and antibiotic expenditure as well.</dc:description>
	<dc:description xml:lang="id-ID">Switch therapy antibiotik merupakan penggantian terapi antibiotik intravena ke oral. Penelitian ini bertujuan untuk mempelajari hubungan ketepatan switch therapy terhadap kesembuhan luka, lama rawatan dan biaya pengobatan antibiotik pasien. Penelitian cross-sectional ini menggunakan data medical record dan pengamatan langsung pada pasien (penilaian luka secara makroskopis). Metode t-test digunakan untuk melihat hubungan ketepatan switch therapy terhadap kesembuhan luka, lama rawatan dan biaya pengobatan antibiotik pasien. Kebermaknaan diambil pada tingkat kepercayaan 95%. Hasil penelitian ini menunjukkan nilai kesembuhan luka pasien yang mendapatkan ketidaktepatan switch therapy tidak berbeda nyata dengan nilai kesembuhan luka pasien yang mendapatkan ketepatan switch therapy (P&amp;gt;0,05). Akan tetapi, lama rawatan pasien yang mendapatkan switch therapy yang tepat lebih pendek secara nyata dibandingkan dengan lama rawatan pasien yang mendapatkan switch therapy tidak tepat (P&amp;lt;0,05). Selanjutnya biaya pengobatan antibiotik pasien tepat switch therapy lebih rendah dibandingkan biaya pengobatan antibiotik pasien tidak tepat switch therapy (P&amp;lt;0,05). Ini berarti bahwa switch therapy yang tepat akan memberikan clinical outcome yang lebih efisien, terutama dalam hal lama rawatan dan biaya pengobatan antibiotik.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/69</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.69</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 145-149</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 145-149</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/69/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/70</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Efficacy of Monopterus albus Extract on The Healing of Burn Wound in The Male Sprague-Dawley Rats</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Pemberian Ekstrak Belut (Monopterus albus) pada Penyembuhan Luka Bakar Tikus Putih Jantan Sprague-Dawley</dc:title>
	<dc:creator>Mulyani, Dwi</dc:creator>
	<dc:creator>Febriyenti, Febriyenti</dc:creator>
	<dc:creator>Almahdy, Almahdy</dc:creator>
	<dc:subject xml:lang="id-ID">ekstrak Monopterus albus</dc:subject>
	<dc:subject xml:lang="id-ID">rendering basah</dc:subject>
	<dc:subject xml:lang="id-ID">penyembuhan luka bakar</dc:subject>
	<dc:subject xml:lang="en-US">monopterus albus extract</dc:subject>
	<dc:subject xml:lang="en-US">wet renderinng</dc:subject>
	<dc:subject xml:lang="en-US">wound healing</dc:subject>
	<dc:description xml:lang="en-US">The aim of this investigation was a clinical evaluation of the accelerating effect of Monopterus albus extract on the burnÂ wound healingÂ in male Sprague-Dawley rats weighted 200-300. The sample then extracted using wet rendering method using aqua-dest as extractor. This was experimental research with posttest only control group design. The subjects were ten male Sprague-Dawley rats devided into two group (control group 1 and experimental group 2). Every group consist of five rats. Heated metal plat (2cm x 2cm) used to get full thickness burn wound on dorsal rat part. Then, Monopterus albus extract was given to group 2 for 20 days. The results showed that Monopterus albus extract have significant effect (p &amp;lt; 0,05) to wound healing of rat models.Â </dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk melihat percepatan penyembuhan luka bakar pada tikus putih jantan Sprague-Dawley (200-300 gram) dengan penggunaan ekstrak belut (Monopterus albus). Sampel diekstrak dengan air menggunakan metoda rendering basah. Penelitian menggunakan 10 hewan uji yang dibagi menjadi dua kelompok ( grup satu sebagai kontrol dan grup dua perlakuan). Tiap grup terdiri dari lima ekor hewan. Plat logam panas (2cm x 2cm) digunakan untuk membuat luka bakar pada punggung tikus. Kemudian ekstrak Monopterus albus dioleskan pada luka bakar grup 2 selama 20 hari. Hasil penelitian menunjukan bahwa ekstrak Monopterus albus mempunyai efek mempercepat penyembuhan luka bakar pada tikus percobaan secara signifikan.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/70</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.70</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 191-194</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 191-194</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/70/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/71</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Development and Validation of TLC-Densitometric Method for Analysis of Paracetamol, Mefenamic Acid and Ibuprofen simultaneously in â€œPegel Linuâ€ Traditional Medicines</dc:title>
	<dc:title xml:lang="id-ID">Pengembangan dan Validasi Metode KLT-Densitometri untuk Analisis secara simultan Parasetamol, Asam Mefenamat dan Ibuprofen dalam Jamu â€œPegel Linuâ€</dc:title>
	<dc:creator>Hayun, Hayun</dc:creator>
	<dc:creator>Karina, Mulia Ade</dc:creator>
	<dc:subject xml:lang="id-ID">asam mefenamat</dc:subject>
	<dc:subject xml:lang="id-ID">ibuprofen</dc:subject>
	<dc:subject xml:lang="id-ID">parasetamol</dc:subject>
	<dc:subject xml:lang="id-ID">jamu pegel linu</dc:subject>
	<dc:subject xml:lang="id-ID">KLT-densitometri</dc:subject>
	<dc:subject xml:lang="id-ID">validasi</dc:subject>
	<dc:subject xml:lang="en-US">ibuprofen</dc:subject>
	<dc:subject xml:lang="en-US">mefenamic acid</dc:subject>
	<dc:subject xml:lang="en-US">paracetamol</dc:subject>
	<dc:subject xml:lang="en-US">pegel linu herbal medicine</dc:subject>
	<dc:subject xml:lang="en-US">TLC-densitometry</dc:subject>
	<dc:subject xml:lang="en-US">validation</dc:subject>
	<dc:description xml:lang="en-US">Jamu is a traditional or herbal medicine that is widely used by Indonesian people for prevention, maintenance and treatment of diseases. Traditional medicines contain plants or extracted plant material, or combinations thereof. The adulteration practice violates the laws. However, the presence of undeclare synthetic chemical drugs in the herbal products are still often found, among others, analgesic and anti-inflammatory drugs. The purpose of this study is to obtain a validated, simpler and lower operational cost of TLC-densitometric method to analyze paracetamol, mefenamic acid and ibuprofen in herbal medicines in â€œpegel linuâ€ herbal medicines. The samples were extracted with ethanol, then separated over silica gel GF254 TLC plate with mixture of chloroform-ethanol (8:1) as mobile phase and analyzed using TLC-densitometry. The method has a satisfactorily specificity and linearity, and met the precision and accuracy criteria at the concentration of 1500 ng/spot for paracetamol, 1250 ng/spot for mefenamic acid, and 2000 ng/spot for ibuprofen. The results of the determination of eight samples showed that four of them were positive containing paracetamol with the concentration of Â 337.12 - 505.55 mg/single dosage.</dc:description>
	<dc:description xml:lang="id-ID">Jamu merupakan obat tradisional yang banyak digunakan oleh masyarakat Indonesia untuk pencegahan, pemeliharan dan pengobatan penyakit. Obat tradisional mengandung bahan tumbuhan atau hasil sarian atau campurannya. Praktek penambahan bahan kimia obat (BKO) adalah perbuatan melawan hukum. Namun masih banyak ditemukan BKO dalam produk jamu, antara lain obat analgetika dan anti inflamasi. Penelitian ini bertujuan memperolehÂ  metode KLT-densitometri yang tervalidasi, lebih sederhana dan lebih rendah biaya pelaksanaannya untuk menganalisis parasetamol, asam mefenamat dan ibuprofen dalam jamu â€œpegel linuâ€.Â  Sampel diekstraksi dengan etanol, kemudian dipisahkan di atas lempeng KLT silika gel GF254 dengan fase gerak campuran kloroform-etanol (8:1) dan dianalisis dengan menggunakan KLT-densitometri. Metode mempunyai spesifisitas, dan linieritas yang memuaskan, dan memenuhi kriteria presisi dan akurasi pada konsentrasi 1500 ng/bercak untuk parasetamol, 1250 ng/bercak untuk asam mefenamat, dan 2000 ng/bercak untuk ibuprofen. Hasil analisis delapan sampel menunjukkan empat diantaranya positif mengandung parasetamol dengan kandungan 337,12-505,55 mg/dosis tunggal pemakaian.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/71</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.71</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 150-161</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 150-161</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/71/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/72</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Potential of Red Spinach Leaves (Amaranthus tricolor L. ) Ethanolic Extract Standardized as Antihyperlipidemia: in Vivo Study Based on LDL (Low Density Lipoprotein) Parameter</dc:title>
	<dc:title xml:lang="id-ID">Potensi Antihiperlipidemia Ekstrak Etanolik Daun Bayam Merah (Amaranthus tricolor L.) Terstandar secara in Vivo Berdasarkan Parameter LDL (Low Density Lipoprotein)</dc:title>
	<dc:creator>Pradana, Dimas Adhi</dc:creator>
	<dc:creator>Rahmah, Faras Sophia</dc:creator>
	<dc:creator>Setyaningrum, Tri Ratna</dc:creator>
	<dc:subject xml:lang="id-ID">amaranthus tricolor</dc:subject>
	<dc:subject xml:lang="id-ID">ekstrak etanolik</dc:subject>
	<dc:subject xml:lang="id-ID">kuratif</dc:subject>
	<dc:subject xml:lang="id-ID">ldl</dc:subject>
	<dc:subject xml:lang="id-ID">standardisasi</dc:subject>
	<dc:subject xml:lang="en-US">amaranthus tricolor</dc:subject>
	<dc:subject xml:lang="en-US">ethanolic extract</dc:subject>
	<dc:subject xml:lang="en-US">curative</dc:subject>
	<dc:subject xml:lang="en-US">ldl</dc:subject>
	<dc:subject xml:lang="en-US">standardization</dc:subject>
	<dc:description xml:lang="en-US">This study aims to determine the potential for curative therapy ethanolic extract of red spinach leaves (Amaranthus tricolor L.) standardized to decrease LDL levels in vivo. Animal model used in this study were 30 male Wistar rats aged 2-3 months were randomly divided into 6 groups include normal control, negative control, positive control and three doses ratings eksktrak. Induction of hyperlipidemia using poloxamer on day 1st and propylthiouracil on day 5th to day 18th. The positive control groups were given by simvastatin and the treatment group were given three doses of the extract variations on each - each group ie 200 mg / kg, 400 mg / kg, and 800 mg / kg rat. Ethanolic extract of red spinach leaves that are used have been through a standardized test based on specific parameters and non-specific. Determination of plasma LDL levels was done 3 times, day 0 (baseline), day 4th (after induction process) and day 19th (after treatment). The results obtained show the ethanolic extract of red amaranth (Amaranthus tricolor L.) standardized at a dose of 800 mg / kg body weight can lower LDL levels statistically significant (p &amp;lt;0.05) compared with normal and negative group. It can be concluded that the ethanolic extract red spinach leaves standardized has activity as a curative therapy for hyperlipidemia.Â </dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk mengetahui potensi kuratif ekstrak etanolik daun bayam merah (Amaranthus tricolor L.) terstandar terhadap penurunan kadar LDL secara in vivo. Hewan uji yang dipergunakan dalam penelitian ini adalah 30 ekor tikus Wistar jantan berusia 2 â€“ 3 bulan yang terbagi secara acak dalam 6 kelompok meliputi kontrol normal, kontrol negatif, kontrol positif dan 3 peringkat dosis eksktrak. Induksi hiperlipidemia dilakukan dengan menggunakan poloxamer pada hari ke-1 dan propiltiourasil pada hari ke-5 sampai hari ke-18. Pada kelompok kontrol positif diberikan terapi simvastatin sedangkan pada kelompok perlakuan diberikan 3 variasi dosis ekstrak pada masing â€“ masing kelompok yakni 200mg/kgBB, 400mg/kgBB, dan 800mg/kgBB tikus. Ekstrak etanolik daun bayam merah yang digunakan telah melalui uji standardisasi berdasarkan parameter spesifik dan non-spesifik. Penetapan kadar LDL plasma dilakukan sebanyak 3 kali, yaitu hari ke-0 (baseline), hari ke-4 (setelah proses induksi) dan hari ke-19(setelah terapi). Hasil yang diperoleh menunjukkan pemberian ekstrak etanolik bayam merah (Amaranthus tricolor L.) terstandar pada dosis 800mg/kgBB dapat menurunkan kadar LDL yang signifikan secara statistik (p&amp;lt;0,05) jika dibandingkan terhadap kelompok normal dan kelompok negatif Â sehingga dapat disimpulkan bahwa ekstrak etanolik daun bayam merah terstandar berpotensi sebagai agen terapi kuratif hiperlipidemia.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-07-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/72</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.72</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 122-128</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 122-128</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/72/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/74</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Use of Prophylactic Antibiotics in Caesarean Section (Sectio Caesarea) at Pekanbaru Medical Center (PMC) Hospital 2014</dc:title>
	<dc:title xml:lang="id-ID">Pola Penggunaan Antibiotik Profilaksis pada Pasien Bedah Caesar (Sectio Caesarea) di Rumah Sakit Pekanbaru Medical Center (PMC) Tahun 2014</dc:title>
	<dc:creator>Husnawati, Husnawati</dc:creator>
	<dc:creator>Wandasari, Fitra</dc:creator>
	<dc:subject xml:lang="en-US">caesarean</dc:subject>
	<dc:subject xml:lang="en-US">antibiotics</dc:subject>
	<dc:subject xml:lang="en-US">prophylactic</dc:subject>
	<dc:subject xml:lang="id-ID">caesar</dc:subject>
	<dc:subject xml:lang="id-ID">antibiotik</dc:subject>
	<dc:subject xml:lang="id-ID">profilaksis</dc:subject>
	<dc:description xml:lang="en-US">The research has been done on the use of prophylactic antibiotics in caesarean section at Pekanbaru Medical Center (PMC) hospital in 2014. The aim of this study was to overview the use of prophylactic antibiotics caesarean section. Type of research was an observational study designed a descriptive by conducting a review of the medical records of patients that using prophylactic antibiotics in cesarean section during Januari until December 2014. The samples used were 73 patients who met the inclusion criteria with purposive sampling. The results of this study suggest that the use of prophylactic antibiotics in cesarean section at Pekanbaru Medical Center hospital is a single-dose Ceftriaxone 1g (58.9%) and a combination of gentamicin (80 mg) with Ceftriaxone (1g) (41.1%), where all the form generic drugs (100%) with the time of prophylactic antibiotics for the majority that is 0-2 hours before surgery (100%) with the intravenous route (100%).</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian pola penggunaan antibiotik profilaksis pada pasien bedah caesar (Seksio Sesare) di Rumah Sakit Pekanbaru Medical Center (PMC) tahun 2014. Tujuan penelitian ini untuk mengetahui pola penggunaan antibiotik profilaksis bedah sesar. Jenis penelitian yang dilakukan adalah penelitian observasional yang dirancang dengan studi deskriptif dengan cara melakukan kajian terhadap rekam medis pasien yang menggunakan antibiotik profilaksis pada bedah sesar selama bulan Januari sampai dengan bulan Desember 2014. Sampel yang digunakan adalah 73 pasien yang memenuhi kriteria inklusi dengan teknik purposive sampling. Hasil penelitian ini menyatakan bahwa penggunaan antibiotik profilaksis bedah sesar di Rumah Sakit Pekanbaru Medical Center adalah Seftriakson tunggal dengan dosis 1g (58,9%) dan kombinasi Gentamisin (80 mg) dengan Seftriakson (1g) (41,1%), dimana semuanya dalam bentuk obat generik (100%) dengan waktu pemberian antibiotik 0-2 jam sebelum operasi (100%) dengan rute pemberian secara intravena (100%).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-05-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/74</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.74</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 303-307</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 303-307</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/74/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/75</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Study of Antibiotic Using on Septic Patients with Kidney Disorder)</dc:title>
	<dc:title xml:lang="id-ID">Kajian Penggunaan Antibiotik pada Pasien Sepsis dengan Gangguan Ginjal</dc:title>
	<dc:creator>Hidayati, Hidayati</dc:creator>
	<dc:creator>Arifin, Helmi</dc:creator>
	<dc:creator>Raveinal, Raveinal</dc:creator>
	<dc:subject xml:lang="en-US">antibiotic</dc:subject>
	<dc:subject xml:lang="en-US">septic</dc:subject>
	<dc:subject xml:lang="en-US">renal disorder</dc:subject>
	<dc:subject xml:lang="en-US">dose adjustment</dc:subject>
	<dc:subject xml:lang="en-US">antibiotic quality.</dc:subject>
	<dc:subject xml:lang="id-ID">antibiotik</dc:subject>
	<dc:subject xml:lang="id-ID">sepsis</dc:subject>
	<dc:subject xml:lang="id-ID">gangguan ginjal</dc:subject>
	<dc:subject xml:lang="id-ID">penyesuaian dosis</dc:subject>
	<dc:subject xml:lang="id-ID">kualitas antibiotik</dc:subject>
	<dc:description xml:lang="en-US">Prospective observational study was conducted to investigate antibiotic using, by evaluating clinical pharmacokinetic and antibiotic quality on septic patient with kidney disorder in Interne Department at Hospital X. Septic patients with kidney disorder treated with antibiotic for 4 months. The evaluated antibiotic are excreted by kidney mainly. The clinical aspects of evaluation are kinds of antibiotic, dosage, frequency, period of treatment, and clinical drug interaction. The evaluation of antibiotic quality used Gyssens method. Total respondens were 40 patients, treated with 8 kinds of antibiotic. Among 8 of them, there were 5 antibiotic which were excreted mainly by kidney. From five antibiotics, it was found that the accurate dosage adjustment on 29 patients (74,3%), and unproperly adjustment in 10 patients (10,25%) that adjust upper individual dosage that calculate pharmacokinetically. There were five interactions that clinically significant. The evaluation of antibiotic using qualitatively by Gyssens method found that 4 patients (10%) as incomplete therapy/VI category, two patients (5%) were ineffective category IVa, 1 patient (2,5%) as unsafe category IVb, 9 patients (22,5%) as inappropriate dosage adjustment, and 23 patients (57,5%) as appropriate antibiotic category 0. Conclusion: Using antibiotic that mainly excreted by kidney in septic patients with kidney disorder, generally doesnâ€™t show bad impact in kidney of patient.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan kajian observasional secara prospektif terhadap penggunaan antibiotik meliputi aspek farmakokinetika klinik dan kualitas antibiotik secara kualitatif pada pasien sepsis dengan gangguan ginjal di Rawat Inap Penyakit Dalam Rumah Sakit X. Pasien sepsis dengan gangguan ginjal ini diterapi dengan antibiotik selama 4 bulan. Antibiotik yang dievaluasi adalah yang ekskresi utamanya di ginjal meliputi jenis antibiotik, dosis, frekwensi, lama penggunaan, dan interaksi yang bermakna klinis. Evaluasi antibiotik secara kualitatif menggunakan metode Gyssens. Total pasien berjumlah 40 orang, diterapi dengan 8 jenis antibiotik dan diantaranya ada 5 antibiotik diekskresi utama melalui ginjal. Dari 5 jenis tersebut, ditemukan penyesuaian dosis dengan tepat pada (n=29;74,3%) dan penyesuaian dosis yang tidak tepat (n=10;25,7%) yang melebihi dosis individual yang dihitung secara farmakokinetik. Terdapat 5 jenis interaksi yang bermakna secara klinik. Evaluasi pemakaian antibiotik secara kualitatif dengan metode Gyssens, diperoleh kategori pasien tidak lengkap/VI (N=4; 10%), kategori tidak efektif/IVa (n=2; 5%), kategori tidak aman/IVb (n=1; 2,5%), kategori spektrum tidak sempit/IVd (n=1; 2,5%), kategori dosis tidak tepat/IIa (n=9; 22,5%), dan kategori bijak/tepat/0 (n=23; 57,5%). Dari penelitian ini dapat disimpulkan bahwa secara umum penggunaan antibiotik yang diekskresikan sebagian besar melalui ginjal tidak memperlihatkan dampak yang buruk pada fungsi ginjal pasien.ABSTRACT: Prospective observational study was conducted to investigate antibiotic using, by evaluating clinical pharmacokinetic and antibiotic quality on septic patient with kidney disorder in Interne Department at Hospital X. Septic patients with kidney disorder treated with antibiotic for 4 months. The evaluated antibiotic are excreted by kidney mainly. The clinical aspects of evaluation are kinds of antibiotic, dosage, frequency, period of treatment, and clinical Â drug interaction. The evaluation of antibiotic quality used Gyssens method. Total respondens were 40 patients, treated with 8 kinds of antibiotic. Among 8 of them, there were 5 antibiotic which were excreted mainly by kidney. From five antibiotics, it was found that the accurate dosage adjustment on 29 patients (74,3%), and unproperly adjustment in 10 patients (10,25%) that adjust upper individual dosage that calculate pharmacokinetically. There were five interactions that clinically significant. The evaluation of antibiotic using qualitatively by Gyssens method found that 4 patients (10%) as incomplete therapy/VI category, two patients (5%) were ineffective category IVa, 1 patient (2,5%) as unsafe category IVb, 9 patients (22,5%) as inappropriate dosage adjustment, and 23 patients (57,5%) as appropriate antibiotic category 0. Conclusion: Using antibiotic that mainly excreted by kidney in septic patients with kidney disorder, generally doesnâ€™t show bad impact in kidney of patient.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-05-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/75</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.75</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 129-137</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 129-137</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/75/66</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/79</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">RETRACTED: [Impact of pharmacist counseling on the knowledge and adherence  of patients with HIV/AIDS in VCT Polyclinic of Dr. M. Djamil Hospital Padang]</dc:title>
	<dc:title xml:lang="id-ID">ARTIKEL DITARIK: [Pengaruh Konseling Farmasis Terhadap Pengetahuan dan Kepatuhan Pasien HIV/AIDS di Poliklinik VCT RSUP Dr. M. Djamil Padang]</dc:title>
	<dc:creator>Permatasari, Jelly</dc:creator>
	<dc:creator>Almasdy, Dedy</dc:creator>
	<dc:creator>Raveinal, Raveinal</dc:creator>
	<dc:subject xml:lang="id-ID">HIV/AIDS</dc:subject>
	<dc:subject xml:lang="id-ID">konseling</dc:subject>
	<dc:subject xml:lang="id-ID">farmasis</dc:subject>
	<dc:subject xml:lang="en-US">pharmaceutical care</dc:subject>
	<dc:subject xml:lang="en-US">HIV/AIDS</dc:subject>
	<dc:subject xml:lang="en-US">pharmacist counseling</dc:subject>
	<dc:subject xml:lang="en-US">quality of life</dc:subject>
	<dc:subject xml:lang="en-US">outpatients.</dc:subject>
	<dc:description xml:lang="en-US">Adherence to antiretroviral therapy is key to sustained HIV suppression, reduced risk of drug resistance, improved quality of life, and survival of HIV/AIDS patients. A pharmacist is in charge in optimizing the result of the therapy by providing counseling to increase the patientsâ€™ knowledge which finally increases the quality of life. The objective of this study was to explore the impact of pharmacist counseling toward knowledge and adherence of patients with HIV/AIDS. The study was conducted in quasi-experiment with a design of one group pretest-posttest. The setting of this study was conducted in VCT RSUP DR. M. Djamil Padang. Data were collected through questionnaires and medical records. Patientsâ€™ knowledge and adherence were scored by using knowledge aspect questionnaire and MMAS-8 questionnaire. All questionnaires had been tested for validity and reliability. The data were analyzed by Wilcoxon test and paired t-test. A number of 124 patients completed all follow-ups of study. The result of this study showed that there was a significant increase of patientsâ€™ knowledge (p=0,00) and adherence (p=0,00) after the counseling. The study concluded that pharmacist counseling could increase patientsâ€™ knowledge and adherence to the therapy.</dc:description>
	<dc:description xml:lang="id-ID">Permasalahan dalam pengobatan HIV/AIDS sangat kompleks, hal ini dikarenakan perjalanan penyakit yang cukup panjang dengan sistem imunitas yang menurun secara progresif dan munculnya beberapa penyakit infeksi oportunitis secara bersamaan. Terapi ARV adalah salah satu cara untuk meningkatkan sistem kekebalan tubuh. Terapi ARV membutuhkan kepatuhan yang tinggi agar tujuan dari terapi tercapai dan mampu meningkatkan kualitas hidupÂ  Farmasis berada pada posisi yang sangat baik untuk membantu pasien mengatasi masalah terkait kepatuhan melalui konseling dengan meningkatkan pengetahuan pasien terkait pengobatan dan penyakitnya. Telah dilakukan penelitian quasi-eksperimental dengan konsep single pretest-postets design untuk menilai pengaruh konseling farmasis terhadap pengetahuan dan kepatuhan pasien HIV/AIDS di Poliklinik VCT RSUP Dr. M. Djamil Padang. Pengetahuan dan kepatuhan dinilai dengan menggunakan kuesioner pada pertemuan pertama dan kedua. Sebanyak 124 pasien menjadi responden pada penelitian ini. Analisa data menggunakan Wilcoxon test. Hasil penelitian menunjukkan adanya perbedaan pengetahuan yang signifikan (p=0,00) dan kepatuhan (p=0,00) responden sebelum dan setelah konseling farmasis. Penelitian menunjukkan bahwa adanya pengaruh positif konseling farmasis terhadap pengetahuan dan kepatuhan pasien HIV/AIDS.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>image/jpeg</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/79</dc:identifier>
	<dc:identifier>10.25077/jsfk.3.2.178-185.2017</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 178-185</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 178-185</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/79/pdf</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/79/377</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/84</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Determination of berberine content of ethanol extract of root and stem of â€œsekunyitâ€ (Fibraurea tinctoria Lour) using high performance liquid chromatography (HPLC) method</dc:title>
	<dc:title xml:lang="id-ID">Penetapan Kadar Berberin dari Ekstrak Etanol Akar dan Batang Sekunyit (Fibraurea Tinctoria Lour) dengan Metode KCKT</dc:title>
	<dc:creator>Utami, Rahayu</dc:creator>
	<dc:creator>Fernando, Armon</dc:creator>
	<dc:creator>Sari, Indah Puspita</dc:creator>
	<dc:creator>Furi, Mustika</dc:creator>
	<dc:subject xml:lang="id-ID">Berberin</dc:subject>
	<dc:subject xml:lang="id-ID">Fibraurea tinctoria</dc:subject>
	<dc:subject xml:lang="id-ID">KCKT</dc:subject>
	<dc:subject xml:lang="en-US">berberine</dc:subject>
	<dc:subject xml:lang="en-US">Fibraurea tinctoria</dc:subject>
	<dc:subject xml:lang="en-US">HPLC.</dc:subject>
	<dc:description xml:lang="en-US">Determination of berberine content of ethanol extract of root and stem of â€œsekunyitâ€ (Fibraurea tinctoria Lour) has been conducted. â€œSekunyitâ€ is one of medicinal plant that has been used to treat several diseases traditionally. Its root and stem could relieve jaundice, diarrhea, conjunctivitis as well as antidiabetic agent. Based on previous study, it is known that Fibraurea tinctoria contains isoquinoline alkaloid, berberine. This present study aims to determine berberine content which was done by HPLC (High Performance Liquid Chromatography) method using C-18 reverse phase column, methanol : phosphate buffer (pH 6,8) as its mobile phase with flow rate of 1 ml/min and UV detector. The analysis was performed at wavelength 346 nm. The result showed that the ethanol extract contains 25.8% of berberine</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penetapan kadar senyawa berberin dari ekstrak etanol akar dan batang sekunyit (Fibraurea tinctoria Lour). Sekunyit merupakan tumbuhan berbentuk liana yang telah digunakan oleh masyarakat dalam menyembuhkan berbagai macam penyakit. Akar dan batang tumbuhan ini berkhasiat mengobati demam kuning, diare, sakit mata dan diabetes. Fibraurea tinctoria diketahui sebagai spesies tumbuhan yang mengandung senyawa alkaloid isokuinolin berberin. Penelitian ini dilakukan untuk mengetahui kadar senyawa berberin dari ekstrak etanol akar dan batang tumbuhan sekunyit.Â  Penelitian dilakukan menggunakan kolom C-18 (ODS) dengan metode KCKT, fase gerak berupa campuran eluen metanol : buffer fosfat pH 6,8 (gradien elusi), laju alirnya 1 ml/menit dideteksi dengan detektor UV. Analisa dilakukan pada panjang gelombang 346 nm. Hasil penelitian menunjukkan bahwa ekstrak etanol diketahui mengandung senyawa berberin sebesar 25,8%.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/84</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.84</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 115-119</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 115-119</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/84/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/85</identifier>
				<datestamp>2019-06-30T21:28:51Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Effectiveness of Liposome Delivery System of Catechin as Antioxidant</dc:title>
	<dc:title xml:lang="id-ID">Efektivitas Sistem Penghantaran Liposom pada Katekin Sebagai Antioksidan</dc:title>
	<dc:creator>Verawaty, Verawaty</dc:creator>
	<dc:creator>Halim, Auzal</dc:creator>
	<dc:creator>Febriyenti, Febriyenti</dc:creator>
	<dc:subject xml:lang="id-ID">liposom</dc:subject>
	<dc:subject xml:lang="id-ID">katekin</dc:subject>
	<dc:subject xml:lang="id-ID">antioksidan</dc:subject>
	<dc:subject xml:lang="en-US">liposomes</dc:subject>
	<dc:subject xml:lang="en-US">catechins</dc:subject>
	<dc:subject xml:lang="en-US">antioxidants</dc:subject>
	<dc:description xml:lang="en-US">A study on the effectiveness of liposome delivery system of catechin as an antioxidant has been done. Liposome was derived from phosphatidylcholine of egg and cholesterol. The method used to prepared liposome in this research was thin layer hydration method by using rotary evaporator. Liposome was made in 3 formulas with different comparison between phosphatidylcholine and cholesterol. The first formula with ratio of 1:1; second formula with ratio of 1:2 and third formula with a ratio of 2:1. The result found that the observation with SEM seen sperical liposome and some oval liposomes. The level of entrapment efficiency (%EP) obtained on Formula I, II, and III were 24.49%, 24.67%, and 20.06%, respectively. We can conclude that the increase of cholesterol will increase the efficiency of drug entrapment. Test of the effectiveness of antioxidant found formula II was better than formula I and formula III. It can be concluded that the increase of cholesterol was able to improve the formulation and stability of liposome.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian efektivitas sistem penghantaran liposom pada katekin sebagai antioksidan. Liposom dibuat dari fosfatidilkolin yang berasal dari telur dan kolesterol. Metoda liposom yang digunakan pada penelitian ini adalah metoda hidrasi lapis tipis menggunakan rotary evaporator. Liposom dibuat dalam 3 formula yang memiliki perbandingan berbeda antara fosfatidilkolin dan kolesterol. Formula 1 dengan perbandingan 1:1; formula 2 dengan perbandingan 1:2 dan formula 3 dengan perbandingan 2:1. Dari hasil pengamatan dengan SEM terlihat globul-globul liposom berbentuk bola sferis dan ada juga yang lonjong. Efisiensi penjerapan (% EP) didapatkan formula I sebesar 24,49%, Formula II sebesar 24,67% dan formula III sebesar 20,06%. Disini terlihat bahwa semakin meningkatnya kolesterol yang digunakan akan semakin meningkat pula efisiensi penjerapan obat. Pada uji daya antioksidan pada supernatan didapatkan formula II lebih baik dibandingkan formula I dan formula III, sehingga dapat disimpulkan bahwa semakin besar kolesterol maka formulasi liposom akan lebih bagus dan stabil.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-05-12</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/85</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.2.2.85</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 2 No. 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 176-182</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 2 No 2 (2016): J Sains Farm Klin 2(2), Mei 2016; 176-182</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/85/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/86</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Effects of Fibroblast Growth Factor (FGF) from Fertilized Chicken Egg to Blood Glucose Level in Hyperglycemic Mice</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Pemberian Fibroblast Growth Factor (FGF) dari Telur Ayam Terfertilisasi Terhadap Kadar Glukosa Darah Mencit Hiperglikemia</dc:title>
	<dc:creator>Dewi, Irene Puspa</dc:creator>
	<dc:creator>Dharma, Surya</dc:creator>
	<dc:creator>Marlina, Marlina</dc:creator>
	<dc:subject xml:lang="id-ID">Fibroblast Growth Factor (FGF)</dc:subject>
	<dc:subject xml:lang="id-ID">Diabetes</dc:subject>
	<dc:subject xml:lang="id-ID">Kadar glukosa darah</dc:subject>
	<dc:subject xml:lang="en-US">Fibroblast Growth Factor (FGF)</dc:subject>
	<dc:subject xml:lang="en-US">diabetic</dc:subject>
	<dc:subject xml:lang="en-US">blood glucose level.</dc:subject>
	<dc:description xml:lang="en-US">A study on the effect of Fibroblast Growth factor (FGF) derived from fertilized chicken egg on blood glucose level in hyperglycemia mice induced by alloxan has been done. FGF taken from fertilized chicken egg white, the egg white dried with Freeze dryer method and powdered into flour. The egg powdered was tested quantitatively by ELISA (The Enzimed-Link immunosorbent assay ) method to determine the levels of FGF contained therein. And then, FGF was given to hyperglycemia mice induced alloxan. Blood glucose levels were observed periodically every week for 4 weeks after administration of FGF preparations. The results found, the levels of FGF in fertilized chicken egg white powder contained about 219 ng / L and the induction of FGF to hyperglycemia mice were able to improve blood glucose levels in mice hyperglycemia.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian tentang pengaruh pemberian Fibroblast Growth Factor (FGF) yang berasal dari telur ayam terfertilisasi terhadap kadar glukosa darah mencit yang diinduksi aloksan. FGF diambil dari putih telur ayam terfertilisasi, kemudian putih telur tersebut dikeringkan dengan metode Freeze Dryer dan diserbukkan hingga menjadi tepung putih telur. Tepung putih telur diuji secara kuantitatif dengan metode ELISA (The Enzimed - Link Immunosorbent Assay) untuk menentukan kadar FGF yang terkandung didalamnya. FGF tersebut diberikan kepada mencit hiperglikemia yang induksi aloksan. Dilakukan pengamatan kadar glukosa darah mencit secara periodik setiap minggu selama 4 minggu setelah pemberian sediaan FGF. Hasil yang didapat bahwa didalam tepung putih telur ayam terfertilisasi terkandung FGF dengan kadar 219 ng/L dan pemberian FGF terhadap mencit hiperglikemia mampu memperbaiki kadar glukosa darah mencit hiperglikemia.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/86</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.86</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 1-5</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 1-5</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/86/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/89</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Potential of Red Spinach Leaves Ethanolic Extract (Amaranthus tricolor L.) as a Complementary Therapy For Hiperlipidemia: Study in Vivo of Histopathologic and Activity of Alanin Aminotransferase (ALT)</dc:title>
	<dc:title xml:lang="id-ID">Potential of Red Spinach Leaves Ethanolic Extract (Amaranthus tricolor L.) as a Complementary Therapy For Hiperlipidemia: Study in Vivo of Histopathologic and Activity of Alanin Aminotransferase (ALT)</dc:title>
	<dc:creator>Pradana, Dimas Adhi</dc:creator>
	<dc:creator>Anggriani, Irna Destya</dc:creator>
	<dc:creator>Setyaningrum, Tri Ratna</dc:creator>
	<dc:subject xml:lang="id-ID">Amaranthus tricolor L.</dc:subject>
	<dc:subject xml:lang="id-ID">Alanin Aminotransferase Hyperlipidemic</dc:subject>
	<dc:subject xml:lang="id-ID">Complementary</dc:subject>
	<dc:subject xml:lang="id-ID">Histopathologic</dc:subject>
	<dc:subject xml:lang="en-US">Amaranthus tricolor L.</dc:subject>
	<dc:subject xml:lang="en-US">Alanin Aminotransferase Hyperlipidemic</dc:subject>
	<dc:subject xml:lang="en-US">Complementary</dc:subject>
	<dc:subject xml:lang="en-US">Histopathologic</dc:subject>
	<dc:description xml:lang="en-US">This study was conducted to determine the potential of ethanolic extract of red spinachÂ leaves (Amaranthus tricolor L.) with control quality as a complementary treatment of hyperlipidemic based on histopathology and activity of alanin aminotrasferase (ALT). A total of 24 male Wistar rats were randomized in 6 groups: normal group; positive control group were given the drug simvastatin; negative control group; 1st treatment group was given extract at dose of 400mg/kgBW rat, 2nd group was given extract at dose of 400mg/kgBW rat and simvastatin dose 0.18 mg/kgBW rat; 3rd treatment groups were given extract at dose of 800mg/kgBW rat and simvastatin dose 0.18 mg/kgBW rat. Induction hyperlipidemic using high fat diet and poloxamer. The data obtained were tested normality with the Shapiro-Wilk test. Statistical analysis using Oneway ANOVA and Post-Hoc Tukey HSD to determine the significance of differences between groups for ALT parameter. Result show the use of ethanolic extract of red spinach leaves can reduce fatty liver condition based on decreased level of ALT and liver histopathologic. It is concluded that the ethanolic extract of red spinach leaves dose 400mg/kgBW rat combine with simvastatin can reduce activity of ALT until 31.57 U1-1.</dc:description>
	<dc:description xml:lang="id-ID">This study was conducted to determine the potential of ethanolic extract of red spinachÂ leaves (Amaranthus tricolor L.) with control quality as a complementary treatment of hyperlipidemic based on histopathology and activity of alanin aminotrasferase (ALT). A total of 24 male Wistar rats were randomized in 6 groups: normal group; positive control group were given the drug simvastatin; negative control group; 1st treatment group was given extract at dose of 400mg/kgBW rat, 2nd group was given extract at dose of 400mg/kgBW rat and simvastatin dose 0.18 mg/kgBW rat; 3rd treatment groups were given extract at dose of 800mg/kgBW rat and simvastatin dose 0.18 mg/kgBW rat. Induction hyperlipidemic using high fat diet and poloxamer. The data obtained were tested normality with the Shapiro-Wilk test. Statistical analysis using Oneway ANOVA and Post-Hoc Tukey HSD to determine the significance of differences between groups for ALT parameter. Result show the use of ethanolic extract of red spinach leaves can reduce fatty liver condition based on decreased level of ALT and liver histopathologic. It is concluded that the ethanolic extract of red spinach leaves dose 400mg/kgBW rat combine with simvastatin can reduce activity of ALT until 31.57 U1-1.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/89</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.89</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 6-13</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 6-13</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/89/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/90</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antibacterial Inhibition Test of Endophytic Fungi on Lime Peel (Citrus aurantifolia) Against Staphylococcus aureus</dc:title>
	<dc:title xml:lang="id-ID">Uji Daya Hambat Antibakteri Fungi Endofit Kulit Jeruk Nipis (Citrus aurantifolia) Terhadap Bakteri Staphylococcus aureus</dc:title>
	<dc:creator>Setiawan, Muhammad Azdar</dc:creator>
	<dc:creator>Hasnawati, Hasnawati</dc:creator>
	<dc:creator>Sernita, Sernita</dc:creator>
	<dc:creator>Sulistia, Lisa</dc:creator>
	<dc:subject xml:lang="id-ID">antibakteri</dc:subject>
	<dc:subject xml:lang="id-ID">jamur</dc:subject>
	<dc:subject xml:lang="id-ID">endofit</dc:subject>
	<dc:subject xml:lang="id-ID">kulit</dc:subject>
	<dc:subject xml:lang="id-ID">jeruk nipis (Citrus aurantifolia).</dc:subject>
	<dc:subject xml:lang="en-US">antibacterial</dc:subject>
	<dc:subject xml:lang="en-US">endophytic</dc:subject>
	<dc:subject xml:lang="en-US">fungi</dc:subject>
	<dc:subject xml:lang="en-US">lime peel</dc:subject>
	<dc:description xml:lang="en-US">Endophytic fungi is fungi that lives within plant tissue and it is not harm to the plant it self. Endophytic fungi can produce a substance potencial to be antibacteria. This research aimed to test the antibacterial effect of endophytic fungi that has been isolated from lime skin Citrus auranti folia of Staphylococcus aureus. The methods that has been used to test antibacterial effect was paper disc method, done by gluing paper disc containing of endophytic fungi in agar combination media that has been smear with Staphylococcus aureus. The result of this researh is both endophytic fungi has effect as antibacterial against Staphylococcus aureus, but the type II of endophytic fungi has more effective and stronger antibacterial effect compare to endophytic fungi type I.</dc:description>
	<dc:description xml:lang="id-ID">Fungi endofit merupakan jamur yang hidup didalam jaringan tumbuhan dan tidak membahayakan tumbuhan tersebut. Jamur endofit dapat menghasilkan senyawa yang berpotensi sebagai Â antibakteri. Penelitian ini bertujuan Â untuk menguji Â ada Â tidaknya efek antibakteri pada jamur endofit yang diisolasi dari kulit jeruk nipis (Citrus aurantifolia) terhadap bakteri Staphylococcus aureus. Metode yang digunakan yaitu metode kertas cakram, dilakukan dengan cara menempelkan kertas cakram yang berisi supernatan fungi endofit pada media agar kombinasi yang telah dioleskan bakteri uji. Dari penelitian yang dilakukan diperoleh dua jenis fungi endofit yang Â diisolasi dari kulit jeruk nipis Citrus aurantifolia. Kedua jamur endofit memiliki Â efek sebagai antibakteri terhadap bakteri uji, akan tetapi jamur endofit tipe II memiliki efek antibakteri yang lebih baik dibandingkan dengan jamur endofit tipe I.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/90</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.90</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 14-18</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 14-18</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/90/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/92</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antioxidant and Sunscreen Activities of Ethanol Extract of Strawberry Leaves  (Fragaria x ananassa A.N. Duchesne)</dc:title>
	<dc:title xml:lang="id-ID">Aktivitas Antioksidan dan Tabir Surya Ekstrak Etanol Daun Stroberi (Fragaria x ananassa A.N. Duchesne)</dc:title>
	<dc:creator>Widyastuti, Widyastuti</dc:creator>
	<dc:creator>Kusuma, Ariya Eka</dc:creator>
	<dc:creator>Nurlaili, Nurlaili</dc:creator>
	<dc:creator>Sukmawati, Fitriani</dc:creator>
	<dc:subject xml:lang="id-ID">antioksidan</dc:subject>
	<dc:subject xml:lang="id-ID">daun stroberi</dc:subject>
	<dc:subject xml:lang="id-ID">tabir surya</dc:subject>
	<dc:subject xml:lang="en-US">antioxidant</dc:subject>
	<dc:subject xml:lang="en-US">strawberry leaves</dc:subject>
	<dc:subject xml:lang="en-US">sunscreen</dc:subject>
	<dc:description xml:lang="en-US">Strawberry fruit extract contains polyphenols compounds, which have antioxidant activity and may inhibit cancer cell growth. In this study attempted to see activity from leaves of strawberry (Fragaria x ananassa A.N. Duchesne) does also have antioxidant activity and sunscreen. Antioxidant testing using the DPPH method with comparative of vitamin C. The result showed IC50 values of ethanol extract of the leaves of strawberries 363.551 ppm and for vitamin C 33.573 ppm . On testing the activity as a sunscreen using spectrophotometric method wherein the ethanol extract of the leaves of strawberries have SPF values above 15 at a concentration of 175 ppm , which amounted to 20.090 with erythema percentage of 5.496 and 5.074 percentage by pigmentation. It can be concluded from the ethanol extract of leaves of strawberry has antioxidant activity and sunscreen.</dc:description>
	<dc:description xml:lang="id-ID">Ekstrak buah stroberi mengandung senyawa polifenol yang mempunyai aktivitas antioksidan dan dapat menghambat pertumbuhan sel kanker. Pada penelitian ini dicoba untuk melihat aktivitas dari daun stroberi (Fragaria x ananassa A.N. Duchesne) apakah juga mempunyai aktivitas antioksidan dan tabir surya. Pengujian antioksidan menggunakan metode DPPH dengan pembanding vitamin C. Dari hasil penelitian didapatkan nilai IC50 ekstrak etanol daun stroberi sebesar 363,551 ppm dan untuk vitamin C sebesar 33,573 ppm. Pada pengujian aktivitas sebagai tabir surya menggunakan metode spektrofotometri dimana ekstrak etanol daun stroberi mempunyai nilai SPF diatas 15 pada konsentrasi 175 ppm, yaitu sebesar 20,090 dengan persentase eritema sebesar 5,496 dan persentase pigmentasi sebesar 5,074. Dari hasil penelitian dapat disimpulkan ekstrak etanol daun stroberi mempunyai aktivitas antioksidan dan tabir surya.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/92</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.92</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 19-24</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 19-24</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/92/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/93</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulations Slow Release Tablet Diclofenac Sodium Using  Starch From  Saba Banana (Musa balbisiana L)</dc:title>
	<dc:title xml:lang="id-ID">Formulasi Tablet Lepas Lambat Natrium Diklofenak Menggunakan Pati Pisang Kepok (Musa balbisiana L) Sebagai Matriks</dc:title>
	<dc:creator>Anggraini, Deni</dc:creator>
	<dc:creator>Lukman, Anita</dc:creator>
	<dc:creator>Mulyani, Ria</dc:creator>
	<dc:subject xml:lang="id-ID">matriks</dc:subject>
	<dc:subject xml:lang="id-ID">lepas lambat</dc:subject>
	<dc:subject xml:lang="id-ID">pati</dc:subject>
	<dc:subject xml:lang="id-ID">pisang kepok</dc:subject>
	<dc:subject xml:lang="en-US">matrix</dc:subject>
	<dc:subject xml:lang="en-US">sustained release</dc:subject>
	<dc:subject xml:lang="en-US">starch</dc:subject>
	<dc:subject xml:lang="en-US">kepok banana</dc:subject>
	<dc:description xml:lang="en-US">The formulation of slow release tablet of diclofenac sodium using a matrix of starch from saba banana and sodium carboxyl methyl cellulose as a comparison has been done. The purpose of this study was to determine whether the slow-release preparations produced with starch from saba banana met the requirements of slow-release tablet . The dissolution test results show the formula I (starch of saba banana) was dissolved 110.24 %, formula II ( sodium carboxyl methyl cellulose ) was disolved 39.04 % within 8 hours. The dissolution test results showed that starch of saba banana did not meet the requirements as a matrix because it could not not reduce the rate of dissolution . The kinetics of the release of active substances from the matrix between the two formulas followed Higuchi equation .</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan formulasi tablet lepas lambat Natrium Diklofenak menggunakan matriks pati pisang kepok dan natrium karboksil metil selulosa sebagai pembandingnya. Tujuan penelitian ini untuk mengetahui apakah sediaan lepas lambat yang dibuat dengan matriks pati pisang kepok memenuhi persyaratan tablet lepas lambat. Hasil uji disolusi menunjukan formula I (Pati Pisang Kepok) terdisolusi sebesar 110,24 %, formula II (Natrium Karboksil Metil Selulosa) sebesar 39,04 % dalam waktu 8 jam. Dari hasil uji disolusi menunjukan bahwa pati pisang kepok belum memenuhi persyaratan sebagai matriks karena belum dapat memperlambat laju disolusi. Kinetika pelepasan zat aktif dari matriks antara kedua formula mengikuti persamaan Higuchi.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/93</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.93</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 25-30</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 25-30</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/93/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/95</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Identification of  Human Papillomavirus Type 18 (HPV 18) E7 Gene from Cervical Cancer Patients</dc:title>
	<dc:title xml:lang="id-ID">Identifikasi Gen E7 Isolat Human Papillomavirus Tipe 18 (HPV18) dari Penderita Kanker Serviks</dc:title>
	<dc:creator>Arfiandi, Arfiandi</dc:creator>
	<dc:creator>Sopianti, Densi Selpia</dc:creator>
	<dc:creator>Hari, Dewi Gulyla</dc:creator>
	<dc:creator>Marlina, Marlina</dc:creator>
	<dc:creator>Aldi, Yufri</dc:creator>
	<dc:creator>Putra, Andani Eka</dc:creator>
	<dc:creator>Djamaan, Akmal</dc:creator>
	<dc:creator>Rustini, Rustini</dc:creator>
	<dc:subject xml:lang="id-ID">kanker serviks</dc:subject>
	<dc:subject xml:lang="id-ID">gen E7</dc:subject>
	<dc:subject xml:lang="id-ID">HPV18</dc:subject>
	<dc:subject xml:lang="en-US">cervical cancer</dc:subject>
	<dc:subject xml:lang="en-US">gene E7</dc:subject>
	<dc:subject xml:lang="en-US">HPV 18</dc:subject>
	<dc:description xml:lang="en-US">One oncoprotein that is always expressed by HPV 18 in cervical cancer is the E7 gene. Persistent infection by the human papillomavirus (HPV) high risk is a major etiologic factor for cervical cancer and expression of E7 Oncoproteins suggested to be a potential marker for tumor progression. E7 will affect the activity of tumor suppressor pRB and bind and activate cyclin complexes that can cause cervical cancer. In this study will be identification of the isolates HPV18 E7 gene of patients with cervical cancer derived from M. Jamil Hospital in Padang, West Sumatra and Arifin Ahmad, Pekanbaru, Riau. The identification process was conducted using Polymerase Chain Reaction (PCR) using primers specific for HPV18 E7 gene. Of the fifteen isolates HPV18 were amplified with specific primers HPV18 E7 gene, obtained ten E7 genes identified positive samples (66.6%), while five other samples were not identified. Infection cancer in patients with cervical cancer that come from the M. Jamil Padang and Arifin Ahmad, Pekanbaru, Riau hospitals mostly caused by HPV18 E7 gene so that it can be used as a potential marker for tumor progression for patients with cervical cancer in West Sumatra and Riau in particular and Indonesia in general.</dc:description>
	<dc:description xml:lang="id-ID">Gen E7 HPV18 merupakan salah satu onkoprotein yang selalu diekspresikan oleh HPV pada sel yang terinfeksi. Infeksi persisten oleh Human papillomavirus (HPV) beresiko tinggi adalah faktor etiologi utama untuk kanker serviks dan ekspresi Onkoprotein HPV E7 disarankan untuk menjadi penanda potensial untuk perkembangan tumor. E7 akan mempengaruhi aktivitas pRB supresor tumor serta mengikat dan mengaktifkan kompleks cyclin sehingga dapat menimbulkan kanker serviks. Dalam penelitian ini akan dilakukan identifikasi terhadap Gen E7 isolat HPV18 dari penderita kanker serviks yang berasal dari RSUP M. Jamil Padang, Sumatera Barat dan RSUD Arifin Ahmad, Pekan Baru, Riau. Proses identifikasi dilakukan dengan metode Polymerase Chain Reaction (PCR) menggunakan primer spesifik untuk gen E7 HPV18. Dari lima belas isolat HPV18 yang diamplifikasi dengan primer spesifik gen E7 HPV18, didapatkan sepuluh sampel positif teridentifikasi gen E7 (66,6%) sedangkan lima sampel lainnya tidak teridentifikasi. Infeksi kanker pada penderita kanker serviks yang berasal dari RSUP. M. Jamil, Padang dan RSUD. Arifin Ahmad, Pekan Baru, Riau sebagian besar disebabkan oleh gen E7 HPV18 sehingga hal ini bisa dijadikan penanda potensial untuk perkembangan tumor bagi penderita kanker serviks di Sumatera Barat dan Riau pada khususnya serta di Indonesia pada umumnya.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/95</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.95</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 31-34</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 31-34</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/95/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/97</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Drugs Management Evaluation at Community Health Centers  in Pariaman City, Indonesia</dc:title>
	<dc:title xml:lang="id-ID">Evaluasi Pengelolaan Obat pada Puskesmas di Kota Pariaman</dc:title>
	<dc:creator>Chaira, Syukriati</dc:creator>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:creator>Augia, Trisfa</dc:creator>
	<dc:subject xml:lang="en-US">drug management</dc:subject>
	<dc:subject xml:lang="en-US">health centers</dc:subject>
	<dc:subject xml:lang="en-US">evaluation</dc:subject>
	<dc:subject xml:lang="id-ID">pengelolaan obat</dc:subject>
	<dc:subject xml:lang="id-ID">puskesmas</dc:subject>
	<dc:subject xml:lang="id-ID">evaluasi</dc:subject>
	<dc:description xml:lang="en-US">Drug Management at health centers need to be well, because exellent drugs management will ensure the continuity of availability and affordability of drugs that are efficient, effective and rational. This study aims to determine drugs management at seven community health centers in Pariaman, based indicators of drugs management stipulated by Ministry Health of Republic Indonesia. This research is descriptive-evaluative, with quantitative and qualitative methods, using retrospective data in 2013 and 2014. The results showed that suitability of drug provided by DOEN 64.70%-73.51%, accuracy of drug demand, 2:28%-24.47%, accuracy of drug distribution 4.66% -35.59%, percentage of drugs that are not prescribed, 5:00%-23.49%, percentage of prescribing generic drugs 97.27% -100%, percentage differences in recording of stock card with amount of physical drugs, 0.00%-13.13%, it can be concluded that drugs management at health centers in Pariaman is not good, because it is not accordance with established standards.</dc:description>
	<dc:description xml:lang="id-ID">Pengelolaan obat di puskesmas perlu dilakukan dengan baik, karena pengelolaan obat yang baik akan menjamin kelangsungan ketersediaan dan keterjangkauan pelayanan obat yang efisien, efektif dan rasional. Penelitian ini bertujuan untuk mengetahui pengelolaan obat pada tujuh puskesmas di kota Pariaman, berdasarkan indikator pengelolaan obat yang ditetapkan oleh Departemen Kesehatan RI. Penelitian ini adalah penelitian deskriptif-evaluatif, dengan metode kuantitatif dan kualitatif, menggunakan data retrospektif tahun 2013 dan 2014. Hasil penelitian menunjukkan bahwa kesesuaian jenis obat yang tersedia dengan DOEN : 64.70%-73.51%, ketepatan permintaan obat 2.28%-24.47%, ketepatan distribusi obat, 4.66%-35.59%, persentase obat yang tidak diresepkan, 5.00%-23.49%, persentase peresepan obat generik 97.27%-100%, persentase perbedaan pencatatan kartu stok dengan jumlah fisik obat, 0.00%-13.13%, maka dapat disimpulkan bahwa pengelolaan obat pada puskesmas di kota Pariaman belum baik, karena belum sesuai dengan standar yang ditetapkan.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/97</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.97</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 35-41</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 35-41</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/97/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/98</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulation of Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.) Extract into a Gel  Toothpaste</dc:title>
	<dc:title xml:lang="id-ID">Formulasi Pasta Gigi Gel Ekstrak Etanol  Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.)</dc:title>
	<dc:creator>Warnida, Husnul</dc:creator>
	<dc:creator>Juliannor, Ade</dc:creator>
	<dc:creator>Sukawaty, Yullia</dc:creator>
	<dc:subject xml:lang="en-US">bawang dayak (Eleutherine bulbosa)</dc:subject>
	<dc:subject xml:lang="en-US">carboxymethyl cellulose</dc:subject>
	<dc:subject xml:lang="en-US">dental caries</dc:subject>
	<dc:subject xml:lang="en-US">gel.</dc:subject>
	<dc:subject xml:lang="id-ID">bawang dayak (Eleutherine bulbosa)</dc:subject>
	<dc:subject xml:lang="id-ID">gel</dc:subject>
	<dc:subject xml:lang="id-ID">karboksimetil selulosa</dc:subject>
	<dc:subject xml:lang="id-ID">karies gigi</dc:subject>
	<dc:subject xml:lang="id-ID">pasta gigi</dc:subject>
	<dc:description xml:lang="en-US">Dental caries is a disease of tooth decay that starts from the surface and evolve in the direction of the tooth, beginning with the process of tooth demineralization. Tooth decay is usually caused by the bacterium Streptococcus mutans. Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.) has antibacterial activity due to its compound i.e. flavonoid, fenol, triterpenoid, dan antrakuinon. This study aims to formulate the bawang dayak ethanol extract into a stable gel toothpaste. Bawang dayak ethanol extract 2,5% was formulated in 5 formulas with varying degree of sorbitol (5 - 50%) and carboxymethyl cellulose (3 - 7%). Physical stability of bawang dayak ethanol extract gel toothpastes were evaluated including organoleptic and homogeneity test, pH measurement, viscosity measurement, spreading test, and freeze-thaw cycling test. The result showed bawang dayak ethanol extract gel toothpastes have pH range of 5.50 - 5.80, spreading area 4.61 - 5.82, viscosity value 17066 - 99877 mPas. Organoleptic and homogeneity in 7 days showed two layers color of gel toothpaste. Consistency test and Freeze-thaw cycling test results showed no change in organoleptic, homogeneity, pH, and viscosity of gel toothpastes.</dc:description>
	<dc:description xml:lang="id-ID">Karies gigi adalah suatu kerusakan gigi yang dimulai dari permukaan dan berkembang ke arah dalam pada gigi, diawali dengan proses demineralisasi gigi. Karies gigi biasanya disebabkan oleh bakteri streptococcus mutans. Bawang dayak (Eleutherine bulbosa (Mill.) Urb) dapat menghambat pertumbuhan bakteri karena mengandung metabolit sekunder seperti flavonoid, fenol, triterpenoid, dan antrakuinon. Penelitian ini bertujuan memformulasikan ekstrak etanol bawang dayak (Eleutherine bulbosa) ke dalam bentuk sediaan pasta gigi gel. Ekstrak bawang tiwai dengan konsentrasi 2,5% diformulasi menjadi pasta gigi gel dengan variasi sorbitol 5% - 50% dan CMC 3% - 7%. Evaluasi yang dilakukan meliputi organoleptis, homogenitas, pH, viskositas, daya sebar dan freeze-thaw cycling test. Hasil pengamatan organoleptik menunjukan adanya perubahan warna pasta gigi gel menjadi terbentuk 2 lapisan gel. Rentang pH pasta gigi gel 5,50 - 5,80, rentang uji daya sebar 4,61 â€“ 5,82 cm, rentang viskositas 17066 - 99877 mPas. Hasil sentrifugasi dan cycling test menunjukkan tidak terjadi perubahan organoleptis, homogenitas, pH, dan viskositas pasta gigi gel.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/98</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.98</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 42-49</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 42-49</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/98/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/99</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulation of Tempuyung (Sonchus arvensis L.) Nano Herbal in Self Nano-Emulsion Drug Delivery System (SNEDDS) Preperation</dc:title>
	<dc:title xml:lang="id-ID">Formulasi Sediaan Nano Herbal Tempuyung  (Sonchus arvensis L.) dalam Bentuk Self Nano-Emulsifying Drug Delivery System (SNEDDS)</dc:title>
	<dc:creator>Wijiyanto, Budy</dc:creator>
	<dc:creator>Damayanti, Primadara</dc:creator>
	<dc:creator>Sitorus, Mira Amaliasari</dc:creator>
	<dc:creator>Listianingrum, Ratih Dyah</dc:creator>
	<dc:creator>Dea, Arifa Caryn</dc:creator>
	<dc:creator>Syukri, Yandi</dc:creator>
	<dc:subject xml:lang="id-ID">tempuyung</dc:subject>
	<dc:subject xml:lang="id-ID">nano herbal</dc:subject>
	<dc:subject xml:lang="id-ID">SNEDDS</dc:subject>
	<dc:subject xml:lang="en-US">tempuyung</dc:subject>
	<dc:subject xml:lang="en-US">nano herbs</dc:subject>
	<dc:subject xml:lang="en-US">SNEDDS</dc:subject>
	<dc:description xml:lang="en-US">Tempuyung (Sonchus arvensis L.) is a plant native to Indonesia with a diuretic and antioxidant effect. To obtain the optimal therapeutic effect need innovation to make it the nano herbs preparations. This research aims to preparation and characterization of nano herbal tempuyung in the form of Nano Self-emulsifying Drug Delivery System (SNEDDS). The active substance of tempuyung was extracted with ethanol and the solvent evaporated to obtain a viscous extract. Extracts were standardized following the Indonesian Pharmacopeia Herbal. Next, the SNEDDS of tempuyung were made using Capryol-90 as oils, tween 20 as surfactants and PEG 400 as co-surfactant. SNEDDS was characterized include particle size and zeta potential. The viscous extract obtained from extraction was 77.52 g. This result has been eligible if compared with Indonesian Pharmacopoeia Herbal that mentions the acquisition of thick leaf extract tempuyung yield is not less than 7.5%. Tempuyung formulation in dosage forms SNEDDS obtained a clear nanoemulsion with a particle size of 16.2 Â± 1.06 nm and zeta potential value of -37.48 Â± 0.74 mV. It can be concluded that the tempuyung extract can produce a nano herbs in SNEDDS preparation.</dc:description>
	<dc:description xml:lang="id-ID">Tempuyung (Sonchus arvensis L.) merupakan tanaman asli Indonesia yang berhkasiat sebagai diuretik dan antioksidan. Untuk mendapatkan efek terapi yang optimal perlu inovasi untuk membuatnya menjadi sediaan nano herbal. Penelitian ini bertujuan Â membuat sediaan nano herbal tempuyung dalam bentuk Self Nano-Emulsifying Drug Delivery System (SNEDDS). Â Kandungan zat aktif tempuyung diekstraksi dengan etanol dan berikut diuapkan pelarutnya untuk mendapatkan ekstrak kental. Ekstrak yang diperoleh distandarisasi menurut Farmakope Herbal Indonesia. Berikutnya dibuat SNEDDS tempuyung dengan menggunakan minyak Capryol-90, surfaktan tween 20 dan ko-surfaktan PEG 400. SNEDDS yang diperoleh dikarakterisasi meliputi ukuran partikel dan zeta potensial. Dari ekstraksi diperoleh ekstrak kental sebanyak 77,52 g. Hasil ini telah memenuhi syarat jika dibandingkan dengan Farmakope Herbal yang menyebutkan perolehan rendemen ekstrak kental daun tempuyung adalah tidak kurang dari 7,5%. Â Formulasi tempuyung dalam bentuk sediaan SNEDDS diperoleh suatu nanoemulsi yang jernih dengan ukuran partikel 16,2 Â± 1,06 nm dan nilai zeta potensial -37,48Â±0,74 mV. Dapat disimpulkan bahwa ekstrak tempuyung menghasilkan suatu nano herbal dalam bentuk sediaan SNEDDS.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/99</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.99</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 50-53</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 50-53</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/99/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/100</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Identification of the type of human papillomavirus (HPV)  in patients with cervical cancer</dc:title>
	<dc:title xml:lang="id-ID">Identifikasi Type Human Papillomavirus (HPV) pada Penderita Kanker Serviks</dc:title>
	<dc:creator>Marlina, Marlina</dc:creator>
	<dc:creator>Aldi, Yufri</dc:creator>
	<dc:creator>Putra, Andani Eka</dc:creator>
	<dc:creator>Sopianti, Densi Selpia</dc:creator>
	<dc:creator>Hari, Dewi Gulyla</dc:creator>
	<dc:creator>Arfiandi, Arfiandi</dc:creator>
	<dc:creator>Djamaan, Akmal</dc:creator>
	<dc:creator>Rustini, Rustini</dc:creator>
	<dc:subject xml:lang="en-US">cervical cancer</dc:subject>
	<dc:subject xml:lang="en-US">HPV DNA</dc:subject>
	<dc:subject xml:lang="en-US">HPV type</dc:subject>
	<dc:subject xml:lang="id-ID">Kanker serviks</dc:subject>
	<dc:subject xml:lang="id-ID">DNA HPV</dc:subject>
	<dc:subject xml:lang="id-ID">type HPV</dc:subject>
	<dc:description xml:lang="en-US">Human Papillomavirus (HPV) is the most significant risk factor for the cause of cervical cancer. The purpose of this study for identification of HPV types 16, 18, 31, 33, 45 and 52 in cervical cancer patients. HPV is a row of high-risk HPV types that can cause cervical cancer. Total sample of 78 diisolat DNA derived from FFPE, cervical smears and cervical cancer fresh tissue obtained from Dr. Dr. M. Djamil, Padang and hospitals. Arifin Achmad, Pekanbaru. HPV DNA detection is done by using Polymerase Chain Reaction (PCR) using universal primers GP5 +/6 +. HPV types were identified by PCR with specific primers. Total sample types obtained with concentrations varying between 0.9 to 645 ng / ml with purity DNA in accordance with the specified purity for PCR amplification. The results of the study of 78 patients with cervical cancer samples, 42 samples (54%) identified HPV DNA. HPV type 18 is more dominant and followed by HPV type 16 as compared to the other types, namely the percentage of 40.4% and 28.5%. HPV type 45 (7.1%), HPV type 52 (2.3%) and HPV 31 and HPV type 33 was not detected.</dc:description>
	<dc:description xml:lang="id-ID">Human Papillomavirus (HPV) merupakan faktor resiko yang paling signifikan penyebab dari kanker serviks. Tujuan penelitian ini untuk identifikasi tipe HPV 16, 18, 31, 33, 45 dan 52 pada pasien kanker serviks. HPV tipe ini merupakan deretan HPV tipe high risk yang dapat menyebabkan kanker serviks. Total sampel sebanyak 78 diisolat DNAl yang berasal dari FFPE, apusan serviks dan jaringan segar kanker serviks yang diperoleh dari RSUP. Dr. M Djami., Padang dan RSUD. Achmad Arifin, Pekanbaru. Deteksi DNA HPV dilakukan dengan menggunakan Polymerase Chain Reaction (PCR) menggunakan primer universal GP5+/6+. Tipe HPV yang diidentifikasi dengan metode PCR dengan primer spesifik. Total tipe sampel yang didapat bervariasi dengan konsentrasi antara 0,9-645 ng/ml dengan kemurnian DNA sesuai dengan kemurnian yang ditetapkan untuk amplifikasi PCR. Hasil penelitian dari 78 sampel penderita kanker serviks, 42 sampel (54 %) teridentifikasi DNA HPV. HPV type 18 lebih mendominasi dan disusul HPV type 16 dibandingkan dengan type lainnya yaitu dengan persentase 40,4 % dan 28,5%. Â HPV type 45 (7,1%), HPV type 52 (2,3%) dan HPV 31 dan HPV type 33 tidak terdeteksi.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/100</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.100</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 54-63</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 54-63</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/100/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/101</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Vancomycin Dosing Adjustment on Patientâ€™s with Chronic Kidney Disease Stage 3 and 4 in Internal Ward of Dr. M. Djamil Padang Hospital</dc:title>
	<dc:title xml:lang="id-ID">Kesesuaian Dosis Vankomisin pada Pasien Penyakit Ginjal Kronik  Stadium 3 dan 4 di Bangsal Penyakit Dalam  RSUP Dr. M. Djamil Padang</dc:title>
	<dc:creator>Suardi, Muslim</dc:creator>
	<dc:creator>Sofjan, Marissa</dc:creator>
	<dc:creator>Raveinal, Raveinal</dc:creator>
	<dc:subject xml:lang="en-US">vancomycin</dc:subject>
	<dc:subject xml:lang="en-US">dosing adjustment</dc:subject>
	<dc:subject xml:lang="en-US">pharmacokinetic</dc:subject>
	<dc:subject xml:lang="id-ID">vankomisin</dc:subject>
	<dc:subject xml:lang="id-ID">penyesuaian dosis</dc:subject>
	<dc:subject xml:lang="id-ID">farmakokinetik</dc:subject>
	<dc:description xml:lang="en-US">Vancomycin is a glycopeptide antibiotic which almost completely eliminated by renal unchanged in the urine (&amp;gt; 90%). Elimination of vancomycin is delayed in patients with renal insufficiency. The purposes of the research were to examine dosing adjustment and quantity individualized dose of vancomycin in patients with chronic kidney disease in Internal Ward of Dr. M. Djamil Padang Hospital based on pharmacokinetics dosing method. The study was designed by observational retrospective method conducted on patientâ€™s medical record during January 2015 â€“ March 2016. A number of 21 patients were treated using vancomycin with chronic kidney disease stage 3 and 4. Results showed that 19.05% patients received exceed dose based on pharmacokinetic dosing method calculation. Clearance of vancomycin in patients with chronic kidney disease on stage of 3 and 4 were 1.88 Â± 0.28 and 0.88 Â± 0.21L/h, respectively. The elimination half-life prolonged to patients with chronic kidney disease stage 3 and 4 were 14.11 Â± 2.89 and 24.48 Â± 5.44, respectively. While accumulation factor in patients with chronic kidney disease on stage of 3 and 4 were 0.50 Â± 0.1 and 0.67 Â± 0.09, respectively.</dc:description>
	<dc:description xml:lang="id-ID">Vankomisin merupakan antibiotika golongan glikopeptida yang dieliminasi dalam bentuk tidak berubah, terutama melalui ginjal (&amp;gt;90%). Eliminasi vankomisin berkurang pada pasien dengan gangguan fungsi ginjal. Tujuan penelitian ini adalah untuk mengkaji kesesuaian dosis dan menentukan takaran individu pasien penyakit ginjal kronik yang mendapat terapi vankomisin di bangsal penyakit dalam RSUP Dr. M. Djamil Padang. Penelitian ini dilakukan secara observasi retrospektif terhadap data rekam medis pasien dari bulan Januari 2015 hingga Maret 2016. Dua puluh satu pasien yang menerima vankomisin merupakan penderita penyakit ginjal kronik stadium 3 dan 4. Hasil penyesuaian dosis berdasarkan pharmacokinetic dosing method menunjukkan 80,95% mendapatkan dosis sesuai sedangkan 19,05% pasien melebihi dosis individu. Berdasarkan perhitungan farmakokinetik nilai klirens vankomisin masing-masing untuk penyakit ginjal kronik stadium 3 dan 4 masing-masing adalah 1,88 Â± 0,28 L/jam dan 0,88 Â± 0,21 L/jam. Nilai rata-rata waktu paruh eliminasi memanjang pada pasien penyakit ginjal kronik stadium 3 dan 4 masing-masing adalah 14,11 Â± 2,89 jam; 24,48 Â± 5,44 jam. Fraksi vankomisin yang tertinggal dalam tubuh masing-masing untuk penyakit ginjal kronik stadium 3 dan stadium 4 adalah 0,50 Â± 0,1 dan 0,67 Â± 0,09.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/101</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.101</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 64-71</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 64-71</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/101/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/102</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antidiabetic Effect of  Air Leaf  Fraction of Karamunting  (Rhodomyrtus tomentosa (Ait.) Hassk.) in diabetic mice</dc:title>
	<dc:title xml:lang="id-ID">Antidiabetes dari Fraksi Air Daun Karamunting (Rhodomyrtus tomentosa (Ait.) Hassk.) Terhadap Kadar Glukosa Darah  Mencit Diabetes</dc:title>
	<dc:creator>Sinata, Novia</dc:creator>
	<dc:creator>Arifin, Helmi</dc:creator>
	<dc:subject xml:lang="en-US">alloxan</dc:subject>
	<dc:subject xml:lang="en-US">diabetes mellitus</dc:subject>
	<dc:subject xml:lang="en-US">Rhodomyrtus tomentosa (Ait.) Hassk</dc:subject>
	<dc:subject xml:lang="id-ID">aloksan</dc:subject>
	<dc:subject xml:lang="id-ID">diabetes mellitus</dc:subject>
	<dc:subject xml:lang="id-ID">Rhodomyrtus tomentosa (Ait.) Hassk</dc:subject>
	<dc:description xml:lang="en-US">Karamunting is one of the plants used in traditional medicine of diabetes mellitus. The antidiabetic effect of aqueous fraction of Rhodomyrtus tomentosa (Ait.) Hassk leaves has been investigated on male white mice that were induced with alloxan dose 200 mg/kgBW intraperitoneally. The fraction was given orally at dose 10, 20, 40 mg/KgBW for 15 days. Parameters that were measured are decrease concentration of blood glucose, body weight, urin output and water intake. Result showed that the aqueous fraction of Rhodomyrtus tomentosa (Ait.) Hassk leaves at dose 10, 20, 40 mg/KgBW has effect on decreasing blood glucose level on diabetic mice induced alloxan (P&amp;lt;0.05). This fraction also improved body weight, urine output dan reduced water intake (P&amp;lt;0.05).</dc:description>
	<dc:description xml:lang="id-ID">Karamunting salah satu tumbuhan yang digunakan sebagai obat tradisional penyakit diabetes mellitus. Penelitian telah dilakukan terhadap uji efek antidiabetes fraksi air daun karamunting (Rhodomyrtus tomentosa (Ait.) Hassk.) pada mencit putih jantan diabetes yang diinduksi dengan aloksan dosis 200 mg/kgBB secara intraperitonial. Fraksi air diberikan secara oral dengan dosis 10, 20 dan 40 ml/kgBB selama 15 hari. Parameter yang diukur adalah kadar glukosa darah, berat badan, volume urin, dan volume air minum. Hasil penelitian menunjukkan bahwa fraksi air daun Rhodomyrtus tomentosa (Ait.) Hassk oral dengan dosis 10, 20 dan 40 mg/kgBB mampu menurunkan kadar glukosa darah mencit diabetes yang diinduksi aloksan Â secara bermakna (P&amp;lt;0,05), dapat memperbaiki berat badan, volume urin, dan konsumsi air minum mencit diabetes (P&amp;lt;0,05).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/102</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.102</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 72-78</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 72-78</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/102/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/103</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Effect of Ethanolic Extract of Vernonia amygdalina, Del Leaves on Serum Creatinin Level of Male White Mice</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Ekstrak Etanol Daun Vernonia amygdalina, Del  terhadap Kadar Kreatinin Serum Mencit Putih Jantan</dc:title>
	<dc:creator>Suryati, Suryati</dc:creator>
	<dc:creator>Dillasamola, Dwisari</dc:creator>
	<dc:creator>Rahadiant, Fridhani</dc:creator>
	<dc:subject xml:lang="id-ID">Vernonia amygdalina</dc:subject>
	<dc:subject xml:lang="id-ID">kadar kreatinin serum</dc:subject>
	<dc:subject xml:lang="en-US">Vernonia amygdalina</dc:subject>
	<dc:subject xml:lang="en-US">serum creatinin level</dc:subject>
	<dc:description xml:lang="en-US">Vernonia amygdalina, Del leaves which are locally known as Afrika Selatan leaves used as traditional medicine for diabetes, fever, hypertension and uric acid. A study on the effect of their ethanolic extract on serum creatinin level of male white mice has been done. A twenty of male white mice were divided into four groups which were control group and three test group (A, B, C) which given extract with dose 100 mg/kg BW, 200 mg/kgBW and 400 mg/kgBW respectively. Test group were given extract orally for 21 days. The mice neck was cut and their blood collected at 7th, 14th and 21st day. The serum creatinin level was measured by using spectrophotometer UV-Visible at 492 nm. The result showed all doses of ethanolic extract gave statistically difference on the serum creatinin level (p&amp;lt;0.05). The doses at 400 mg/kgBW showed the most effective in reducing serum creatinin level.</dc:description>
	<dc:description xml:lang="id-ID">Daun Vernonia amygdalina yang dikenal sebagai daun Afrika Selatan digunakan sebagai obat-obatan Â tradisional untuk mengobati diabetes, demam, hipertensi dan asam urat. Penelitan tentang efek ekstrak etanol daun Â ini terhadap kadar kreatinin dalam serum Â mencit putih jantan telah dilakukan. Dua puluh Â ekor mencit putih jantan dikelompokkan ke dalam empat kelompok yaitu satu kelompok kontrol dan tiga kelompok hewan uji (A, B, C) yang diberikan ekstrak etanol dengan dosis 100 mg/kg BB, 200 mg/kgBB dan 400 mg/kgBB. Kelompok uji diberikan Â ekstrak secara oral selama 21 hari. Leher mencit dipotong dan darah dikumpulkan pada hari ke 7, 14 dan 21. Kadar kreatinin dalam serum darah diukur menggunakan Spektrofotometer Â UV-Visibel pada panjang gelombang 492 nm. Hasil menunjukkan bahwa Â semua dosis sampel Â uji memberikan Â perbedaan yang signifikan terhadap kadar kreatinin dalam serum darah (p&amp;lt;0,05). Â Ekstrak etanol dengan dosis 400 mg/kgBB menunjukkan dosis paling efektif menurunkan kadar kreatinin dalam serum darah.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/103</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.103</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 79-83</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 79-83</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/103/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/104</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Brief Counseling Effect on Physical Activity of Hypertensive Patients in Hospital Dr. H. Moch Ansari Saleh Banjarmasin, Indonesia</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Brief Counseling Terhadap Aktifitas Fisik pada  Pasien Hipertensi Di RSUD Dr. H. Moch Ansari Saleh  Banjarmasin</dc:title>
	<dc:creator>Aryzki, Saftia</dc:creator>
	<dc:creator>Alfian, Riza</dc:creator>
	<dc:subject xml:lang="en-US">hypertension</dc:subject>
	<dc:subject xml:lang="en-US">brief counseling-5A</dc:subject>
	<dc:subject xml:lang="en-US">physical activity</dc:subject>
	<dc:subject xml:lang="id-ID">hipertensi</dc:subject>
	<dc:subject xml:lang="id-ID">brief counseling-5A</dc:subject>
	<dc:subject xml:lang="id-ID">aktifitas fisik</dc:subject>
	<dc:description xml:lang="en-US">Behavior lack of physical activity can lead to failure to achieve the goal of therapy in hypertensive patients. The study aims to determine the effect of brief counseling-5A toward physical activity in hypertensive patients in hospital outpatient Moch. Ansari H. Saleh Banjarmasin. Quasi-experimental study using two group pretest and posttest with prospective data collection. Subjects who met the inclusion criteria a number of 68 patients into two groups: 34 patients and 34 intervention patients did not intervene. Exclusion criteria were patients with the condition of pregnancy, deaf and was not present at the next visit. The collection of data through interviews and questionnaires International Physical Activity Questionnaire (IPAQ). The results showed the treatment group experienced significant changes, the average value of Î”1 increases = 243.60 Â± 1237.68 and p = 0.00, which Î”2 = 90.42 Â± 319.95 and p = 0.31. It was concluded that brief counseling-5A can positively change the behavior of the patient in physical activity in the treatment group.</dc:description>
	<dc:description xml:lang="id-ID">Perilaku kurangnya beraktifitas fisik dapat menyebabkan tidak tercapainya tujuan terapi pasien hipertensi. Penelitian bertujuan untuk mengetahui pengaruh brief counseling-5A terhadap aktifitas fisik pada pasien hipertensi rawat jalan di RSUD H. Moch.Ansari Saleh Banjarmasin. Penelitian kuasi-eksperimental menggunakan two group pretest and postest dengan pengambilan data secara prospektif. Subjek yang memenuhi kriteria inklusi sejumlah 68 pasien menjadi dua kelompok yaitu 34 pasien intervensi dan 34 pasien tidak intervensi. Kriteria eksklusi adalah pasien dengan kondisi hamil, tuli dan tidak hadir pada kunjungan berikutnya. Pengumpulan data dengan wawancara dan pengisian kuesioner International Physical Activity Questionnaire (IPAQ). Hasil penelitian menunjukkan pada kelompok perlakuan mengalami perubahan yang signifikan, nilai rata-rata dari Î”1 meningkat = 243,60 Â± 1237,68 dan p = 0,00, yang Î”2 = 90,42 Â± 319,95 dan p = 0,31. Disimpulkan bahwa brief counseling-5A positif dapat mengubah perilaku pasien dalam melakukan aktifitas fisik pada kelompok perlakuan.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/104</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.104</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 84-90</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 84-90</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/104/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/105</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Sociodemographic Characteristic and Health Related Quality of Life in Outpatients of Type 2 Diabetes Mellitus under JKN</dc:title>
	<dc:title xml:lang="id-ID">Karakteristik Sosiodemografi dan Health Related Quality of Life Pasien Rawat Jalan Diabetes Mellitus Tipe 2 pada Era JKN</dc:title>
	<dc:creator>Restinia, Mita</dc:creator>
	<dc:creator>Anggriani, Yusi</dc:creator>
	<dc:creator>Meryta, Aries</dc:creator>
	<dc:creator>Kusumaeni, Tri</dc:creator>
	<dc:subject xml:lang="en-US">type 2 diabetes mellitus</dc:subject>
	<dc:subject xml:lang="en-US">health related quality of life</dc:subject>
	<dc:subject xml:lang="en-US">sociodemographic</dc:subject>
	<dc:subject xml:lang="id-ID">Diabetes mellitus tipe 2</dc:subject>
	<dc:subject xml:lang="id-ID">health related quality of life</dc:subject>
	<dc:subject xml:lang="id-ID">sosiodemografi</dc:subject>
	<dc:description xml:lang="en-US">The aim of Â study was carried out to determine differences of health related qualitiy of life (HRQoL) with sociodemographic characteristic in type 2 diabetes mellitus outpatiens at one of government hospital in Jakarta. It was a cross-sectional study conducted Â from February Â to April 2015. Total of samples were 83 patients. Male 31(37.4%) and female 52(62.6%). HRQoL associated with level education Â was difference significantly (P&amp;lt;0.05). Â Based on score of domain quality of life, female had higher score (69.82 Â± 3.14) of frequency of symptoms domain than male (67.32 Â± 4.50) (P&amp;lt;0.05). The oldest patients had the highest score (P&amp;lt;0.05) in domain of satisfaction. In contrast, the oldest patients had the the most decrease score (64.14 Â± 4.03) in domain of frequency of symptoms (P&amp;lt;0.05). Patients of senior high school had lower score (60.17 Â± 24.65) in domain of treatmant satisfaction than patients of Â diploma/bachelor (78.78 Â± 21.98). Score of domain of frequency of symptoms was higher on patients employed Â than none (P&amp;lt;0.05). The household income did not influence all domain (P&amp;gt;0.05). Furthermore, diabetes duration affected both domain of satisfaction (P=0.005) and frequency of symptoms (P=0.00). In conclusion, only education level of characteristic sociodemographic had difference significantly to HRQoL among type 2 diabetes mellitus outpatients..</dc:description>
	<dc:description xml:lang="id-ID">Penelitian dilakukan untuk mengetahui perbedaan Health Related Quality of Life (HRQoL) terhadap karakteristik sosiodemografi antara pasien diabetes mellitus tipe 2 pada Â salah satu rumah sakit pemerintah di Jakarta. Penelitian dilaksanakan secara cross-sectional dari Februari sampai April 2015. Total sampel 83 pasien. Laki-laki 31(37,4%) dan perempuan 52 (62,6%). Terdapat perbedaan yang signifikan (P&amp;lt;0,05) nilai HRQoL terhadap tingkat pendidikan. Berdasarkan nilai domain HRQoL, perempuan memiliki nilai lebih tinggi (69.82 Â± 3.14) dibandingkan dengan laki-laki (67.32 Â± 4.50) pada domain frekuensi gejala (P&amp;lt;0,05). Pasien dengan usia yang lebih lanjut memiliki nilai tertinggi pada domain kepuasan (P&amp;lt;0,05). Sebaliknya, pasien dengan usia lebih lanjut memiliki nilai terendah (64,14 Â± 4,03) Â pada domain frekuensi gejala (P&amp;lt;0,05). Pasien dengan tingkat pendikan SMA memiliki nilai lebih rendah (60,17 Â± 24,65) pada domain kepuasan pengobatan dibandingkan dengan pasien dengan pendidikan diploma/sarjana (78,78 Â± 21,98). Nilai domain frekuensi gejala lebih tinggi pada pasien bekerja dibandingkan dengan tidak bekerja (P&amp;lt;0,05). Jumlah pendapatan tidak mempengaruhi secara signifikan terhadap nilai semua domain (P&amp;gt;0,05) HRQoL. Selanjutnya, lama menderita diabetes mempengaruhi nilai domain kepuasan (P=0,05) dan frekuensi gejala (P=0,00). Sehingga dapat disimpulkan, karakteristik sosiodemografi meliputi tingkat pendidikan memiliki perbedaan secara signifikan terhadap kualitas hidup antara pasien rawat jalan diabetes mellitus tipe 2.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/105</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.105</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 91-98</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 91-98</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/105/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/106</identifier>
				<datestamp>2019-06-30T21:26:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Effect of Pharmacist Presence to Pharmaceutical Service at Pharmacies of  Padang City, Indonesia)</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Kehadiran Apoteker Terhadap Pelayanan  Kefarmasian di Apotek di Kota Padang</dc:title>
	<dc:creator>Dominica, Dwi</dc:creator>
	<dc:creator>Putra, Deddi Prima</dc:creator>
	<dc:creator>Yulihasri, Yulihasri</dc:creator>
	<dc:subject xml:lang="en-US">pharmacist</dc:subject>
	<dc:subject xml:lang="en-US">attendance</dc:subject>
	<dc:subject xml:lang="en-US">pharmaceutical services</dc:subject>
	<dc:subject xml:lang="en-US">pharmacy</dc:subject>
	<dc:subject xml:lang="en-US">Padang</dc:subject>
	<dc:subject xml:lang="id-ID">apoteker</dc:subject>
	<dc:subject xml:lang="id-ID">kehadiran</dc:subject>
	<dc:subject xml:lang="id-ID">pelayanan kefarmasian</dc:subject>
	<dc:subject xml:lang="id-ID">apotek</dc:subject>
	<dc:subject xml:lang="id-ID">Padang</dc:subject>
	<dc:description xml:lang="en-US">Standard pharmacy services is measure used especially in implementing pharmacist pharmacy services. This study examines effect of presence of Pharmacists to pharmacy services, is crosssectional study using questionnaires in February - August2015. The research sample 90 Pharmacists in pharmacies taken random. results Showed the percentage of the presence of the pharmacist in the pharmacy Padang city 58.67% and Pharmaceutical Services Categorized less (inspection recipe 57.06%, 55.12% prescription preparation, and delivery prescriptions 51.89%) with average percentage 54,69%. Linear regression analysis of test results can be known effect X on Y positive. Testing shows the product moment correlation coefficient X to Y Strong where: r=0.910, in testing the coefficient of determination shows X higher influence on Y equal to 82.8% and 17.2% influenced other factors. Based on the F test 422,579 with significance of 0.000. Due significant levels &amp;lt;0.05, can concluded that the presence of Pharmacists have influence on Pharmaceutical Services.</dc:description>
	<dc:description xml:lang="id-ID">Standar pelayanan kefarmasian merupakan tolok ukur yang digunakan khususnya apoteker dalam melaksanakan pelayanan kefarmasian. Penelitian ini bertujuan melihat pengaruh kehadiran apoteker terhadap pelayanan kefarmasian, bersifat cross sectional Â menggunakan kuisioner bulan Febuari â€“ Agustus 2015. Sampel penelitian 90 apoteker di Apotek diambil secara random. Hasil penelitian menunjukkan bahwa Persentase kehadiran apoteker di apotek kota Padang sebesar 58,67% dan Pelayanan Kefarmasian dikategorikan kurang (pemeriksaan resep 57,06%, penyiapan resep 55,12%, dan penyerahan resep 51,89%) dengan persentase rata-rata 54,69%. Hasil pengujian analisis regresi linear dapat diketahui pengaruh X terhadap Y positif. Pengujian Koefisien Product moment Â menunjukkan hubungan X terhadap Y kuat dimana : r=0,910, dalam pengujian koefisen determinasi menunjukkan bahwa X mempunyai pengaruh tinggi terhadap Y yaitu sebesar 82,8% dan 17,2% dipengaruhi oleh faktor lain. Berdasarkan tabel uji F test sebesar 422.579 dengan signifikansi 0,000. Karena tingkat signifikan &amp;lt; 0,05, maka dapat disimpulkan bahwa variabel Kehadiran Apoteker mempunyai pengaruh terhadap Pelayanan Kefarmasian.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2016-12-28</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/106</dc:identifier>
	<dc:identifier>10.29208/jsfk.2016.3.1.106</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 1 (2016): J Sains Farm Klin 3(1), November 2016; 99-107</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 1 (2016): J Sains Farm Klin 3(1), November 2016; 99-107</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/106/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2016 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/108</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antipsychotics use and side effects in patients with schizophrenia   at Sambang Lihum Hospital South Kalimantan, Indonesia</dc:title>
	<dc:title xml:lang="id-ID">Studi Penggunaan Antipsikotik dan Efek Samping  pada Pasien  Skizofrenia di Rumah Sakit Jiwa Sambang Lihum  Kalimantan Selatan</dc:title>
	<dc:creator>Yulianty, Mawar Dwi</dc:creator>
	<dc:creator>Cahaya, Noor</dc:creator>
	<dc:creator>Srikartika, Valentina Meta</dc:creator>
	<dc:subject xml:lang="id-ID">skizofrenia</dc:subject>
	<dc:subject xml:lang="id-ID">antipsikotik</dc:subject>
	<dc:subject xml:lang="id-ID">pola penggunaan obat</dc:subject>
	<dc:subject xml:lang="id-ID">efek samping.</dc:subject>
	<dc:subject xml:lang="en-US">schizophrenia</dc:subject>
	<dc:subject xml:lang="en-US">antipsychotic</dc:subject>
	<dc:subject xml:lang="en-US">pattern of drug use</dc:subject>
	<dc:subject xml:lang="en-US">side effects.</dc:subject>
	<dc:description xml:lang="en-US">Based on RISKESDAS 2013, schizophrenia prevalence in South Kalimantan is 1.4 per one thousand population. The main therapy for schizophrenia is anti-psychotic medication. A variety of side effects arise from the use of antipsychotic drugs including extrapyramidal syndrome and metabolic syndrome. The aim of the study was to evaluate the prescription pattern and side effects of antipsychotic drugs in patients with schizophrenia at Sambang Lihum Psychiatric Hospital, South Kalimantan, Indonesia. The type of this study was non-experimental observation with prospective data collection. Population in this study was all of the schizophrenia inpatients in February 2016 who met the inclusion criteria. The data were collected from 59 patients. The results showed that anti-psychotics combination therapy was the most widely used medications (90.6%), in which the combination of haloperidol-clozapine was the most frequent one (26.04%). The side effects commonly observed were extrapyramidal syndrome (98.3%); orthostatic hypotension (86,4%); anticholinergic effect (76.3%); sedation (44.1%); nausea / vomiting (27.1%); diarrhea (27.1%); insomnia (16.9%); loss of appetite (10.2%); red-itchy rashes (6.8%); anorexia (5.1%); frequent urination (5.1%); decreased consciousness (1.7%), shortness of breath and cough (1.7%); impairment of Hb (1.7%); increase in AST (1.7%); increase in ALT (1.7%); and foaming from nose (1.7%).</dc:description>
	<dc:description xml:lang="id-ID">Berdasarkan data RISKESDAS 2013, prevalensi skizofrenia di Kalimantan Selatan adalah 1,4 per seribu penduduk. Terapi utama skizofrenia menggunakan antipsikotik. Beberapa penelitian menyebutkan bahwa efek samping utama penggunaan antipsikotik adalah sindrom ekstrapiramidal dan sindrom metabolik. Penelitian ini bertujuan untuk mendeskripsikan pola penggunaan antipsikotik dan berbagai kejadiaan efek samping yang terjadi selama terapi pengobatan antipsikotik pada pasien rawat inap skizofrenia di Rumah Sakit Jiwa Sambang Lihum Kalimantan Selatan. Jenis penelitian adalah non eksperimental observasional dengan pengambilan data secara prospektif. Populasi sampel adalah seluruh pasien skizofrenia rawat inap yang masuk pada bulan Februari 2016 di RSJ Sambang Lihum yang memenuhi kriteria inklusi. Jumlah subyek penelitian sebanyak 59 pasien. Hasil penelitian menunjukkan bahwa terapi kombinasi antipsikotik adalah terapi yang paling banyak digunakan (90,6%), dengan obat yang paling banyak digunakan adalah haloperidol-clozapin (26,06%). Efek samping yang terjadi pada 59 pasien adalah sindrom ekstrapiramidal (98,3%), hipotensi orthostatik (86,4%), efek antikolinergik (76,3%); sedasi (44,1%); mual/muntah (27,1%); diare (27,1%); insomnia (16,9%); tidak nafsu makan (10,2%); gatal kemerahan (6,8%); anoreksia (5,1%); sering buang air kecil (5,1%); kesadaran menurun (1,7%), sesak nafas dan batuk (1,7%); penurunan nilai Hb (1,7%); kenaikan AST (1,7%); kenaikan ALT (1,7%); Keluar busa di hidung (1,7%).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/108</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.108</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 153-164</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 153-164</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/108/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/112</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Impact of service quality and patient satisfaction of BPJS participants  as the mediation to patient loyalty</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Kualitas Pelayanan dan Kepuasan Pasien Peserta BPJS Kesehatan sebagai Mediasi terhadap Loyalitas Pasien</dc:title>
	<dc:creator>Rizal, Rosiana</dc:creator>
	<dc:creator>Suardi, Muslim</dc:creator>
	<dc:creator>Yulihasri, Yulihasri</dc:creator>
	<dc:subject xml:lang="id-ID">kualitas pelayanan</dc:subject>
	<dc:subject xml:lang="id-ID">kepuasan</dc:subject>
	<dc:subject xml:lang="id-ID">loyalitas.</dc:subject>
	<dc:subject xml:lang="en-US">service quality</dc:subject>
	<dc:subject xml:lang="en-US">satisfaction</dc:subject>
	<dc:subject xml:lang="en-US">loyalty.</dc:subject>
	<dc:description xml:lang="en-US">The formation of a positive perception of the patient is expected to bring satisfaction in pharmaceutical services, especially drug information services to improve patientsâ€™ loyalty to health care services they have used. The design of this research is probability sampling, with a population of patients in public hospitals in Padang city: Dr. M. Djamil Hospital; Dr. Rasidin Hospital; and Dr. Reksodiwiryo Hospital Padang who have used the service of National Health Insurance (BPJS) from January to June 2014. The sampling technique was simple random sampling (105 patients) by using a questionnaire. Data analysis was performed using Cronbachâ€™s alpha analysis, Multiple Regression, R Square, t-test and path analysis. The results of this study indicated that the service quality affected patientsâ€™ satisfaction in the dimensions of responsiveness, assurance and direct evidence (p &amp;lt;0.05); toward the loyalty of patients in the direct evidence dimension (p&amp;lt;0.05); and towards patientsâ€™ loyalty mediated by patientsâ€™ satisfaction in the dimension of direct evidence (p &amp;lt;0.05).</dc:description>
	<dc:description xml:lang="id-ID">Terbentuknya persepsi positif dari pasien diharapkan dapat memunculkan kepuasan pelayanan farmasi terutama dalam informasi obat sehingga adanya loyalitas pasien atas jasa lembaga pelayanan kesehatan yang pernah digunakannya. Rancangan jenis penelitian ini adalah probability sampling, dengan populasi pasien dilingkungan rumah sakit umum pemerintah di kota Padang, yaitu RSUP Dr. M. Djamil Padang, RSUD Dr. Rasidin Padang dan RST Dr. Reksodiwiryo Padang yang pernah berobat menggunakan kartu BPJS Kesehatan dari Januari sampai Juni 2014. Teknik pengambilan sampel berupa Simple Random Sampling (105 pasien) dengan kuesioner. Analisis data dilakukan dengan menggunakan Analisis cronbachâ€™s alpha, Regresi Berganda, R Square, Uji t dan path analysis dengan SPSS versi 11.5. Hasil penelitian ini menunjukkan bahwa kualitas pelayanan berpengaruh terhadap kepuasan pasien pada dimensi daya tanggap, jaminan dan bukti langsung bernilai p&amp;lt;0,05 sedangkan terhadap loyalitas pasien pada dimensi bukti langsung bernilai p&amp;lt;0,05 dan terhadap loyalitas pasien dengan dimediasi kepuasan pasien pada dimensi bukti langsung bernilai p&amp;lt;0,05.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/112</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.112</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 108-114</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 108-114</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/112/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/115</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">A retrospective descriptive study on antibiotic dosage regimen  in pediatric pneumonia patients at Dr. M. Djamil Hospital Padang</dc:title>
	<dc:title xml:lang="id-ID">Kajian Deskriptif Retrospektif Regimen Dosis Antibiotik  Pasien Pneumonia Anak di RSUP. Dr. M. Djamil Padang</dc:title>
	<dc:creator>Juwita, Dian Ayu</dc:creator>
	<dc:creator>Arifin, Helmi</dc:creator>
	<dc:creator>Yulianti, Nelfa</dc:creator>
	<dc:subject xml:lang="id-ID">regimen dosis</dc:subject>
	<dc:subject xml:lang="id-ID">antibiotika</dc:subject>
	<dc:subject xml:lang="id-ID">pneumonia</dc:subject>
	<dc:subject xml:lang="id-ID">pediatri.</dc:subject>
	<dc:subject xml:lang="en-US">dosage regimen</dc:subject>
	<dc:subject xml:lang="en-US">antibiotic</dc:subject>
	<dc:subject xml:lang="en-US">pneumonia</dc:subject>
	<dc:subject xml:lang="en-US">pediatrics.</dc:subject>
	<dc:description xml:lang="en-US">Pneumonia is one of acute respiratory tract infection which a major causes mortality in children and infant. The role of antibiotics in reducing morbidity and mortality this infectious disease is still dominant. Improper use of antibiotics can lead to the development of bacteria resistant to antibiotics and the occurrence of toxicity/side effects of drugs. The objective of this study was to determine the appropriateness of dosage regimen of antibiotics in children with pneumonia compared to standard literature. The study was conducted by retrospective descriptive analysis, using medical records of children with pneumonia during 2013. The results showed inappropriateness in several dosage regimen of antibiotics, such as chloramphenicol (5%), meropenem (50%), erythromycin (100%), azithromycin (100%), ceftazidime (100%), clindamycin (100%), ampicillin (100%) and gentamicin (100%). The inappropriateness of frequency of administration (administration interval) was also found in ampicillin (50%), gentamicin (20%), and cefotaxime (100%). The inappropriateness of dosage duration was found in amoxicillin (44.45%), chloramphenicol (45%), gentamicin (70%), meropenem (33.34%), ceftriaxone (66.67%), ampicillin (50%), cefotaxime (100%). While the route of administration of antibiotics was 100% appropriate.</dc:description>
	<dc:description xml:lang="id-ID">Pneumonia merupakan salah satu penyakit infeksi saluran pernafasan akut yang menduduki peringkat atas sebagai penyebab kematian pada anak dan balita. Peranan antibiotik dalam menurunkan morbilitas dan mortilitas penyakit infeksi ini masih sangat dominan. Penggunaan antibiotik yang tidak tepat dapat mengakibatkan berkembangnya bakteri yang resisten terhadap antibiotik serta timbulnya toksisitas/efek samping obat. Penelitian ini bertujuan untuk mengkaji regimen dosis antibiotik yang diberikan pada pasien pneumonia anak dibandingkan dengan regimen dosis pada literatur resmi. Penelitian dilakukan dengan metode observasi deskriptif retrospektif menggunakan data rekam medik pasien pneumonia anak selama tahun 2013. Hasil penelitian menunjukkan adanya ketidaktepatan pada beberapa regimen dosis antibiotik, seperti ketidaktepatan dosis kloramfenikol (5%), meropenem (50%), eritromisin (100%), azitromisin (100%), seftazidim (100%) klindamisin (100%), ampisilin (100%) dan gentamisin (100%). Ketidaktepatan frekuensi pemberian (interval pemberian) ampisilin (50%), gentamisin (20%) sefotaksim (100%). Ketidaktepatan lama pemberian amoksisilin (44.45%), kloramfenikol (45%), gentamisin (70%), meropenem (33,34%), seftriakson (66,67%), ampisilin (50%), sefotaksim (100%). Sedangkan rute pemberian antibiotik sudah tepat 100%.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/115</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.115</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 134-140</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 134-140</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/115/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/118</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Correlation between Adherence and Quality of Life in Dyspepsia Outpatients at M. Djamil Hospital Padang</dc:title>
	<dc:title xml:lang="id-ID">Hubungan Depresi Terhadap Tingkat Kepatuhan dan Kualitas Hidup Pasien Sindrom Dispepsia di RSUP Dr. M. Djamil Padang</dc:title>
	<dc:creator>Hemriyantton, Bobbi</dc:creator>
	<dc:creator>Arifin, Helmi</dc:creator>
	<dc:creator>Murni, Arina Widya</dc:creator>
	<dc:subject xml:lang="en-US">depression</dc:subject>
	<dc:subject xml:lang="en-US">adherence</dc:subject>
	<dc:subject xml:lang="en-US">quality of life</dc:subject>
	<dc:subject xml:lang="en-US">dyspepsia</dc:subject>
	<dc:subject xml:lang="id-ID">depresi</dc:subject>
	<dc:subject xml:lang="id-ID">kepatuhan</dc:subject>
	<dc:subject xml:lang="id-ID">kualitas hidup</dc:subject>
	<dc:subject xml:lang="id-ID">dispepsia</dc:subject>
	<dc:description xml:lang="en-US">The objective of this study was to examine the correlation of depression, adherence, and quality of life in dyspepsia patient. Cross-sectional data were collected from 61 outpatient with dyspepsia at a special clinic in M. Djamil Hospital Padang. Patients were interviewed based on BDI II (Back Depression Inventory II) to assess depression, Morisky scale to assess adherence. Patient with BDI scores more than 12 was consulted to a special clinic of psychosomatic to diagnose for depression. Correlation between depression, adherence, and quality of life was analyzed with Spearman correlation. Coefficient correlation of depression and adherence was 0.272, while the correlation between depression and quality of life was 0.655. This finding demonstrates that there is a high correlation between depression and quality of life, while there is a low correlation between depression and adherence. Keywords: Depression, adherence, quality of life, dyspepsia.</dc:description>
	<dc:description xml:lang="id-ID">Tujuan penelitian ini adalah untuk melihat hubungan depresi terhadap kepatuhan dan kualitas hidup. Metode penelitian yang digunakan adalah cross sectional yang dilakukan terhadap 61 pasien sindrom dispepsia yang berobat jalan di poliklinik khusus penyakit dalam di RSUP DR. M. Djamil Padang pada Januari - Maret tahun 2015. Pasien diwawancarai dengan menggunakan kuisioner BDI II (untuk menilai depresi), kuisioner skala morisky (untuk menilai kepatuhan) dan kuisioner SF-36 (untuk menilai kualitas hidup). Pasien dengan nilai skor BDI II lebih dari 13 di konsultasikan ke poliklinik khusus psikosomatik untuk menegakkan diagnosa depresi. Hubungan antara depresi dengan kepatuhan dan kualitas hidup dianalisa dengan menggunakan SPSS 22 dengan uji korelasi bivariat spearman. Persentase depresi pada pasien sindrom dispepsia adalah 67.2%. Koefisien korelasi untuk depresi dan kepatuhan adalah 0.272, depresi dan kualitas hidup 0.655. Penelitian ini menunjukkan ada korelasi yang tinggi antara depresi dengan kualitas hidup, dan korelasi yang rendah antara depresi dengan kepatuhan.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/118</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.118</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 141-145</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 141-145</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/118/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/119</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Drug related problems in chronic suppurative otitis media inpatients  at ENT ward of M. Djamil Hospital Padang</dc:title>
	<dc:title xml:lang="id-ID">Kajian Drug Related Problems Pasien Otitis Media Supuratif Kronis di Bangsal THT RSUP. Dr. M. Djamil Padang</dc:title>
	<dc:creator>Suhatri, Suhatri</dc:creator>
	<dc:creator>Handayani, Popy</dc:creator>
	<dc:creator>Harisman, Harisman</dc:creator>
	<dc:subject xml:lang="id-ID">drug releated problem</dc:subject>
	<dc:subject xml:lang="id-ID">otitis media supuratif kronis</dc:subject>
	<dc:subject xml:lang="id-ID">OMSK.</dc:subject>
	<dc:subject xml:lang="en-US">drug releated problem</dc:subject>
	<dc:subject xml:lang="en-US">chronic suppurative otitis media</dc:subject>
	<dc:subject xml:lang="en-US">CSOM.</dc:subject>
	<dc:description xml:lang="en-US">A study of drug related problems in patients with chronic suppurative otitis media has been done in the ENT ward of Dr. M. Djamil Hospital Padang. The study was conducted retrospectively and prospectively by tracking the patientâ€™s condition, medical record, Drug Instruction Card (KIO) and nursing care records in patients with chronic suppurative otitis media. The data obtained is then analyzed descriptively. The results showed that the most prevalent DRPs category was drug interactions. There were 10 cases of drug interactions of 11 DRPs incidents from retrospective data and 5 cases of drug interaction of 10 DRPs incidents from prospective data in chronic suppurative otitis media in the ENT ward of Dr. M. Djamil Hospital Padang. The other DRPs categories were from dose retrospective data of less than 1 case (3.84%) and from prospective data of adverse drug reactions of 5 cases (45.45%). From the results of this study, it can be concluded that the category of drug related problems found in patients suppurative chronic otitis media in the ENT ward of Dr. M. Djamil Hospital Padang is drug interaction, less dosage, and adverse drug reactions.</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan penelitian kajian drug related problems pada pasien otitis media supuratif kronik rawat inap di bangsal THT RSUP Dr. M. Djamil Padang. Penelitian ini dilakukan secara retrospektif dan prospektif melalui penelusuran terhadap kondisi pasien, catatan rekam medik, Kartu Instruksi Obat (KIO) dan catatan asuhan keperawatan pada pasien otitis media supuratif kronik. Data yang diperoleh selanjutnya di analisis secara deskriptif. Hasil penelitian menunjukkan bahwa kategori DRPs yang paling banyak terjadi adalah interaksi obat. Dari data retrospektif terdapat 10 kasus interaksi obat dari 11 kejadian DRPs dan data prospektif terdapat 5 kasus interaksi obat dari 10 kejadian DRPs pada pasien otitis media supuratif kronik rawat inap dibangsal THT RSUP Dr. M. Djamil padang. Kategori DRPs yang lain adalah dari data retrospektif dosis kurang 1 kasus (3,84%), Dan dari data prospektif reaksi obat yang merugikan 5 kasus (45,45%). Dari hasil penelitian ini dapat disimpulkan bahwa kategori drug related problems yang ditemukan pada pasien otitis media supuratif kronik rawat inap di bangsal THT RSUP Dr. M. Djamil Padang adalah interaksi obat, dosis kurang dan reaksi obat yang merugikan.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/119</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.119</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 172-177</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 172-177</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/119/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/120</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Enhanced Dissolution Rate of Ketoprofen by Co-grinding Technique with Hydroxypropyl Methylcellulose E6 polymer</dc:title>
	<dc:title xml:lang="id-ID">Peningkatan Laju Disolusi Ketoprofen Dengan Teknik Co-Grinding Menggunakan Polimer Hydroxypropyl Methylcellulose E6</dc:title>
	<dc:creator>Hilaliyati, Najmi</dc:creator>
	<dc:creator>Ben, Elfi Sahlan</dc:creator>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:subject xml:lang="id-ID">ketoprofen</dc:subject>
	<dc:subject xml:lang="id-ID">hidroksipropil metilselulosa</dc:subject>
	<dc:subject xml:lang="id-ID">co-grinding</dc:subject>
	<dc:subject xml:lang="id-ID">laju disolusi.</dc:subject>
	<dc:subject xml:lang="en-US">ketoprofen</dc:subject>
	<dc:subject xml:lang="en-US">hydroxypropyl methylcellulose</dc:subject>
	<dc:subject xml:lang="en-US">co-grinding</dc:subject>
	<dc:subject xml:lang="en-US">dissolution rate.</dc:subject>
	<dc:description xml:lang="en-US">Improvement of the dissolution rate of ketoprofen as a model for a poorly water-soluble drug by solid state co-grinding technique with hydrophilic polymer hydroxypropyl methylcellulose E6 (HPMC) using mortar grinder apparatus have been investigated. Three different formulations prepared with varying drug : carrier ratio 1:2, 1:1, and 2:1 (w/w). Physical mixture prepared with ratio 1:1 (w/w). X-ray diffraction showed decrease of peak intensity of ketoprofen. DSC analysis showed decrease of melting point of ketoprofen. FTIR analysis showed no chemical interaction between drug and polymer. In this investigation, it was found that solubility tended to increase with increase in the amount of polymer used. Solid dispersion ratio 1:2 showed the highest solubility (6,5 fold). However, unlike the solubility results, the dissolution rate increased with decreases in polymer concentration due to thick diffusion layer formation of the polymer. Solid dispersion ratio 2:1 showed the highest dissolution (2,1 fold).</dc:description>
	<dc:description xml:lang="id-ID">Telah dilakukan peningkatan laju disolusi ketoprofen sebagai model zat aktif yang sukar larut air dengan teknik penggilingan bersama (co-grinding) dengan polimer hidrofilk hydroxypropyl methylcellulose E6 (HPMC) menggunakan alat mortar grinder. Tiga formula disiapkan dengan perbandingan zat aktif : polimer 1:2, 1:1, dan 2:1 (b/b), dan campuran fisik dibuat dengan menggunakan perbandingan 1:1 (b/b). Difraktogram sinar-X menunjukkan terjadinya penurunan intensitas puncak ketoprofen. Termogram DSC menunjukkan terjadinya penurunan titik leleh ketoprofen. Analisis FTIR menunjukkan tidak terdapat interaksi kimia antara zat aktif dengan polimer. Pada penelitian ini didapatkan bahwa kelarutan obat meningkat dengan meningkatnya konsentrasi polimer. Dispersi padat rasio 1:2 menunjukkan peningkatan kelarutan terbesar (6,5 kali). Tidak seperti kelarutan, laju disolusi ketoprofen meningkat dengan menurunnya kosentrasi polimer karena terbentuknya lapisan difusi yang tebal oleh polimer. Dispersi padat resio 2:1 menunjukkan peningkatan disolusi tertinggi (2,1 kali).</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/120</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.120</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 193-201</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 193-201</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/120/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/124</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Patient knowledge and rationality of self-medication in three pharmacies of Panyabungan City, Indonesia</dc:title>
	<dc:title xml:lang="id-ID">Pengetahuan Pasien dan Rasionalitas Swamedikasi di Tiga Apotek Kota Panyabungan</dc:title>
	<dc:creator>Harahap, Nur Aini</dc:creator>
	<dc:creator>Khairunnisa, Khairunnisa</dc:creator>
	<dc:creator>Tanuwijaya, Juanita</dc:creator>
	<dc:subject xml:lang="id-ID">swamedikasi</dc:subject>
	<dc:subject xml:lang="id-ID">apotek</dc:subject>
	<dc:subject xml:lang="id-ID">pengetahuan</dc:subject>
	<dc:subject xml:lang="id-ID">rasionalitas penggunaan obat</dc:subject>
	<dc:subject xml:lang="en-US">self medication</dc:subject>
	<dc:subject xml:lang="en-US">pharmacies</dc:subject>
	<dc:subject xml:lang="en-US">knowledge</dc:subject>
	<dc:subject xml:lang="en-US">rationality drug use</dc:subject>
	<dc:description xml:lang="en-US">Self-medication is a part of community effort to preserve their health. In practice, the self-medication can be a source of drug related problem because of lack of knowledge about drugs and their use. The aim of this study was to determine the level of knowledge and rationality of medicinal use self-medication. This study was using survey cross-sectional method. Total respondents (n=342) were involved this study of three pharmacies. Respondents were 18-60 years old and selected by consecutive sampling method. Data was collected by using a validated questionnaire. Data were analyzed by Chi-square test and Fisher test using Statistical Product and Servicer Solution (SPSS) version 17. The research showed that level knowledge of patients 20.5 % were good, 41.8% were medium, and 37.7% were low. Drug use self-medication was 59.4% rational and 40.6% irrational used. Based the result of Chi-square and Fisher test, educated and jobs can influence the level of knowledge, meanwhile rationality of self-medication use was not influenced by sociodemographic factor. Based on the research results obtained that majority level knowledge of patient was good classified. Irrational drug use on self medication reached 40.6%.</dc:description>
	<dc:description xml:lang="id-ID">Pengobatan sendiri (swamedikasi) merupakan bagian dari upaya masyarakat menjaga kesehatannya sendiri. Pada pelaksanaannya, pengobatan sendiri dapat menjadi sumber masalah terkait obat (Drug related problem) akibat terbatasnya pengetahuan mengenai obat dan penggunaannya. Tujuan penelitian ini adalah untuk mengetahui tingkat pengetahuan dan rasionalitas penggunaan obat swamedikasi. Penelitian ini menggunakan metode survei cross sectional. Sebanyak 342 responden dari tiga apotek terlibat dalam penelitian ini. Responden berusia 18-60 tahun dan dipilih dengan metode consecutive sampling. Pengambilan data dilakukan melalui pengisian kuisioner yang telah diuji validitas dan reliabilitasnya. Data dianalisis dengan uji Chi- square dan uji Fisher menggunakan Statistical Product and Servicer Solution (SPSS) versi 17. Hasil penelitian menunjukkan bahwa tingkat pengetahuan pasien 20,5% tergolong baik, 41,8% tergolong sedang, dan 37,7% tergolong buruk (37,7%). Penggunaan obat swamedikasi 59,4% rasional dan 40,6% tidak rasional. Berdasarkan hasil uji Chi-square dan uji Fisher, tingkat pengetahuan dipengaruhi oleh pendidikan terakhir dan pekerjaan. Sedangkan rasionalitas swamedikasi tidak dipengaruhi faktor sosiodemografi. Berdasarkan hasil penelitian diperoleh bahwa mayoritas tingkat pengetahuan pasien tergolong sedang. Penggunaan obat swamedikasi yang tidak rasional mencapai 40,6%.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/124</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.124</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 186-192</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 186-192</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/124/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/126</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Sub-chronic toxicity evaluation of ethyl acetate fraction of fruit rind of â€œasam kandisâ€  (Garcinia cowa Roxb.) against liver and kidney function of female white mice</dc:title>
	<dc:title xml:lang="id-ID">Uji Toksisitas Subkronis Fraksi Etil Asetat Kulit Buah Asam  Kandis (Garcinia cowa Roxb.) terhadap Fungsi Hati dan Ginjal Mencit Putih Betina</dc:title>
	<dc:creator>Wahyuni, Fatma Sri</dc:creator>
	<dc:creator>Putri, Intan Nedia</dc:creator>
	<dc:creator>Arisanti, Dessy</dc:creator>
	<dc:subject xml:lang="id-ID">toksistas sub kronik</dc:subject>
	<dc:subject xml:lang="id-ID">fraksi etil asetat</dc:subject>
	<dc:subject xml:lang="id-ID">Garcinia cowa</dc:subject>
	<dc:subject xml:lang="id-ID">asam kandis</dc:subject>
	<dc:subject xml:lang="id-ID">kulit buah.</dc:subject>
	<dc:subject xml:lang="en-US">sub-chronic toxicity</dc:subject>
	<dc:subject xml:lang="en-US">ethyl acetat fraction</dc:subject>
	<dc:subject xml:lang="en-US">Garcinia cowa</dc:subject>
	<dc:subject xml:lang="en-US">cowa mangosteen</dc:subject>
	<dc:subject xml:lang="en-US">fruit rind.</dc:subject>
	<dc:description xml:lang="en-US">The sub-chronic toxicity testing of ethyl acetate fraction of fruit rind of â€œasam kandisâ€ (Garcinia cowa Roxb.) to the liver and kidney function has been carried out to female white mice. A total of 18 female white mice aged 2-3 months weighing 20-30 grams are used as test animals. Animals were divided into three groups: one control group and two treatment groups. Groups were given daily ethyl acetate fraction at the doses of 500 and 1000 mg/kg orally for 60 days. Parameters observed were the activity of SGPT and liver weight ratio to observe the liver function; serum creatinine level and kidney weight ratio to determine kidney function. Data of SGPT, serum creatinine and the weight ratio of liver and kidney were analyzed by two-way ANOVA. Results show that the activity of SGPT and serum creatinine level were directly affected by the dose (p&amp;lt;0.05), while the organ weight ratio of liver and kidney were not affected by the dose and duration of administration (p&amp;gt;0.05). The study concluded that the dosage of ethyl acetate fraction of the fruit rind of G. cowa had a significant effect on the activity of SGPT and serum creatinine level of female white mice. The duration of administration did not give a significant effect on the increase of serum creatine level as well as the organ weight ratio of liver and kidney of mice.</dc:description>
	<dc:description xml:lang="id-ID">Pengujian toksisitas subkronis fraksi etil asetat kulit buah asam kandis (Garcinia cowa Roxb.) terhadap fungsi hati dan ginjal mencit putih betina telah dilakukan. Sebanyak 18 ekor mencit putih betina berusia 2-3 bulan dengan berat badan 20-30 gram digunakan sebagai hewan uji. Hewan dibagi menjadi 3 kelompok yaitu 1 kelompok kontrol dan 2 kelompoj perlakuan yang diberi fraksi etil asetat kulit buah asam kandis dengan dosis 500 dan 1000mg/kgBB sekali sehari secara oral selama 60 hari. Parameter yang diamati yaitu aktivitas SGPT dan rasio berat hati untuk fungsi hati dan aktivitas kreatinin serum dan rasio berat ginjal untuk aktivitas ginjal. Data aktivitas SGPT, kreatinin serum dan rasio berat organ hati dan ginjal dianalisis dengan ANOVA dua arah. Hasil penelitian menunjukan bahwa aktivitas SGPT, Kreatinin serum dipengaruhi secara langsung oleh dosis (p&amp;lt;0,05) dan untuk rasio berat hati dan ginjal tidak dipengaruhi secara langsung oleh dosis dan lama pemberian (p&amp;gt;0,05). Dapat disimpulkan bahwa dosis pemberian fraksi etil asetat kulit buah asam kandis memberikan pengaruh yang bermakna terhadap aktivitas SGPT dan kadar kreatinin serum mencit putih betina. Lama pemberian tidak memberikan pengaruh yang bermakna terhadap peningkatan kadar kreatinin serum mencit putih betina dan rasio berat hati dan ginjal mencit putih betina.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/126</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.126</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 202-212</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 202-212</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/126/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/138</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antibiotic Compound of Symbiotic Bacillus sp1 (HA1)  from Marine Sponge Haliclona fascigera</dc:title>
	<dc:title xml:lang="id-ID">Senyawa Antibiotik dari Bacillus sp1 (HA1)  yang Bersimbiosis pada Spon Laut Haliclona fascigera</dc:title>
	<dc:creator>Sari, Wiza Leila Puspita</dc:creator>
	<dc:creator>Putra, Deddi Prima</dc:creator>
	<dc:creator>Handayani, Dian</dc:creator>
	<dc:subject xml:lang="id-ID">bakteri simbion</dc:subject>
	<dc:subject xml:lang="id-ID">Bacillus sp.</dc:subject>
	<dc:subject xml:lang="id-ID">aktivitas antibakteri</dc:subject>
	<dc:subject xml:lang="id-ID">spon laut</dc:subject>
	<dc:subject xml:lang="id-ID">Haliclona fascigera.</dc:subject>
	<dc:subject xml:lang="en-US">symbiotic bacteria</dc:subject>
	<dc:subject xml:lang="en-US">Bacillus sp.</dc:subject>
	<dc:subject xml:lang="en-US">antibacterial activity</dc:subject>
	<dc:subject xml:lang="en-US">marine sponge</dc:subject>
	<dc:subject xml:lang="en-US">Haliclona fascigera</dc:subject>
	<dc:description xml:lang="en-US">Symbiotic bacteria are bacteria that live within a host tissue and do not harm the host itself. These bacteria can produce various bioactive compounds such as antibacterial compounds. This study aimed to isolate the antibiotic compounds from ethyl acetate extract of symbiotic bacteria Bacillus sp.1 (HA1) of marine sponge Haliclona fascigera. Bacterial cultivation was performed on Nutrient Broth medium using incubator shaker at 150 rpm at 37ÂºC for 24 hours. The isolation of antibiotic compound was done by column chromatography method and testing of antibacterial activity was conducted by agar diffusion method. The study revealed 2 pure compounds W1 and W2. The compound W1 (10.8 mg) was soluble in the ethyl acetate and methanol but was difficult to dissolve in n-hexane. This compound could inhibit the growth of pathogenic bacteria Staphylococcus aureus ATCC 25923 with 1% of minimum inhibition concentration (MIC). While the compound W2 (2.3 mg) was soluble in dichloromethane and methanol but was difficult to dissolve in n-hexane. The W2 compound could not inhibit the growth of Staphylococcus aureus ATCC 25923.</dc:description>
	<dc:description xml:lang="id-ID">Bakteri simbion merupakan bakteri yang hidup dalam jaringan suatu host dan tidak merugikan host tersebut. Bakteri ini dapat menghasilkan berbagai senyawa bioaktif seperti antibakteri. Penelitian ini bertujuan untuk mengisolasi senyawa antibiotik dari ekstrak etil asetat bakteri Bacillus sp1 (HA1) yang bersimbiosis dengan spon laut Haliclona fascigera. Metoda yang digunakan yaitu kultivasi bakteri Â pada media Nutrient Broth menggunakan Incubator Shaker dengan kecepatan 150 RPM pada suhu 37ÂºC selama 24 jam. Isolasi senyawa antibakteri dilakukan dengan metoda kromatografi kolom dan pengujian aktivitas antibakteri dengan metode difusi agar. Dari penelitian yang telah dilakukan diperoleh 2 senyawa antibakteri W1 dan W2. Senyawa W1 (10,8 mg) larut dalam pelarut etil asetat dan metanol, tapi sukar larut dalam n-heksana. Senyawa ini dapat menghambat pertumbuhan bakteri patogen Staphylococcus aureus ATCC 25923 dengan Konsentrasi Hambat Minimum (KHM) 1%. Sedangkan senyawa W2 (2,3 mg) larut dalam diklorometana dan metanol, namun sukar larut dalam n-heksana. Senyawa W2 tidak dapat menghambat pertumbuhan Staphylococcus aureus ATCC 25923.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/138</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.138</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 128-133</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 128-133</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/138/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/139</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Activities of Red Spinach (Amaranthus tricolor L.) Ethanolic Extract in Steatosis Prevention: in Vivo Study</dc:title>
	<dc:title xml:lang="id-ID">Aktivitas Ekstrak Etanolik Bayam Merah (Amaranthus tricolor L.) Terstandar sebagai Upaya Preventif Steatosis: Studi in Vivo</dc:title>
	<dc:creator>Adhi Pradana, Dimas</dc:creator>
	<dc:creator>Dwiratna, Deasy Wulan</dc:creator>
	<dc:creator>Widyarini, Sitarina</dc:creator>
	<dc:subject xml:lang="id-ID">daun bayam merah</dc:subject>
	<dc:subject xml:lang="id-ID">perlemakan hati</dc:subject>
	<dc:subject xml:lang="id-ID">preventif</dc:subject>
	<dc:subject xml:lang="en-US">ALT</dc:subject>
	<dc:subject xml:lang="en-US">red spinach leaves</dc:subject>
	<dc:subject xml:lang="en-US">fatty liver</dc:subject>
	<dc:subject xml:lang="en-US">histopathological</dc:subject>
	<dc:subject xml:lang="en-US">preventive</dc:subject>
	<dc:description xml:lang="en-US">This study aimed to examine the activities of red spinach (Amaranthus tricolor L.) ethanolic extract in preventing steatosis by referring to ALT activities and liver histopathological parameters. Thirty male Sprague-Dawley rats were divided into 6 groups of normal, negative control, positive control (0.9 mg/kgBW simvastatin), treatment I (200 mg/kgBW extract), treatment II (400 mg/kgBW extract), and treatment III (800 mg/kgBW extract). From day 1 to day 67, apart from the normal and negative-control groups, all other groups were given preventive therapy, and high-fat, high-cholesterol diet was applied two hours after preventive therapy from day 8 to day 67. ALT parameters were determined on day 0 and 67. Histopathological changes in the liver were examined on day 68. One-way ANOVA was performed followed by post-hoc Tukey HSD test. The results indicated that the ethanolic extract of red spinach at doses of 200 mg/kgBW, 400 mg/kgBW and 800 mg/kgBW could maintain ALT levels at normal values. Histopathological image of the liver treated with ethanolic extract of red spinach at doses of 200 mg/kgBW, 400 mg/kgBW, and 800 mg/kgBW showed normal condition. These findings suggest that standardized ethanol extract of red spinach leaves has the potential to prevent steatosis.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan untuk mengetahui aktivitas ekstrak etanolik daun bayam (Amaranthus tricolor L.) terstandar sebagai upaya preventif steatosis berdasarkan aktivitas enzim ALT dan histopatologis hati. Hewan uji yang dipergunakan adalah tikus Sprague-Dawley jantan. Sebanyak 30 tikus dibagi ke dalam 6 kelompok yaitu kelompok normal, kontrol negatif, kontrol positif (simvastatin 0,9 mg/kgBB), perlakuan I (ekstrak bayam merah 200 mg/kgBB), perlakuan II (ekstrak bayam merah 400 mg/kgBB), dan perlakuan III (ekstrak bayam merah 800 mg/kgBB). Hari pertama sampai hari ke-67 seluruh kelompok kecuali kelompok normal dan kontrol negatif dilakukan pemberian terapi preventif, selanjutnya hari ke-8 sampai hari ke-67 dilakukan induksi diet tinggi lemak dua jam setelah pemberian terapi preventif. Penetapan kadar ALT dilakukan pada hari ke-0 dan 67. Pada hari ke-68 dilakukan pemeriksaan histopatologi hati. Analisis menggunakan One Way Anova yang dilanjutkan analisis Post-Hoc Tukey HSD. Hasil penelitian menunjukkan ekstrak etanolik daun bayam merah terstandar dosis 200 mg/kgBB, 400 mg/kgBB dan 800 mg/kgBB dapat mempertahankan kadar ALT dalam rentang normal dan memperlihatkan gambaran histopatologi hati yang normal. Disimpulkan bahwa ekstrak etanolik daun bayam merah terstandar berpotensi sebagai terapi preventif steatosis.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/139</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.139</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 120-127</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 120-127</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/139/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/140</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Preparation of amorphous solid dispersion of azithromycin dihydrate  with hydroxypropyl methylcellulose (HPMC)</dc:title>
	<dc:title xml:lang="id-ID">Pembentukan Sistem Dispersi Padat Amorf Azitromisin Dihidrat dengan Hikroksipropil Metilselulosa (HPMC)</dc:title>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:creator>Novitasari, Netty</dc:creator>
	<dc:creator>Octavia, Maria Dona</dc:creator>
	<dc:subject xml:lang="id-ID">azitromisin dihidrat</dc:subject>
	<dc:subject xml:lang="id-ID">hidroksipropil metilselulosa</dc:subject>
	<dc:subject xml:lang="id-ID">dispersi padat amorf</dc:subject>
	<dc:subject xml:lang="id-ID">laju disolusi</dc:subject>
	<dc:subject xml:lang="en-US">azithromycin dihidrate</dc:subject>
	<dc:subject xml:lang="en-US">hydroxypropyl methylcellulose</dc:subject>
	<dc:subject xml:lang="en-US">amorphous solid dispersion</dc:subject>
	<dc:subject xml:lang="en-US">dissolution rate.</dc:subject>
	<dc:description xml:lang="en-US">The aim of present study is to develop solid dispersion system of azithromycin dihydrate with hydroxypropyl methylcellulose E5 LV (HPMC) for improving the dissolution rate of azithromycin dihydrate. Amorphous solid dispersions were prepared by solvent method at 1:1; 1:2 and 2:1 (w/w) drug to polymer ratios. Solid state properties of amorphous solid dispersion were evaluated by X-ray powder diffraction (XRPD), scanning electron microscopy and spectroscopy FT-IR. Furthermore, the dissolution rate profile was investigated by type II USP dissolution apparatus. Based on X-ray powder diffractometry analysis, azithromycin dihydrate was transformed partially from the crystalline phase to the amorphous state as confirmed by significant reduction of the crystalline peaks intensity. FT-IR spectroscopy analysis revealed the absence of chemical interaction between azithromycin dihydrate and HPMC. The dissolution rate of azithromycin dihydrate from amorphous solid dispersion was substantially higher than azithromycin dihydrate intact and its physical mixture. The dissolution rate of azithromycin dihydrate increased with an increasing drug to polymer ratio.</dc:description>
	<dc:description xml:lang="id-ID">Tujuan penelitian ini untuk mengembangkan sistem dispersi padat azitromisin dihidrat dengan pembawa hidroksipropil metilselulosa E5 LV agar laju disolusi azitromisin dihidrat meningkat. Dispersi padat amorf dibuat dengan metode pelarutan pada perbandingan obat : polimer 1:1; 1:2 and 2:1. Sifat padatan dispersi padat amorf dievaluasi dengan analisa difraksi sinar-X, mikroskopik SEM dan spekroskopi FT-IR. Lebih lanjut, profil laju disolusi dilakukan dengan alat uji disolusi tipe II USP. Menurut analisa difraksi sinar-X, azitromisin dihidrat mengalami transformasi sebagian dari fase kristalin ke fase amorf, yang diindikasikan dengan penururan secara signifikan puncak-puncak difraksi pada difraktogram. Analisis spektroskopi FT-IR membuktikan tidak terjadi interaksi secara kimiawi antara obat dan pembawa. Laju disolusi azitromisin dihidrat dari sistem dispersi padat amorf lebih tinggi dibandingkan azitromisin dihidrat murni dan campuran fisika. Laju disolusi azitromisin dihidrat meningkat dengan peningkatan rasio obat : polimer.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/140</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.140</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 165-171</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 165-171</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/140/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/141</identifier>
				<datestamp>2019-06-30T21:25:04Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Thin layer chromatography (TLC) analysis and antihyperuricemic activity of bamboo shoots extract {Schizostachyum brachycladum Kurz (Kurz)} in male white mice</dc:title>
	<dc:title xml:lang="id-ID">Analisis Kromatografi Lapis Tipis (KLT) dan Aktivitas Antihiperurisemia Ekstrak Rebung Schizostachyum brachycladum Kurz (Kurz) pada Mencit Putih Jantan</dc:title>
	<dc:creator>Alen, Yohannes</dc:creator>
	<dc:creator>Agresa, Fitria Lavita</dc:creator>
	<dc:creator>Yuliandra, Yori</dc:creator>
	<dc:subject xml:lang="id-ID">Schizostachyum brachycladum</dc:subject>
	<dc:subject xml:lang="id-ID">TLC analysis</dc:subject>
	<dc:subject xml:lang="id-ID">uric acid</dc:subject>
	<dc:subject xml:lang="id-ID">antihyperuricemia.</dc:subject>
	<dc:subject xml:lang="en-US">bamboo shoots</dc:subject>
	<dc:subject xml:lang="en-US">Schizostachyum brachycladum</dc:subject>
	<dc:subject xml:lang="en-US">TLC analysis</dc:subject>
	<dc:subject xml:lang="en-US">uric acid</dc:subject>
	<dc:subject xml:lang="en-US">antihyperuricemia.</dc:subject>
	<dc:description xml:lang="en-US">Thin-layer chromatography (TLC) analysis of bamboo shoot extract (Schizostachyum brachycladum) and its antihyperuricemic activity evaluation on male mice have been conducted. The extraction was processed by the maceration method, while the determination of the compound was carried out by using various color reagents of TLC plate. To evaluate the antihyperuricemic activity of the extract, a total of 25 male mice were hyperuricemic-induced with daily chicken liver homogenates along with extract suspension at doses of 25, 50 and 100 mg/kg, allopurinol 10 mg/kg, and control group. Another group consisted of 5 mice was treated as the normal group. Serum uric acid level of mice was measured by using the spectrophotometer at the 8th day and analyzed with one-way ANOVA. The TLC analysis showed that the extract contained phenolic compounds and triterpenoids. The measurement of serum uric acid levels revealed that the extract at doses of 25, 50 and 100 mg/kg significantly decreased the uric acid levels of male white mice as compared with control (p&amp;lt;0.05). However, all doses did not show any significant difference in reducing the uric acid level (p&amp;gt;0.05). The study concluded that bamboo shoot extract exhibited antihyperuricemic activity. The effect was seen even at the lowest dose evaluated.Â </dc:description>
	<dc:description xml:lang="id-ID">Ekstraksi dan analisis KLT dari ekstrak rebung Schizostachyum brachycladum Kurz (Kurz), serta uji aktivitas antihiperurisemia pada mencit putih jantan telah dilakukan. Proses ekstraksi dilakukan dengan cara maserasi. Penentuan golongan senyawa dilakukan dengan berbagai reagen warna pada plat KLT. Pengukuran kadar asam urat dilakukan pada hari ke-8 setelah pemberian dosis harian homogenat hati ayam sebagai penginduksi asam urat bersamaan dengan suspensi ekstrak pada dosis 25, 50 dan 100 mg/kg dan allopurinol sebagai pembanding. Kadar asam urat serum mencit putih jantan diukur dengan menggunakan spektrofotometer. Hasil pengukuran memperlihatkan pemberian ekstrak rebung dengan dosis 25, 50 dan 100 mg/kgBB dapat menurunkan kadar asam urat mencit putih jantan dan berbeda secara signifkan dibandingkan dengan kontrol (p&amp;lt;0,05). Ketiga dosis ekstrak tidak memperlihatkan perbedaan yang nyata dalam menurunkan kadar asam urat (p&amp;gt;0,05). Penelitian ini menyimpulkan bahwa ekstrak rebung memiliki aktivitas antihiperurisemia.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-05-29</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/141</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.3.2.141</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 3 No. 2 (2017); 146-152</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 3 No 2 (2017): J Sains Farm Klin 3(2), Mei 2017; 146-152</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/141/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/144</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Effectiveness of antibiotics in patients with diabetic foot ulcers</dc:title>
	<dc:title xml:lang="id-ID">Efektifitas Antibiotik pada Pasien Ulkus Kaki Diabetik</dc:title>
	<dc:creator>Agistia, Nesa</dc:creator>
	<dc:creator>Mukhtar, Husni</dc:creator>
	<dc:creator>Nasif, Hansen</dc:creator>
	<dc:subject xml:lang="id-ID">infeksi</dc:subject>
	<dc:subject xml:lang="id-ID">kaki diabetes</dc:subject>
	<dc:subject xml:lang="id-ID">ulkus</dc:subject>
	<dc:subject xml:lang="id-ID">antibiotik</dc:subject>
	<dc:subject xml:lang="id-ID">efektifitas.</dc:subject>
	<dc:subject xml:lang="en-US">infection</dc:subject>
	<dc:subject xml:lang="en-US">diabetic foot</dc:subject>
	<dc:subject xml:lang="en-US">ulcers</dc:subject>
	<dc:subject xml:lang="en-US">antibiotics</dc:subject>
	<dc:subject xml:lang="en-US">effectiveness.</dc:subject>
	<dc:description xml:lang="en-US">Patients with diabetic foot infection require antibiotics. Generally, antibiotics may have low sensitivity and some bacteria have been resistance to antibiotics. Currently, evaluating the effectiveness of antibiotics is necessary to avoid antibiotic resistance. This study has been conducted using the longitudinal method and prospective sampling technique. Observed parameters were leukocyte, signs of infection and fever after using antibiotics. The data collected were then analyzed to determine the effectiveness of antibiotics based on supporting literature. A number of 19 out of 28 samples of patients with diabetic foot ulcer met the criteria, consisting of 63.16% and 36.84% of male and female patients, respectively. Most of the patients (68,42%) were aged 45-60 years old living with diabetes for more than 10 years. The antimicrobial therapy were given empirically in 8 patients (42,10%) and based on microbial sensitivity (definitive) in 11 patients (57,89%). The use of antibiotics was effective in 15 patients (78,94%) marked by the leukocyte count, signs of infection and fever parameters after 2-3 days using antibiotics. The optimum therapeutic outcome was achieved in 7 to 21 days.</dc:description>
	<dc:description xml:lang="id-ID">Pasien Infeksi ulkus kaki diabetik memerlukan penggunaan antibiotik, antibiotik yang sering digunakan mempunyai sensitifitas rendah dan beberapa pasien pada penggunaannya dalam keadaan resistensi, evaluasi efektifitas antibiotik perlu dilakukan untuk mengatasi masalah penggunaan antibiotik saat ini. Penelitian ini dilakukan dengan studi longitudinal dan teknik pengambilan sampel secara prospektif. Paramater yang diamati adalah keadaan leukosit, tanda infeksi dan demam seteleh pemberian antibiotik. Data yang terkumpul kemudian dianalisis secara deskriptif untuk menentukan efektifitas antibiotik berdasarkan literatur yang mendukung. Hasil perolehan sampel pada penelitian ini adalah sebanyak 19 sampel pasien infeksi ulkus kaki diabetik yang memenuhi kriteria dari 28 orang populasi terdiri dari 63,16% pasien laki-laki dan 36,84% pasien perempuan, 68,42 % usia 45-60 tahun dan lama diabetes terbanyak adalah &amp;gt; 10 tahun. Hasil evaluasi efektifitas antibiotik yaitu ditemukan 8 orang pasien yang menggunakan antibiotik secara dugaan (empiris) dan 11 orang pasien menggunakan antibiotik berdasarkan sensitifitas (definitif). Antibiotik efektif pada 15 orang subjek penelitian yaitu dapat memberikan respon pada leukosit, tanda infeksi dan parameter demam seteleh pemberian antibiotik 2-3 hari dan hasil terapi maksimal pada hari ke 7 sampai 21.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/144</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.144</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 43-48</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 43-48</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/144/pdf</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/144/378</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/146</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Isolation and characterization of antibacterial compounds of ethyl acetate fraction of  bacteria Bacillus sp.3 (a1) that symbiotic with marine sponge Haliclona fascigera</dc:title>
	<dc:title xml:lang="id-ID">Isolasi dan Karakterisasi Senyawa Antibakteri dari Fraksi  Etil Asetat Bakteri Bacillus sp.3 (A1) yang Bersimbiosis  dengan Spon Laut Haliclona fascigera</dc:title>
	<dc:creator>Handayani, Dian</dc:creator>
	<dc:creator>Putra, Rafky</dc:creator>
	<dc:creator>Ismed, Friardi</dc:creator>
	<dc:subject xml:lang="id-ID">Bakteri simbion</dc:subject>
	<dc:subject xml:lang="id-ID">Bacillus sp.</dc:subject>
	<dc:subject xml:lang="id-ID">aktivitas antibakteri</dc:subject>
	<dc:subject xml:lang="id-ID">spon laut</dc:subject>
	<dc:subject xml:lang="id-ID">Haliclona fascigera</dc:subject>
	<dc:subject xml:lang="en-US">symbiotic bacteria</dc:subject>
	<dc:subject xml:lang="en-US">Bacillus sp.</dc:subject>
	<dc:subject xml:lang="en-US">antibacterial activity</dc:subject>
	<dc:subject xml:lang="en-US">marine sponge</dc:subject>
	<dc:subject xml:lang="en-US">Haliclona fascigera</dc:subject>
	<dc:description xml:lang="en-US">Bacillus sp. 3 is one of symbiotic bacteria of marine sponge Haliclona fascigera obtained from Mandeh Island, Pesisir Selatan, West Sumatra that can produce antibacterial compounds. This study aims to isolate the antibacterial compounds produced by Bacillus sp.3 (A1). The methods that has been used were bacterial cultivation on Nutrient Broth medium using Shaker Incubator at 150 RPM at 37ÂºC for 48 hours and isolation of antibacterial compound. The isolation method of the compound was carried out by column chromatography method. The testing of antibacterial activity was done by using agar diffusion method. Characterization of isolated compounds were performed using UV and IR spectrophotometer. From this research, two compounds RJ1 and RJ2 were obtained. The compound RJ1 was yellow oily (2.8 mg). The compound RJ1 can inhibit Staphylococcus aureus ATCC 25923 at a 1% of Minimum Inhibition Concentration (KHM). RJ2 compound was yellow oily (3.1 mg). The RJ2 compound can inhibit Escherichia coli ATCC 25922 at a 1% of Minimum Inhibition Concentration (MIC).</dc:description>
	<dc:description xml:lang="id-ID">Bacillus sp. 3 (A1) merupakan salah satu isolat bakteri simbion spon laut Haliclona fascigera asal Pulau Mandeh, Pesisir Selatan, Sumatra Barat yang dapat memproduksi senyawa antibakteri. Penelitian ini bertujuan untuk mengisolasi senyawa aktif sebagai antibakteri yang dihasilkan oleh Bacillus sp.3 (A1). Metoda yang digunakan yaitu kultivasi bakteri pada media Nutrient Broth menggunakan Inkubator Shaker dengan kecepatan 150 RPM pada suhu 37ÂºC selama 48 jam dan isolasi senyawa antibakteri. Metode pemisahan senyawa dilakukan dengan metoda kromatografi kolom. Pengujian aktivitas antibakteri dlakukan dengan metoda difusi agar. Karakterisasi senyawa hasil isolasi dilakukan dengan menggunakan spektrofotometer UV dan spektrometer IR. Dari penelitian ini didapatkan dua senyawa RJ1 dan RJ2. Senyawa RJ1 berupa minyak berwarna kuning (2,8 mg). Senyawa RJ1 dapat menghambat bakteri uji Staphylococcus aureus ATCC 25923 pada Konsentrasi Hambat Minimum 1%. Senyawa RJ2 berupa minyak berwarna kuning (3.1 mg). Senyawa RJ2 dapat menghambat bakteri uji Escherichia coli ATCC 25922 pada Konsentrasi Hambat Minimum 1%.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/146</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.146</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 24-29</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 24-29</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/146/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/147</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Optimal cultivation time and antibacterial activity from ethyl acetate extracts of  symbiont fungi Aspergillus unguis (WR8) with Haliclona fascigera</dc:title>
	<dc:title xml:lang="id-ID">Waktu Kultivasi Optimal dan Aktivitas Antibakteri  dari Ekstrak Etil Asetat Jamur Simbion  Aspergillus unguis (WR8) dengan Haliclona fascigera</dc:title>
	<dc:creator>Rendowaty, Agnes</dc:creator>
	<dc:creator>Djamaan, Akmal</dc:creator>
	<dc:creator>Handayani, Dian</dc:creator>
	<dc:subject xml:lang="id-ID">jamur simbion</dc:subject>
	<dc:subject xml:lang="id-ID">Aspergillus unguis</dc:subject>
	<dc:subject xml:lang="id-ID">waktu kultivasi</dc:subject>
	<dc:subject xml:lang="id-ID">aktivitas antibakteri</dc:subject>
	<dc:subject xml:lang="id-ID">Haliclona fascigera.</dc:subject>
	<dc:subject xml:lang="en-US">symbiont fungi</dc:subject>
	<dc:subject xml:lang="en-US">Aspergillus unguis</dc:subject>
	<dc:subject xml:lang="en-US">cultivation time</dc:subject>
	<dc:subject xml:lang="en-US">antibacterial activity</dc:subject>
	<dc:subject xml:lang="en-US">Haliclona fascigera.</dc:subject>
	<dc:description xml:lang="en-US">The optimal cultivation time of symbiont fungi Aspergillus unguis (WR8) with marine sponge Haliclona fascigera and antibacterial activity assay from the ethyl acetate extracts symbiont fungi A. unguis (WR8) have been determined. The fungi was cultivated on Sabaoraud Dextrose Broth medium in both static condition and using shaker incubator at 120 RPM at 25-28oC. Optimal cultivation time was determined by the amount of dry biomass mycelium fungi per unit of time. Liquid medium was extracted with ethyl acetate and used for antibacterial activity assay using agar diffusion method against Staphylococcus aureus. The study showed that the optimal cultivation time of symbiont fungi A. unguis (WR8) in static condition was achieved on day 21 while the extract (5 % w/v) inhibited bacterial growth of S. aureus with an inhibition zone of 21 mm. Meanwhile, The optimal cultivation time in the shaker was achieved on day 14 and the inhibition zone of the extract was 11 mm. The study concludes that the optimal cultivation time for production of antibacterial compounds by symbiont fungi A. unguis (WR8) was obtained at 21 days in static condition.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian tentang penentuan waktu optimal pertumbuhan jamur simbion Aspergillus unguis (WR8) dan pengujian aktivitas antibakteri telah dilakukan. Kultivasi jamur dilakukan dengan menggunakan media Sabaoraud Dextrose Broth (SDB) dalam keadaan statis dan di-shaker (120 rpm) pada suhu 25-28oC. Pertumbuhan jamur secara optimal ditentukan berdasarkan jumlah biomassa kering miselia jamur per satuan waktu. Media cair diekstraksi dengan pelarut etil asetat, ekstrak etil asetat selanjutnya digunakan untuk pengujian aktivitas antibakteri menggunakan metode difusi agar terhadap bakteri Staphylococcus aureus. Hasil penelitian menunjukkan bahwa waktu optimal pertumbuhan jamur simbion tersebut dalam keadaan statis adalah pada hari ke-21 dan diameter hambat ekstrak (5 %b/v) adalah 21 mm. Sedangkan waktu optimal pertumbuhan jamur yang di shaker adalah pada hari ke-14 dan diameter hambat ekstrak sebesar 11 mm. Dapat disimpulkan waktu kultivasi optimal untuk menghasilkan senyawa antibakteri dari jamur A. unguis (WR8) adalah selama 21 hari secara statis menggunakan media cair.Â Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/147</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.147</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 49-54</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 49-54</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/147/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/155</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Optimization of levofloxacin tablet containing PVP K-30 and Vivasol</dc:title>
	<dc:title xml:lang="id-ID">Optimasi Tablet Levofloksasin yang Mengandung Bahan Pengikat PVP K-30 dan Disintegran Vivasol</dc:title>
	<dc:creator>Fatmawati, Dina Ayu</dc:creator>
	<dc:creator>Widjaja, Bambang</dc:creator>
	<dc:creator>Setyawan, Dwi</dc:creator>
	<dc:subject xml:lang="id-ID">levofloksasin</dc:subject>
	<dc:subject xml:lang="id-ID">PVP K-30</dc:subject>
	<dc:subject xml:lang="id-ID">vivasol</dc:subject>
	<dc:subject xml:lang="id-ID">granulasi basah</dc:subject>
	<dc:subject xml:lang="id-ID">desain faktorial.</dc:subject>
	<dc:subject xml:lang="en-US">levofloxacin</dc:subject>
	<dc:subject xml:lang="en-US">PVP K-30</dc:subject>
	<dc:subject xml:lang="en-US">vivasol</dc:subject>
	<dc:subject xml:lang="en-US">wet granulation</dc:subject>
	<dc:subject xml:lang="en-US">factorial design.</dc:subject>
	<dc:description xml:lang="en-US">The aim of this research was to get optimal formula of levofloxacin tablet prepared with variation of PVP K-30 as binder and vivasol as disintegrant. The making of levofloxacin tablets was done by wet granulation. Tablet was prepared with various levels of PVP K-30 and disintegrant vivasol, compressed using a hydraulic press with 12 mm punch diameter, for 3 seconds. Physical quality (hardness, friability, and disintegration time) and dissolution rate of tablet was evaluated. The optimization of the formula was done by factorial design of 22 factorial experiments with 2 factors (PVP K-30 and vivasol) and 2 levels (2% and 4%). Optimization results showed that elevated levels of PVP K-30 increased tablet hardness, reduced friability of tablet, decreased disintegrating time, and increased dissolution rate of levofloxacin tablets. Meanwhile, elevated levels of vivasol increased the hardness of tablets, decreased the disintegrating time of tablets, decreased the dissolution rate of levofloxacin tablets, but did not affect the friability of tablets. In conclusion, the optimal tablet that meet the specifications of physical quality (hardness, friability, and disintegrating time) and dissolution rate was made by 2.4 to 3.7% of PVP K-30 and 2.0 to 3.2% vivasol as shown in the feasible area of design space.</dc:description>
	<dc:description xml:lang="id-ID">Penelitian ini bertujuan mendapatkan formula yang optimal tablet levofloksasin yang dibuat dengan variasi PVP K-30 sebagai pengikat dan vivasol sebagai disintegran. Metode pembuatan tablet levofloksasin dilakukan secara granulasi basah. Formula tablet dibuat dengan variasi PVP K-30 dan disintegran vivasol, dikempa menggunakan alat hidrolik press dengan puch diameter 12 mm, selama 3 detik. Evaluasi mutu fisik (kekerasan, kerapuhan, dan waktu hancur) dan laju disolusi tablet. Optimasi formula dilakukan dengan desain faktorial 22 yaitu eksperimen faktorial dengan 2 faktor (PVP K-30 dan vivasol) dan 2 level (2% dan 4%). Hasil optimasi menunjukkan bahwa peningkatan kadar PVP K-30 meningkatkan kekerasan tablet, menurunkan kerapuhan tablet, dan menurunkan waktu hancur tablet, serta meningkatkan laju disolusi dari tablet levofloksasin. Peningkatan kadar vivasol meningkatkan kekerasan tablet, tidak mempengaruhi kerapuhan tablet, dan menurunkan waktu hancur tablet, serta menurunkan laju disolusi tablet levofloksasin. Kesimpulan penelitian ini menunjukkan bahwa tablet yang optimal serta memenuhi spesifikasi dari mutu fisik (kekerasan, kerapuhan, dan waktu hancur) dan laju disolusi ditunjukkan pada daerah feasible dari design space yaitu kadar PVP K-30 antara 2,4 sampai 3,7 % dan kadar vivasol 2,0 sampai 3,2%.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/155</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.155</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 9-15</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 9-15</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/155/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/168</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Formulation and characterization SNE (self nanoemulsion) of astaxanthin  from Haematococcus pluvialis as natural super antioxidant</dc:title>
	<dc:title xml:lang="id-ID">Formulasi dan Karakterisasi SNE (Self Nanoemulsion) Astaxanthin dari Haematococcus pluvialis sebagai Super Antioksidan Alami</dc:title>
	<dc:creator>Nurdianti, Lusi</dc:creator>
	<dc:creator>Aryani, Ratih</dc:creator>
	<dc:creator>Indra, Indra</dc:creator>
	<dc:subject xml:lang="id-ID">astaxanthin</dc:subject>
	<dc:subject xml:lang="id-ID">karotenoid xantofil</dc:subject>
	<dc:subject xml:lang="id-ID">bioavailabilitas</dc:subject>
	<dc:subject xml:lang="id-ID">nanoemulsi spontan.</dc:subject>
	<dc:subject xml:lang="en-US">astaxanthin</dc:subject>
	<dc:subject xml:lang="en-US">xanthophyll carotenoid</dc:subject>
	<dc:subject xml:lang="en-US">bioavailability</dc:subject>
	<dc:subject xml:lang="en-US">self nanoemulsion.</dc:subject>
	<dc:description xml:lang="en-US">Astaxanthin is a group of fat-soluble xanthophyll carotenoid found in many microorganisms and marine animals. The problem that exists in its use as active compound of antioxidants is due to lipophilicity and poor stability in the gastrointestinal tract thereby making low bioavailability. In this research offers the nanotechnology to develop astaxanthin nanoemulsion which is intended to improve the stability in the dosage form and also further developing new delivery paths in the use of antioxidants through transdermal delivery route so it has the optimal deliveries. In this research will be made nanoemulsion astaxanthin formulation to produce good physical and chemical characteristics. Nanoemulsion were prepared by using the self-nanoemulsifying (SNE) method. Optimizations of formula were performed ranging from oil phase screening, surfactant type screening, and optimization of ratio of oil phase : surfactant : co-surfactant. Characterization of nanoemulsion were carried out by physical characterizations including globul size and polydispersity index, zeta potential, visual appearance, and globul morphology. Chemical Characterization included the entrapment efficiency test. The results showed that the nanoemulsion Astaxanthin has a 10-20 nm globul size (with normal size distribution curve), the polydispersity index value is less than 0.5, the zeta potential is greater than (-20) mV, the entrapment efficiency is between 80-87%, and has spherical globules form.</dc:description>
	<dc:description xml:lang="id-ID">Astaxanthin merupakan kelompok karotenoid xantofil larut lemak yang banyak ditemukan pada berbagai mikroorganisme dan hewan laut. Permasalahan yang terdapat di dalam pengunaannya sebagai bahan aktif sumber antioksidan adalah karena lipofilisitasnya dan stabilitas astaxanthin yang rendah di dalam saluran cerna sehingga membuat ketersediaan hayati yang rendah. Di dalam penelitian ini menawarkan teknologi nano untuk mengembangkan nanoemulsi astaxanthin yang ditujukan untuk meningkatkan stabilitas astaxanthin di dalam sediaan dan juga kedepannya untuk mengembangkan jalur penghantaran baru dalam pemakaian antioksidan yakni melalui rute transdermal sehingga ditujukan agar penggunaan astaxanthin dapat optimal. Di dalam penelitian ini akan dibuat formulasi nanoemulsi astaxanthin untuk menghasilkan karakteristik fisik dan kimia yang baik. Nanoemulsi dibuat dengan menggunakan metode Nanoemulsi spontan (SNE). Dilakukan optimasi formula mulai dari skrining fase minyak, skrining jenis surfaktan, dan optimasi rasio fase minyak:surfaktan:kosurfaktan. Karakterisasi nanoemulsi berupa karakterisasi secara fisik meliputi ukuran globul dan indeks polidispersitas, potensial zeta, tampilan visual, dan morfologi globul. Karakterisasi secara kimia meliputi uji efisiensi penjeratan. Hasil penelitian menunjukkan nanoemulsi Astaxanthin yang dikembangkan memiliki ukuran globul 10-20 nm (dengan kurva distribusi ukuran globul normal), nilai indeks polidispersitas kurang dari 0.5, potensial zeta lebih besar dari (-20) mV, dan efisiensi penjeratan berkisar antara 80-87% serta morfologi globul yang berbentuk sferis.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>image/jpeg</dc:format>
	<dc:format>image/jpeg</dc:format>
	<dc:format>image/jpeg</dc:format>
	<dc:format>image/x-ms-bmp</dc:format>
	<dc:format>image/x-ms-bmp</dc:format>
	<dc:format>image/x-ms-bmp</dc:format>
	<dc:format>image/x-ms-bmp</dc:format>
	<dc:format>image/x-ms-bmp</dc:format>
	<dc:format>image/x-ms-bmp</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.168</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 36-42</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 36-42</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/pdf</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/379</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/380</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/381</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/382</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/383</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/384</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/385</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/386</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/387</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/388</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/389</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/390</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/391</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/392</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/168/393</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/169</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Off-label drug use for children at community pharmacies in Yogyakarta, Indonesia</dc:title>
	<dc:title xml:lang="id-ID">Penggunaan Obat Off-Label pada Anak  di Apotek Kota Yogyakarta</dc:title>
	<dc:creator>Setyaningrum, Ndaru</dc:creator>
	<dc:creator>Gredynadita, Viara</dc:creator>
	<dc:creator>Gartina, Suci</dc:creator>
	<dc:subject xml:lang="id-ID">obat off-label</dc:subject>
	<dc:subject xml:lang="id-ID">anak</dc:subject>
	<dc:subject xml:lang="id-ID">apotek</dc:subject>
	<dc:subject xml:lang="id-ID">peresepan</dc:subject>
	<dc:subject xml:lang="id-ID">Yogyakarta</dc:subject>
	<dc:subject xml:lang="en-US">off-label drugs</dc:subject>
	<dc:subject xml:lang="en-US">children</dc:subject>
	<dc:subject xml:lang="en-US">pharmacy</dc:subject>
	<dc:subject xml:lang="en-US">community</dc:subject>
	<dc:subject xml:lang="en-US">prescription</dc:subject>
	<dc:subject xml:lang="en-US">Yogyakarta</dc:subject>
	<dc:description xml:lang="en-US">Population of children is at risk of getting off-label medication because of its particular condition. This study was conducted to find out how the prevalence of off-label drug use for children at community pharmacies in Yogyakarta. This was a retrospective, medical record-based study using the 2014-2015. The study subjects consisted of children under 12 years old. About 828 prescriptions were reviewed, 268 were included accord with completeness diagnose data in patients medical records. The accumulative of drug use among 268 prescriptions were 816 drugs use with 76 item drugs. We have identified 268 prescriptions, of those 268 prescriptions, we found off label drugs in 57 prescriptions (21%). identified, off-label use accounted for 57 prescriptions (21%). The prevalence of off-label use classified as off-label age accounted for 91 use (11.1%); off-label indications accounted for 7 use (0.8%); and did not find off-label category dosage, route of administration and contraindication. The three highest use off-label drugs respectively pseudoephedrine accounted for 47 (5.7%), tripolidine 20 (2.4%), and dextromethorphan 14 (1.7%) of all drug use. Based on the results of this study, we found that the use of off-label drugs in children is quite high (21%) so that supervision-related risks of drug use need to be done.</dc:description>
	<dc:description xml:lang="id-ID">Populasi anak sangat berisiko mendapatkan peresepan obat off-label disebabkan kekhususan kondisinya. Penelitian ini dilakukan untuk mengetahui bagaimana prevalensi penggunaan obat off-label pada anak di apotek kota Yogyakarta. Penelitian dilakukan secara retrospektif dengan pengambilan data berdasarkan rekam medis anak tahun 2014 â€“ 2015. Subjek penelitian merupakan anak dengan batasan usia di bawah 12 tahun. Total peresepan anak selama periode penelitian sebanyak 828 rekam medis diantaranya sejumlah 268 peresepan memenuhi kriteria inklusi dengan kelengkapan data diagnosa pada catatan medis pasien. Total penggunaan obat dari 268 peresepan adalah 816 obat dengan 76 jenis obat. Berdasarkan review dari 268 peresepan, ditemukan sejumlah 57 (21%) peresepan off-label. Prevalensi penggunaan obat off-label diklasifikasikan sebagai off-label usia sejumlah 91 (11,1%) penggunaan, off-label indikasi sejumlah 7 (0,8%), dan tidak ditemukan off-label obat kategori dosis, rute pemberian dan kontraindikasi. Jenis obat paling dominan digunakan secara off-label antara lain pseudoefedrin sejumlah 47(5,7%), tripolidin 20 (2,4%) dan dekstrometorfan 14 (1,7%) dari total penggunaan obat. Berdasarkan hasil penelitian ini diketahui bahwa penggunaan obat off-label pada anak cukup tinggi (21%) sehingga pengawasan terkait risiko penggunaan obat perlu dilakukan.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/169</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.169</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 30-35</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 30-35</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/169/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/172</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Gel formulation of edible birdâ€™s nest (Aerodramus fushipagus)  and evaluation of wound healing activity on second-degree burns in mice</dc:title>
	<dc:title xml:lang="id-ID">Formulasi Gel Sarang Burung Walet Putih  (Aerodramus fushipagus) dan Uji Penyembuhan Luka Bakar Derajat II pada Mencit</dc:title>
	<dc:creator>Anggraini, Deni</dc:creator>
	<dc:creator>Kasmawati, Lisa Yunus</dc:creator>
	<dc:subject xml:lang="id-ID">Luka bakar</dc:subject>
	<dc:subject xml:lang="id-ID">penyembuhan luka</dc:subject>
	<dc:subject xml:lang="id-ID">sarang burung walet</dc:subject>
	<dc:subject xml:lang="id-ID">gel.</dc:subject>
	<dc:subject xml:lang="en-US">burns</dc:subject>
	<dc:subject xml:lang="en-US">wound healing</dc:subject>
	<dc:subject xml:lang="en-US">edible birdâ€™s nest</dc:subject>
	<dc:subject xml:lang="en-US">gel.</dc:subject>
	<dc:description xml:lang="en-US">The gel formulation from Edible Birdâ€™s Nest (Aerodramus fushipagus) and evaluation of wound healing activity in mice (Mus musculus) has been done. This study aimed to determine the effectiveness of gel formulation from Edible Birdâ€™s Nest with concentrations of 10%, 20% and 30% for second-degree burns in mice. A number of 15 mice were grouped into 5: negative control (base gel), positive control (B), and groups receiving gel formulation in concentrations of 10%, 20%, and 30%. Burns was induced on the back of the mice with 2 cm diameter by using hot metal. The diameter of burns was measured every day for 21 days. Data were analyzed by using two-way ANOVA. The evaluation results show all formulas were homogeneous, stable to temperature and not irritating to the skin. The results showed that the percentage of burn healing between formulations and control were significantly different. The study concludes that all formulas exhibit a wound healing activity as compared with control.</dc:description>
	<dc:description xml:lang="id-ID">Formulasi gel sarang burung walet putih (Aerodramus fushipagus) dan uji penyembuhan luka bakar derajat II pada mencit putih (Mus musculus) jantan telah dilakukan. Penelitian ini bertujuan untuk memformulasikan sediaan gel dari bahan aktif sarang burung walet putih dengan konsentrasi 10%, 20% dan 30% dan melihat efek penyembuhan luka bakar pada kulit mencit. Uji penyembuhan luka bakar dilakukan terhadap 15 ekor mencit putih jantan yang dibagi menjadi 5 kelompok perlakuan yaitu, kontrol negatif (basis gel), kontrol positif dan kelompok perlakuan formula 10%, 20% dan 30%. Luka bakar diinduksi pada bagian punggung dengan diameter 2 cm dengan menggunakan logam panas. Hewan diberi perlakuan dan diameter luka diukur setiap hari selama 21 hari. Hasil evaluasi terhadap gel menunjukkan semua formula homogen, stabil terhadap suhu dan tidak mengiritasi kulit. Uji statistik ANOVA dua arah terhadap persentase penyembuhan luka bakar menunjukkan bahwa terdapat perbedaan yang signifikan antara penyembuhan luka bakar pada kelompok perlakuan dengan kelompok kontrol. Penelitian ini menyimpulkan bahwa ketiga formula memberikan efek penyembuhan luka bakar yang lebih baik dibandingkan kontrol.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:format>application/msword</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/172</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.172</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 55-60</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 55-60</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/172/pdf</dc:relation>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/172/394</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/173</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Antiretroviral Therapy on HIV/AIDS Patients in Dr. M. Djamil Hospital Padang: Socio-demographic Profile and Drug Evaluation</dc:title>
	<dc:title xml:lang="id-ID">Terapi Antiretroviral pada Pasien HIV/AIDS di RSUP. Dr. M. Djamil Padang: Kajian Sosiodemografi dan Evaluasi Obat</dc:title>
	<dc:creator>Yuliandra, Yori</dc:creator>
	<dc:creator>Nosa, Ulfa Syafli</dc:creator>
	<dc:creator>Raveinal, Raveinal</dc:creator>
	<dc:creator>Almasdy, Dedy</dc:creator>
	<dc:subject xml:lang="id-ID">AIDS</dc:subject>
	<dc:subject xml:lang="id-ID">antiretroviral</dc:subject>
	<dc:subject xml:lang="id-ID">evaluasi obat</dc:subject>
	<dc:subject xml:lang="id-ID">HIV</dc:subject>
	<dc:subject xml:lang="id-ID">sosiodemografi</dc:subject>
	<dc:subject xml:lang="en-US">AIDS</dc:subject>
	<dc:subject xml:lang="en-US">antiretroviral</dc:subject>
	<dc:subject xml:lang="en-US">drug evaluation</dc:subject>
	<dc:subject xml:lang="en-US">HIV</dc:subject>
	<dc:subject xml:lang="en-US">socio-demographic</dc:subject>
	<dc:description xml:lang="en-US">The objective of this study was to explore the socio-demographic characteristics of HIV/AIDS patients and to evaluate the appropriateness of antiretroviral drugs use. The study was a descriptive-evaluative with quantitative and qualitative methods using retrospective data within 2015 from Dr. M. Djamil Hospital, Padang, West Sumatra, Indonesia. Medical records of HIV/AIDS patients in both sexes aged 18-65 were included. The socio-demographic profiles were examined, while the appropriateness of drug use was evaluated and compared with standard treatment of the hospital. A number of 89 out of 136 medical records were included, with 76,40% men counted. Patients were mostly at the age range of 26-35 years old (41.57%), dominated with married men/women (58.43%) and those who were senior high school-graduated (56.18%). Private employees and housewife were among the highest percentage (19.10% each). The transmission of the disease was mostly acquired through sexual intercourse (61.80%), mostly with sex workers (38.33%). Evaluation on the drug use showed that the antiretroviral drugs were used in 100% of appropriateness of indication and dose, while only 97.76% of the patients received appropriate drug selection. The study also revealed that 10.11% of the patients had potential drug interaction. The antiretroviral treatment requires the appropriate drug selection to improve the efficacy. Clinical pharmacists are encouraged to participate in the antiretroviral therapy for HIV/AIDS patients..</dc:description>
	<dc:description xml:lang="id-ID">Tujuan dari penelitian ini adalah untuk mengkaji karakteristik sosiodemografi pasien HIV/AIDS dan mengevaluasi penggunaan obat antiretroviral pada pasien tersebut. Penelitian ini bersifat deskriptif-evaluatif dengan metode kuantitatif dan kualitatif dengan menggunakan data retrospektif pada tahun 2015 di RSUP Dr. M. Djamil Padang. Data diperoleh dari rekam medik dengan kriteria: pasien HIV/AIDS laki-laki dan perempuan; berusia 18-65 tahun; dan menggunakan obat antiretroviral. Profil sosiodemografi dianalisis sercara deskriptif, sementara kesesuaian penggunaan obat dievaluasi dan dibandingkan dengan standar pengobatan. Dari 136 rekam medik pasien yang diambil, 89 diantaranya memenuhi kriteria, dimana 76,40% merupakan pasien laki-laki. Pasien kebanyakan berusia antara 26-35 tahun (41,57%), didominasi oleh pasien yang menikah (58,43%) dan mereka yang berpendidikan SMA (56,18%). Pegawai swasta dan ibu rumah tangga merupakan jenis pekerjaanÂ  dengan persentase tertinggi (masing-masing 19,10%). Penyakit ini sebagian besar diperoleh melalui hubungan seksual (61,80%) dengan PSK (Pekerja Seks Komersial) sebagai partner seks yang paling dominan (38,33%). Evaluasi penggunaan obat menunjukkan bahwa obat antiretroviral digunakan dengan 100% kesesuaian indikasi dan dosis, sementara hanya 97,76% pasien yang menerima pemberian obat yang sesuai. Studi tersebut juga mengungkapkan bahwa 10,11% pasien memiliki potensi terjadinya interaksi obat. Pengobatan antiretroviral memerlukan pemilihan obat yang tepat untuk meningkatkan efikasi. Apoteker dianjurkan untuk ikut berpartisipasi dalam pengobatan pasien HIV/AIDS.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/173</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.173</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 1-8</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 1-8</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/173/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/174</identifier>
				<datestamp>2019-06-30T21:21:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="id-ID">Optimasi Formula Lotion Tabir Surya Ekstrak Kulit Buah Naga Super Merah (Hylocereus costaricensis) Menggunakan Metode Desain D-Optimal</dc:title>
	<dc:creator>Daud, Nur Saadah</dc:creator>
	<dc:creator>Musdalipah, Musdalipah</dc:creator>
	<dc:creator>Idayati, Idayati</dc:creator>
	<dc:subject xml:lang="id-ID">lotion</dc:subject>
	<dc:subject xml:lang="id-ID">buah naga super merah</dc:subject>
	<dc:subject xml:lang="id-ID">natrium alginat</dc:subject>
	<dc:subject xml:lang="id-ID">D-optimal</dc:subject>
	<dc:description xml:lang="id-ID">Paparan sinar matahari yang berlebihan dan berlangsung lama dapat menyebabkan eritema dan kulit terbakar, penuaan dini dan kanker kulit. Salah satu bentuk sediaan kosmetik yang dapat digunakan untuk melindungi kulit adalah lotion yang mengandung zat aktif tabir surya. Ekstrak kulit buah naga super merah adalah bahan alam yang memiliki efek antioksidan dan tabir surya.Optimasi formula lotion tabir surya dilakukan menggunakan metode D-Optimal dengan 2 faktor yaitu ekstrak kulit buah naga super merah sebagai bahan aktif dengan range konsentrasi 9-12% dan natrium alginat 3-6% sebagai peningkat viskositas. Nilai SPF, viskositas dan daya sebar ditetapkan sebagai respon. Lotion yang dihasilkan berwarna coklat, berbentuk semi padat khas lotion, homogen, beraroma khas minyak mawar, pH sesuai syarat SNI dengan tipe emulsi minyak dalam air (M/A).Hasil respon yang diperoleh dari 11 formula menghasilkanÂ  nilai SPF dengan range 6,64 â€“ 14,12, nilai viskositas 10,333 â€“ 13,000 cP yang memenuhi standar SNI, dan nilai daya sebar 6,52 â€“ 7,92 cm. Formula optimum hasil prediksi D-Optimal menggunakan perangkat lunak Design ExpertÂ® 7.1.5 ditetapkan konsentrasi ekstrak 12% dan natrium alginat 3%. Peningkatan konsentrasi ekstrak dan Na. alginat menunjukkan tidak berpengaruh signifikan terhadap ketiga respon.Â </dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2018-10-11</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/174</dc:identifier>
	<dc:identifier>10.25077/jsfk.5.2.72-77.2018</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 5 No. 2 (2018): J Sains Farm Klin, Vol 5 No 2, August 2018; 72-77</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 5 No 2 (2018): J Sains Farm Klin 5(2), Agustus 2018; 72-77</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/174/137</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/175</identifier>
				<datestamp>2019-06-30T21:21:47Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The impact of brief counseling on fat consumption in hypertensive patients at  dr. H. Moch Ansari Saleh hospital Banjarmasin</dc:title>
	<dc:title xml:lang="id-ID">Pengaruh Brief Counseling Terhadap Konsumsi Lemak Pada Pasien Hipertensi di RSUD  dr. H. Moch Ansari Saleh Banjarmasin</dc:title>
	<dc:creator>Aryzki, Saftia</dc:creator>
	<dc:creator>Akrom, Akrom</dc:creator>
	<dc:subject xml:lang="id-ID">hypertensive patients</dc:subject>
	<dc:subject xml:lang="id-ID">brief conseling-5A</dc:subject>
	<dc:subject xml:lang="id-ID">fat Intake</dc:subject>
	<dc:subject xml:lang="id-ID">food frequency questionnaire (FFQ)</dc:subject>
	<dc:subject xml:lang="en-US">hipertensi</dc:subject>
	<dc:subject xml:lang="en-US">brief conseling-5A</dc:subject>
	<dc:subject xml:lang="en-US">asupan lemak</dc:subject>
	<dc:subject xml:lang="en-US">food frequency questionnaire (FFQ)</dc:subject>
	<dc:description xml:lang="en-US">Behavior of patients with high fat intake may lead to inadequate treatment goals resulting in decreased quality of life of hypertensive patients. The objective of this study was to investigate the effect of brief counseling-5A on fat intake in outpatient hypertensive patients at H. Moch.Ansari Saleh General Hospital Banjarmasin.This study is a quasi-experimental study using two group pretest and postest with prospective data retrieval.Subjects meeting the inclusion criteria of 68 patients into two groups of 34 intervention patients and 34 non-intervention patients. Exclusion criteria were patients with conditions of pregnancy, deafness and absenteeism at subsequent visits.Data collection was done by conducting interviews and filling out questionnaires on the level of medical behavior, Food Frequency Questionnaire (FFQ) questionnaire.The results showed that giving a brief counseling-5A can change the behavior of patients to fat intake in the treatment group patients changed significantly with an average increase of Î”1 = -33.52 Â± 24.57 and p = 0.985, at Î”2 = -15.94 Â± 17.11 and p = 0.053. It was concluded that a 5un brief counseling of hypertensive patients could positively alter the patientâ€™s behavior in the fat intake of hypertensive patients.</dc:description>
	<dc:description xml:lang="id-ID">Perilaku pasien dengan asupan lemak tinggi yang dapat menyebabkan tidak tercapainya tujuan terapi sehingga terjadi penurunan kualitas hidup pasien hipertensi. Penelitian bertujuan untuk mengetahui pengaruh brief counseling-5A terhadap asupan lemak pada pasien hipertensi rawat jalan di RSUD H. Moch.Ansari Saleh Banjarmasin. Penelitian ini merupakan studi kuasi-eksperimental dengan menggunakan two group pretest and postest dengan pengambilan data secara prospektif. Subjek yang memenuhi kriteria inklusi sejumlah 68 pasien menjadi dua kelompok yaitu 34 pasien intervensi dan 34 pasien tidak intervensi. Kriteria eksklusi adalah pasien dengan kondisi hamil, tuli dan tidak hadir pada kunjungan berikutnya. Pengumpulan data dilakukan dengan melakukan wawancara dan pengisian kuesioner tingkat perilaku berobat, kuesioner Food Frequency Questionnaire (FFQ). Hasil penelitian menunjukan bahwa pemberian brief counseling-5A dapat merubah perilaku pasien terhadap asupan lemak pada pasien kelompok perlakuan mengalami perubahan secara signifikan dengan rata-rata nilai peningkatan Î”1= -33,52Â±24,57 dan p=0,985, pada Î”2=-15,94Â±17,11 dan p=0,053. Disimpulkan bahwa brief counseling-5A pasien hipertensi secara positif dapat merubah perilaku pasien dalam asupan lemak pasien hipertensi.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2018-04-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/175</dc:identifier>
	<dc:identifier>10.25077/jsfk.5.1.33-40.2018</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 5 No. 1 (2018); 33-40</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 5 No 1 (2018): J Sains Farm Klin 5(1), April 2018; 33-40</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/175/135</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/178</identifier>
				<datestamp>2019-06-30T21:21:47Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Characterization and antioxidant activity study of sappan wood (Caesalpinia sappan L.) ethanol extract</dc:title>
	<dc:title xml:lang="id-ID">Karakterisasi dan Studi Aktivitas Antioksidan dari Ekstrak Etanol Secang (Caesalpinia sappan L.)</dc:title>
	<dc:creator>Febriyenti, Febriyenti</dc:creator>
	<dc:creator>Suharti, Netty</dc:creator>
	<dc:creator>Lucida, Henny</dc:creator>
	<dc:creator>Husni, Elidahanum</dc:creator>
	<dc:creator>Sedona, Olivia</dc:creator>
	<dc:subject xml:lang="id-ID">Caesalpinia sappan L.</dc:subject>
	<dc:subject xml:lang="id-ID">secang</dc:subject>
	<dc:subject xml:lang="id-ID">antioksidan</dc:subject>
	<dc:subject xml:lang="id-ID">fenolik total</dc:subject>
	<dc:subject xml:lang="en-US">Caesalpinia sappan L.</dc:subject>
	<dc:subject xml:lang="en-US">sappan wood</dc:subject>
	<dc:subject xml:lang="en-US">antioxidant</dc:subject>
	<dc:subject xml:lang="en-US">total phenolic</dc:subject>
	<dc:description xml:lang="en-US">Sappan wood (Caesalpinia sappan L.) is traditionally used to treat various diseases. Sappan wood contains phenolic compounds such as gallic acid, brazilin and brazilein. The purposes of this study were to characterize the Sappan wood simplecia and ethanol extract, evaluate the total phenolic content and determine the antioxidant activity of Sappan wood ethanol extract. Characterization of Sappan wood simplicia obtained by loss of drying equal to 10.349 %, water soluble compounds was 3.293 %, ethanol soluble compounds wasÂ  6.026 %, total ash content was 0.6509% and ash content insoluble in acid was 0.480 %. Characterization of Sappan wood ethanol extract obtained total ash content was 1.26 %, ash content insoluble in acid was 0.059 % and water content yielded 8.63 %. The total phenolic content of Sappan wood ethanol extract was 71.144 g / 100g.Â  The higher of the total phenolic content, the higher the antioxidant activity. The antioxidant activity of ethanol extract of wood secang was determined by FRAP (Ferric Reducing Antioxidant Power) method and the result was 13.99 mmol Fe (II) / 100g.</dc:description>
	<dc:description xml:lang="id-ID">Secang (Caesalpinia sappan L.) secara tradisional digunakan untuk mengobati berbagai penyakit. Secang mengandung senyawa fenolik seperti asam gallat, brazilin dan brazilein. Tujuan penelitian ini adalah untuk mengkarakterisasi simplisia dan ekstrak etanol secang, mengevaluasi kandungan fenolik total dan menentukan aktivitas antioksidan ekstrak etanol secang. Karakterisasi simplisia secang diperoleh susut pengeringan sebesar 10,349 %, kadar sari larut air sebesar 3,293 %, kadar sari larut etanol sebesar 6,026 %, kadar abu total sebesar 0,6509 % dan kadar abu tidak larut asam simplisia adalah sebesar 0,480 %. Karakterisasi ekstrak etanol secang diperoleh kadar abu total sebesar 1,26 %, kadar abu tidak larut asam ekstrak sebesar 0,059 %, kadar air ekstrak didapatkan hasil 8,63 %. Kadar fenolik total ekstrak etanol secang adalah 71,144 g/100g. Semakin tinggi kadar fenolik total, maka semakin tinggi pula aktivitas antioksidannya. Aktivitas antioksidan ekstrak etanol secang ditentukan dengan metode FRAP (Ferric Reducing Antioxidant Power) dan hasilnya adalah 13,99 mmol Fe(II)/100g.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2018-04-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/178</dc:identifier>
	<dc:identifier>10.25077/jsfk.5.1.23-27.2018</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 5 No. 1 (2018); 23-27</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 5 No 1 (2018): J Sains Farm Klin 5(1), April 2018; 23-27</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/178/130</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/189</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Interaction of sambiloto extract (Andrographis paniculata (Burm.F.)Nees)  with glibenclamide towards CYP3A4 gene expression in HEPG2 cell line</dc:title>
	<dc:title xml:lang="id-ID">Interaksi Ekstrak Sambiloto (Andrographis paniculata (Burm.F.)Ness) dengan Glibenklamid terhadap Ekspresi Gen CYP3A4 pada Kultur Sel HepG2</dc:title>
	<dc:creator>Shofa, Andzar Fikranus</dc:creator>
	<dc:creator>Purba, Anny Victor</dc:creator>
	<dc:creator>Setyahadi, Siswa</dc:creator>
	<dc:subject xml:lang="id-ID">HepG2</dc:subject>
	<dc:subject xml:lang="id-ID">CYP3A4</dc:subject>
	<dc:subject xml:lang="id-ID">ekspresi gen</dc:subject>
	<dc:subject xml:lang="id-ID">sambiloto</dc:subject>
	<dc:subject xml:lang="id-ID">glibenklamid</dc:subject>
	<dc:subject xml:lang="id-ID">diabetes melitus.</dc:subject>
	<dc:subject xml:lang="en-US">HepG2</dc:subject>
	<dc:subject xml:lang="en-US">CYP3A4</dc:subject>
	<dc:subject xml:lang="en-US">gene expression</dc:subject>
	<dc:subject xml:lang="en-US">sambiloto</dc:subject>
	<dc:subject xml:lang="en-US">glibenclamide</dc:subject>
	<dc:subject xml:lang="en-US">diabetes mellitus</dc:subject>
	<dc:description xml:lang="en-US">ABSTRACT: Diabetes mellitus is one of the chronic metabolic diseases characterized by hyperglycemia. Various therapies are done to overcome hyperglycemia, either with oral antidiabetic drugs or plants that have antidiabetic properties. Sambiloto (Andrographis paniculata (Burm.F.)Ness) is one of antidiabetic plants that is widely used by Indonesian people. However, in many cases, the combination of herbs with synthesis drugs causes interaction when used at the same time. This study was aimed to obtain interaction data of the sambiloto extract with glibenclamide towards CYP3A4 gene expression in HepG2 cell line. The results of this study showed a decreased in the expression of CYP3A4 gene in a single sample test as well as a combination sample at concentrations of 50 and 100 Î¼g/mL for green chiretta extract, glibenclamide and its combination decreased CYP3A4 gene expression respectively 0,82, 0,70; 0,89, 0,53; 0,84, 0,72. It can be concluded there is a decreased in the expression of CYP3A4 gene along with the increase of sample concentration.</dc:description>
	<dc:description xml:lang="id-ID">Diabetes melitus (DM) merupakan salah satu penyakit metabolik kronis yang ditandai dengan hiperglikemia. Berbagai terapi dilakukan untuk mengatasi hiperglikemia, baik dengan menggunakan obat antidiabetes oral maupun tanaman herbal berkhasiat antidiabetes. Sambiloto (Andrographis paniculata (Burm.F.)Nees) merupakan salah satu herbal antidiabetes yang banyak dikonsumsi masyarakat Indonesia. Andrografolida merupakan zat aktif yang terdapat dalam sambiloto yang berperan sebagai agen antidiabetes. Namun, dalam banyak kasus kombinasi antara herbal dan obat sintesis menyebabkan interaksi jika digunakan pada waktu bersamaan. Penelitian ini bertujuan untuk memperoleh data interaksi ekstrak etanol herba sambiloto dengan glibenklamid terhadap ekspresi gen CYP3A4 pada kultur sel HepG2. Hasil penelitian ini menunjukkan bahwa terjadi penurunan ekspresi gen CYP3A4 pada pengujian sampel tunggal maupun kombinasi antara ekstrak etanol herba sambiloto dan glibenklamid dengan bertambahnya konsentrasi. Pada konsentrasi 50 dan 100 Î¼g/mL sambiloto, glibenklamid, dan kombinasinya menyebabkan penurunan ekspresi gen CYP3A4 sekitar 0,82, 0,70; 0,89, 0,53; 0,84, 0,72. Berdasarkan hasil tersebut dapat disimpulkan terjadi penurunan ekspresi gen CYP3A4 dengan bertambahnya konsentrasi sampel.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/189</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.189</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 73-78</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 73-78</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/189/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/194</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Comparison of SYBR Green and hydrolysis probe in analyzing porcine and bovine gelatin DNA using real time PCR</dc:title>
	<dc:title xml:lang="id-ID">Perbandingan Metode SYBR Green dan Hydrolysis Probe dalam Analisis DNA Gelatin Sapi dan Gelatin Babi Menggunakan Real Time Polymerase Chain Reaction</dc:title>
	<dc:creator>Zilhadia, Zilhadia</dc:creator>
	<dc:creator>Izzah, Afifah Nurul</dc:creator>
	<dc:creator>Betha, Ofa Suzanti</dc:creator>
	<dc:subject xml:lang="id-ID">Gelatin</dc:subject>
	<dc:subject xml:lang="id-ID">SYBR Green</dc:subject>
	<dc:subject xml:lang="id-ID">Hydrolysis Probe</dc:subject>
	<dc:subject xml:lang="id-ID">Real Time PCR</dc:subject>
	<dc:subject xml:lang="en-US">gelatin</dc:subject>
	<dc:subject xml:lang="en-US">SYBR green</dc:subject>
	<dc:subject xml:lang="en-US">hydrolysis probe</dc:subject>
	<dc:subject xml:lang="en-US">real time PCR</dc:subject>
	<dc:description xml:lang="en-US">Gelatin has a large application in the food, pharmaceutical and cosmetics industries. Gelatin is mostly derived from the skin or bone of porcine and bovine. Porcine gelatin is forbidden for Muslim and Jews. For this reason, analytical methods to detect gelatin are needed to make sure the source of gelatin. One of the analytical techniques that can differentiate bovine and porcine gelatin is Real Time Polymerase Chain Reaction (PCR). There are two popular methods of fluorescence dye, namely SYBR green and hydrolysis probe. This study was conducted to compare SYBR green and hydrolysis probe method in analyzing porcine and bovine gelatin DNA using Real Time PCR. The DNA was isolated by commercial kit. The obtained porcine and bovine gelatin DNA were 19.38 ng/Î¼l and 13.63 ng/Î¼l with purity were 1,566 and 1,573, respectively. Then, isolated DNA was analyzed by SYBR green and hydrolysis methods. SYBR green methods was done by annealing temperature of 65 oC for bovine primer and 60 oC for porcine primer. Therefore, hydrolysis probe methods were analyzed by annealing temperature of 60 oC for both porcine primer and bovine primer. The result showed that the hydrolysis probe was higher specificity to identify of porcine and bovine gelatin DNA than SYBR green method.</dc:description>
	<dc:description xml:lang="id-ID">Pemanfaatan gelatin secara luas menimbulkan kontroversi dan kekhawatiran bagi masyarakat muslim karena pada umumnya gelatin terbuat dari kulit babi dan sapi. Salah satu teknik analisis yang dapat membedakan gelatin sapi dan gelatin babi adalah Real Time Polymerase Chain Reaction (PCR). Real Time PCR merupakan metode analisis berbasis DNA yang handal, efektif, dan terpecaya. Dalam analisis kualitatif dan kuantitatif, Real Time PCR membutuhkan pewarna fluoresens. Pewarna fluoresens yang umum digunakan adalah SYBR green dan hydrolysis probe. Telah dilakukan perbandingan antara metode SYBR green dan hydrolysis probe dalam analisis DNA gelatin menggunakan Real Time PCR. DNA pada gelatin diisolasi menggunakan kit komersial. Isolat DNA gelatin sapi dan DNA gelatin babi didapatkan sebanyak 19,38 ng/Î¼l dan 13,63 ng/Î¼l dengan kemurnian 1,566 dan 1,573. Isolat DNA yang dianalisis dengan metode SYBR green menggunakan suhu annealing 65o C untuk primer sapi dan suhu annealing 60o C untuk primer babi. Isolat DNA yang dianalisis dengan metode hydrolysis probe menggunakan suhu annealing 60o C untuk primer babi dan primer sapi. Hasil analisis dari kedua metode menunjukkan bahwa metode hydrolysis probe lebih spesifik dalam mengidentifikasi DNA pada gelatin dibandingkan menggunakan metode SYBR green.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/194</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.194</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 16-23</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 16-23</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/194/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/195</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Analysis of Î±-mangostin in the herbal drinks of mangosteen rind (Garcinia mangostana L.) by thin layer chromatography-densitometric method</dc:title>
	<dc:title xml:lang="id-ID">Analisis Î±-Mangostin dalam Minuman Herbal  Kulit Buah Manggis (Garcinia mangostana L.) dengan  Metode Kromatografi Lapis Tipis-Densitometri</dc:title>
	<dc:creator>Andayani, Regina</dc:creator>
	<dc:creator>Ismed, Friardi</dc:creator>
	<dc:subject xml:lang="id-ID">Î±-mangostin</dc:subject>
	<dc:subject xml:lang="id-ID">Garcinia mangostana L</dc:subject>
	<dc:subject xml:lang="id-ID">minuman herbal</dc:subject>
	<dc:subject xml:lang="id-ID">KLT densitometri.</dc:subject>
	<dc:subject xml:lang="en-US">Î±-mangostin</dc:subject>
	<dc:subject xml:lang="en-US">Garcinia mangostana L</dc:subject>
	<dc:subject xml:lang="en-US">herbal drinks</dc:subject>
	<dc:subject xml:lang="en-US">tlc densitometry.</dc:subject>
	<dc:description xml:lang="en-US">Some herbal formulation containing Î±-mangostin as a marker compound in the pericarp of the mangosteen (Garcinia mangostana L.) are marketed now in Indonesia. The determination of the component of preparation both qualitatively and quantitatively is essential to ensure quality of the product. This research is aimed to develop a TLC (Thin Layer Chromatography)-densitometry method to analyze Î±-mangostin in the herbal drinks of mangosteen rind. The analysis was performed with TLC Scanner using Camag TLC Scanner 4 with Wincats software. Silica gel 60 F254 (Merck) plates (20x20 cm: 200 Î¼m thickness) were used as stationary phase and mixture of chloroform and ethyl acetate (9:1,v/v) as a mobile phase. The developed chromatogram was scanned at 316 nm, the wavelength of maximum absorption for Î±-mangostin. At this condition, the Rf value of Î±-mangostin is 0.48. Regression analysis of the calibration data showed an excellent linear relationship between peak-area vs drug concentration. Linearity was found to be in the range of 50-400 Âµg/mL. The suitability of developed TLC densitometry method for estimation of Î±-mangostin was established by validating it as per the ICH guidelines. The limits of detection (LOD) and quantification (LOQ) for Î±-mangostin were found to be 54.38 Î¼g/mL and 181.28 Î¼g/mL. The developed method was found to be linear (r=0,99415), precise (RSD &amp;lt;1.28 % and &amp;lt; 2.39 % for intra-day and inter-day precision) and accurate (mean recovery of 90.04%). Results of the samples analysis showed that sample A does not contain Î±-mangostin, whereas sample B and C contain Î±-mangostin. The average concentrations obtained for samples B and C were 0.040% w/v and 0.118% w/v, respectively. The developed method has been successfully applied for the determination of Î±-mangostin in the herbal drinks of mangosteen rind.</dc:description>
	<dc:description xml:lang="id-ID">Beberapa formulasi herbal yang mengandung Î±-mangostin sebagai senyawa penanda pada kulit buah manggis (Garcinia mangostana L.) sekarang dipasarkan di Indonesia. Penentuan kadar senyawa penanda secara kualitatif dan kuantitatif penting untuk memastikan kualitas produk. Penelitian ini bertujuan untuk mengembangkan metode Kromatografi Lapis Tipis (KLT) densitometri untuk menganalisis Î±-mangostin pada minuman herbal kulit buah manggis. Analisis dilakukan dengan TLC Scanner menggunakan Camag TLC Scanner 4 dengan software Wincats. Pelat silika gel 60 F254 (Merck) (ketebalan 20x20 cm: 200 Î¼m) digunakan sebagai fase diam dan kloroform-etil asetat (9:1,v/v) sebagai fase gerak. Kromatogram yang dikembangkan dipindai pada 316 nm yaitu panjang gelombang serapan maksimum untuk Î±-mangostin. Pada kondisi ini, nilai Rf adalah 0,48. Analisis regresi data kalibrasi menunjukkan hubungan linier antara luas area di bawah puncak vs konsentrasi. Linearitas ditemukan berada pada kisaran 50-400 Î¼g/mL. Kesesuaian metode KLT densitometri yang dikembangkan untuk estimasi Î±-mangostin ditetapkan dengan memvalidasinya sesuai dengan pedoman ICH. Batas deteksi (LOD) dan kuantifikasi (LOQ) untuk Î±-mangostin ditemukan 54,38 Î¼g/mL dan 181,28 Î¼g/mL. Metode yang dikembangkan ditemukan linier (r = 0,99415), tepat (RSD &amp;lt;1,28% dan &amp;lt;2,39% untuk presisi intra hari dan antar hari), dan akurat (rata-rata perolehan kembali 90,04%). Hasil analisis sampel menunjukkan bahwa sampel B dan C mengandung Î±-mangostin, sedangkan sampel A tidak. Rata-rata kadar yang diperoleh untuk sampel B dan C masing-masing adalah 0,040% b/v dan 0,188% b/v. Metode yang dikembangkan telah berhasil diterapkan untuk penentuan Î±-mangostin dalam minuman herbal kulit manggis.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/195</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.195</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 61-66</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 61-66</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/195/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/197</identifier>
				<datestamp>2019-06-30T21:24:28Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Dissolution rate improvement of genistein by amorphous solid dispersion in PVP K-30</dc:title>
	<dc:title xml:lang="id-ID">Peningkatan Laju Disolusi Dispersi Padat Amorf Genistein dengan PVP K-30</dc:title>
	<dc:creator>Zaini, Erizal</dc:creator>
	<dc:creator>Putri, Vike Zulia</dc:creator>
	<dc:creator>Octavia, Maria Dona</dc:creator>
	<dc:creator>Ismed, Friardi</dc:creator>
	<dc:subject xml:lang="id-ID">genistein</dc:subject>
	<dc:subject xml:lang="id-ID">PVP K-30</dc:subject>
	<dc:subject xml:lang="id-ID">dispersi padat</dc:subject>
	<dc:subject xml:lang="id-ID">laju disolusi.</dc:subject>
	<dc:subject xml:lang="en-US">genistein</dc:subject>
	<dc:subject xml:lang="en-US">PVP K-30</dc:subject>
	<dc:subject xml:lang="en-US">solid dispersion</dc:subject>
	<dc:subject xml:lang="en-US">dissolution rate</dc:subject>
	<dc:description xml:lang="en-US">Amorphous solid dispersions of a poorly water-soluble drug genistein in PVP K-30 were prepared by solvent co-evaporation technique using organic solvent methanol. Solid dispersions system was prepared with several variations of drug to polymer 2:1, 1:1 dan 1:2 w/w. Solid state properties of solid dispersion system were evaluated by powder X-ray diffraction, Fourier transform infrared spectroscopy, and differential scanning calorimetry, and microscopic SEM. Dissolution rate profile were conducted in distilled water medium by using dissolution tester apparatus type II USP. Base on X-ray diffractometry analysis, differential scanning calorimetry and microscopic SEM, crystalline phase of genistein decreased in crystallinity index and formation of amophous state. Dissolution rate profile showed that genistein in amorphous solid dispersion had a faster dissolution rate in comparison to intact genistein. This study proved that preparation of solid dispersion of genistein in PVP K-30 is an effective approach to improve dissolution rate of genistein.</dc:description>
	<dc:description xml:lang="id-ID">Sistem dispersi padat amorf senyawa obat yang sukar larut air genistein dalam PVP K-30 dibuat dengan metode penguapan pelarut menggunakan pelarut metanol. Sistem dispersi padat dibuat dengan variasi perbandingan obat : polimer 2:1, 1:1 dan 1:2 b/b. Sifat padatan serbuk sistem dispersi padat dievaluasi dengan metode analisa difraksi sinar-X, termal DSC, spektrokopik FT-IR dan mikroskopik SEM. Profil disolusi dilakukan dalam medium air suling dengan alat uji disolusi tipe II USP. Hasil analisa difraksi sinar-X, termal DSC dan mikroskopik SEM, fase kristalin genistein mengalami penurunan derajat kristalinitas dan pembentukan fase amorf. Profil laju disolusi menunjukkan bahwa sistem dispersi padat genistein memiliki laju disolusi yang lebih tinggi dibandingkan genistein murni. Studi ini membuktikan bahwa pembentukan sistem dispersi padat genistein dengan polimer PVP K-30 efektif memperbaiki laju disolusi genistein.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2017-12-15</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/197</dc:identifier>
	<dc:identifier>10.29208/jsfk.2017.4.1.197</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 4 No. 1 (2017); 67-72</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 4 No 1 (2017): J Sains Farm Klin 4(1), November 2017; 67-72</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/197/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2017 Jurnal Sains Farmasi &amp; Klinis</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<record>
			<header>
				<identifier>oai:ojs.pkp.sfu.ca:article/199</identifier>
				<datestamp>2019-06-30T21:21:47Z</datestamp>
				<setSpec>jsfk:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc
	xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/
	http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Solid dispersion of usnic acid prepared by a freeze drying technique using poloxamer 188 as the polymer</dc:title>
	<dc:title xml:lang="id-ID">Dispersi Padat Asam Usnat dengan Teknik Freeze Drying menggunakan Poloxamer 188 sebagai Polimer</dc:title>
	<dc:creator>Noviza, Deni</dc:creator>
	<dc:creator>Fitriani, Lili</dc:creator>
	<dc:creator>Fauzi, Riana Zikra</dc:creator>
	<dc:subject xml:lang="id-ID">asam usnat</dc:subject>
	<dc:subject xml:lang="id-ID">poloxamer 188</dc:subject>
	<dc:subject xml:lang="id-ID">dispersi padat</dc:subject>
	<dc:subject xml:lang="id-ID">kelarutan</dc:subject>
	<dc:subject xml:lang="en-US">usnic acid</dc:subject>
	<dc:subject xml:lang="en-US">Poloxamer 188</dc:subject>
	<dc:subject xml:lang="en-US">Solid dispersion</dc:subject>
	<dc:subject xml:lang="en-US">Solubility</dc:subject>
	<dc:subject xml:lang="en-US">dissolution</dc:subject>
	<dc:description xml:lang="en-US">This study aimed to improve the solution of usnic acid, a poorly soluble drug using solid dispersions (SDs). The SDs were prepared by a freeze-drying technique with poloxamer 188 as a polymer. The physicochemical properties of the SDs were characterized using X-ray diffractometry (XRD) and Fourier transform-infrared (FT-IR) spectroscopy, Scanning Electron Microscopy (SEM),. In addition, drug content, solution test and dissolution profileÂ  was evaluated by using usnic acid (pure drug) and physical mixture as a reference. The results fromÂ  XRD and SEM showed that usnic acid was molecularly dispersed in the SDs as an amorphous form. The FT-IR results suggested that intermolecular hydrogen bonding had formed between usnic acid and its carriers. The result of solubility test showed that solubility of solid dispersions 1:1; 1:2; 2:1 (5.80 Âµg/ml; 6.94 Âµg/ml ; 4.88 Âµg/ml) were higher than the physical mixture 1:1 ( 0.39 Âµg/mL) and pure asam usnat have the lowest solubility (0.34 Âµg/mL). In conclusion, SDs prepared by a freeze-drying technique used poloxamer as a polymer can be used to enhance solubility of usnic acid</dc:description>
	<dc:description xml:lang="id-ID">Tujuan dari penelitian ini adalah untuk meningkatkan kelarutan dari asam usnat yang memiliki kelarutan rendah di dalam air dengan menggunakan metode solid dispersi. Metode solid dispersi yang digunakan adalah teknik freeze drying dengan menggunakan poloxamer 188 sebagai polimer. Karakteristik dispersi padat yang terbentuk dilakukan dengan analisis difraksi sinar-X (XRD), Fourier Transform Infra Red (FTIR), Scanning Electron Microscopy (SEM). Lebih lanjut, penetapan kadar, uji kelarutan dan profil disolusi dilakukan dengan menggunakan asam usnat murni dan campuran fisik sebagai pembanding. Dari hasil XRD dan SEM menunjukkan bahwa asam usnat terdispersi dalam poloxamer dalam bentuk amorf.Â  Hasil FTIR menunjukkan asam usnat membentuk ikatan hidrogen dengan poloxamer 188. Hasil uji kelarutan menunjukkan kelarutan dispersi padat 1:1; 1:2; 2:1 (5,80 Âµg/ml; 6,94 Âµg/ml; 4,88 Âµg/ml) lebih tinggi dibandingkan campuran fisik 1:1 (0,39 Âµg/ml) dan asam usnat murni memiliki kelarutan yang paling rendah (0,34 Âµg/ml). Kesimpulannya dispersi padat dengan menggunakan poloxamer 188 dengan menggunakan teknik freeze drying dapat meningkatkan kelarutan dari asam usnat.</dc:description>
	<dc:publisher xml:lang="en-US">Fakultas Farmasi Universitas Andalas</dc:publisher>
	<dc:date>2018-04-30</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/199</dc:identifier>
	<dc:identifier>10.25077/jsfk.5.1.41-48.2018</dc:identifier>
	<dc:source xml:lang="en-US">Jurnal Sains Farmasi &amp; Klinis; Vol. 5 No. 1 (2018); 41-48</dc:source>
	<dc:source xml:lang="id-ID">JSFK (Jurnal Sains Farmasi &amp; Klinis); Vol 5 No 1 (2018): J Sains Farm Klin 5(1), April 2018; 41-48</dc:source>
	<dc:source>2442-5435</dc:source>
	<dc:source>2407-7062</dc:source>
	<dc:language>ind</dc:language>
	<dc:relation>https://jsfk.ffarmasi.unand.ac.id/index.php/jsfk/article/view/199/132</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2018 Deni Noviza</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		<resumptionToken expirationDate="2026-04-04T22:32:33Z"
			completeListSize="370"
			cursor="0">3287c5096ae8ba277e18d8711d65ff71</resumptionToken>
	</ListRecords>
</OAI-PMH>
